Loyola University Chicago

Loyola eCommons
Dissertations

Theses and Dissertations

2011

Gestational Diabetes, Depression, and the Impact on Maternal
Child Health Outcomes
Mary Alice Byrn
Loyola University Chicago

Follow this and additional works at: https://ecommons.luc.edu/luc_diss
Part of the Nursing Commons

Recommended Citation
Byrn, Mary Alice, "Gestational Diabetes, Depression, and the Impact on Maternal Child Health Outcomes"
(2011). Dissertations. 193.
https://ecommons.luc.edu/luc_diss/193

This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons.
It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more
information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 2011 Mary Alice Byrn

LOYOLA UNIVERSITY CHICAGO

GESTATIONAL DIABETES, DEPRESSION,
AND THE IMPACT ON MATERNAL CHILD HEALTH OUTCOMES

A DISSERTATION SUBMITTED TO
THE FACULTY OF THE GRADUATE SCHOOL
IN CANDIDACY FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY

PROGRAM IN NURSING

BY
MARY ALICE BYRN
CHICAGO, ILLINOIS
AUGUST 2011

Copyright by Mary Alice Byrn, 2011
All rights reserved

ACKNOWLEDGMENTS
I would like to acknowledge the people that have made this dissertation possible.
I would like to thank the nurses in the outpatient obstetric clinics that were incredibly
helpful through data collection. The nurses made participant recruitment a joy by
welcoming me into the clinic and working with me. I would like to thank Julia Havey
who spent the time to assist in data extraction from the electronic medical record. I
would also like to thank my statistician, Patrick Harrison.
The staff in the School of Nursing made the past six years easier by always being
friendly and answering my questions. Thanks to all of the faculty who had me in class,
inquired about my progress in the program, or exchanged a friendly smile with me in the
hallway. I appreciate the role you played in my education and development as a nurse
researcher.
I would like to thank the members of my committee: Dr. Ida Androwich, Dr.
Penny Marzalick, and Dr. Pat Mumby. This process and work were much improved
through your expertise and guidance. I appreciate your time and service.
Dr. Sue Penckofer, my dissertation chair, was instrumental in the completion of
this dissertation. Dr. Penckofer has spent countless hours in the past four years
mentoring me and teaching me the world of Nursing research. Not only has Dr.
Penckofer impacted my nursing career, but also my personal life. For that, I am forever
grateful.
iii

To my friend Jan, I appreciate your support and encouragement. Our phone
conversations always left a smile on my face.
I would not have been able to complete this program without the endless love,
support, and encouragement from my family. My father provided IT help, insight into
the world of academia, and constant encouragement. My mother was there to call when I
needed to share good or bad news and she spent hours editing my papers. She was a
listening ear and I could always count on her to help me put things into perspective and
give me endless encouragement.
My seven siblings were always supportive and each of them encouraged me in
their own way. My sister Beth was not just there to assist me with clinical questions, but
was always there to provide her support and encouragement. My sister-in-law, Melissa,
was there to help me clear my mind over a glass of wine, a run, or a pedicure. Thanks to
all my nieces and nephews who constantly bring a smile to my face.
Andres, thank you for being a wonderful man. There are not words to thank you
for your patience, support, and encouragement. Thank you for the balance and happiness
that you have brought to my life.

iv

To my parents, Sally and Steve, who made this all possible.

Knowing is not enough; we must apply. Willing is not enough; we must do.
–Johann Wolfgang von Goethe

TABLE OF CONTENTS
ACKNOWLEDGMENTS

iii

LIST OF TABLES

x

LIST OF FIGURES

xiii

ABSTRACT

xiv

CHAPTER ONE: PROBLEM STATEMENT
Postpartum Depression
Gestational Diabetes
Purpose
Theoretical Framework
Specific Aims

1
3
3
6
6
9

CHAPTER TWO: LITERATURE REVIEW
Risk Factors
Maternal Health Factors
Overall Health
Anxiety
Obstetric Complications
Poor Prenatal Care
Postpartum Depression
Infant Health Factors
Preterm Birth
Maternal-Fetal Attachment
Negative Infant Reactivity
Fetal Heart Rate
Developmental Delay
Sudden Infant Death Syndrome (SIDS)
Antenatal Depression Treatment
Depression and Diabetes
Gestational Diabetes and Depression
Electronic Medical Record

11
12
19
19
20
23
26
28
29
29
31
31
34
35
36
36
38
39
45

CHAPTER THREE: METHODOLOGY
Design
Setting
Sample
Recruitment of Study Participants
Collection of Data
Measurements
Human Subjects Protection

50
50
51
51
53
54
58
66
vii

CHAPTER FOUR: RESULTS
Description of the Sample
Data Entry
Missing Data
Comparability of Data from Different Sources
Data Analyses of Key Study Variables
Gestational Diabetes
Depression
Anxiety
Stress
Social Support
Medication Use and Chronic Conditions
Correlations
Data Analysis for Study Aims
Data Analysis: Aim 1
Data Analysis: Aim 2
Data Analysis: Exploratory Aim
Data Analysis of Maternal and Infant Health Outcomes

70
70
73
73
75
75
76
77
80
83
85
87
88
91
91
98
107
109

CHAPTER FIVE: DISCUSSION
Description of the Sample
Discussion of the Variables
Depression
Anxiety
Stress
Social Support
Medications
Discussion of Study Aims
Aim 1: Difference in Depression between Women with and without GDM
Aim 2: Difference in Predictive Factors of Depression between Women with
and without GDM
Aim 3: Race and Depression
Other Findings: Maternal and Infant Health Outcomes
Data Quality of the Electronic Medical Record
Summary of Major Findings
Study Limitations
Nursing Implications
Future Research

118
119
120
120
127
128
129
130
131
131
133
137
138
139
141
143
144
146

APPENDIX A: SELF-REPORT QUESTIONNAIRES

149

APPENDIX B: STUDY FLYER

159

APPENDIX C: ELECTRONIC MEDICAL RECORD DATA COLLECTION FORM 161
viii

APPENDIX D: INFORMED CONSENT DOCUMENT

165

APPENDIX E: MISSING DATA

172

APPENDIX F: COMPARABILITY OF DATA FROM DIFFERENT SOURCES

174

APPENDIX G: DATA ANALYSES ASSUMPTIONS

177

APPENDIX H: PRENATAL DEPRESSION AND DEMOGRAPHIC RISK FACTOR181
REFERENCE LIST

184

VITA

195

ix

LIST OF TABLES
Table

Page

1. Data Collection Methods

55

2. Variables and Measurements of Study

59

3. Description of Sample

72

4. Oral Glucose Tolerance Results

77

5. Mean Depression Scores

78

6. Item Means on the Center for Epidemiologic Studies Scale (CES-D)

79

7. Item Means on the Edinburgh Postpartum Depression Scale (EPDS)

80

8. Mean Anxiety Scores

81

9. Item Means on the State Anxiety Scale

82

10. Item Means on the Trait Anxiety Scale

83

11. Mean Perceived Stress Scores

84

12. Item Means on the Perceived Stress Scale

84

13. Mean Overall Social Support and Subscale Scores

86

14. Item Means on the Multidimensional Perceived Social Support Scale

86

15. Medication Use

87

16. Chronic Conditions

87

17. Correlations between Key Variables

90

x

Table

Page

18. Fisher’s Exact Test for Depression (CES-D)

92

19. Fisher’s Exact Test for Depression (EPDS)

92

20. Independent T-Tests for Depression Measures

93

21. Gestational Diabetes Predicting Depression (CES-D)

95

22. Gestational Diabetes Predicting Depression (EPDS)

96

23. Gestational Diabetes Predicting Depression (CES-D)

96

24. Gestational Diabetes Predicting Depression (EPDS)

97

25. History of Depression Predicting Gestational Diabetes

97

26. History of Depression Predicting Gestational Diabetes

98

27. Multiple Regression with Depression (CES-D) as Outcome

100

28. Multiple Regression with Interaction Terms for Depression (CES-D)
as Outcome

101

29. Predictors of Depression (CES-D) for Women with and without
Gestational Diabetes

103

30. Multiple Regression for Depression (EPDS) as Outcome

104

31. Multiple Regression with Interaction Terms and Depression (EPDS)
as Outcome

105

32. Predictors of Depression (EPDS) for Women with and without
Gestational Diabetes

106

33. Independent T-Tests for Race (CES-D and EPDS)

109

34. Delivery Outcomes for Women with and without Gestational Diabetes

111

35. Delivery Outcomes for Women with and without Depression

112

36. Independent T-Tests for Infant Outcomes in Women with and without
Gestational Diabetes

114

xi

Table

Page

37. Independent T-Tests for Infant Outcomes in Women with and without
Depression (CES-D)

116

38. Independent T-Tests for Infant Outcomes in Women with and without
Depression (EPDS)

116

39. Prenatal Depression Research (CES-D)

122

40. Prenatal Depression Research (EPDS)

125

xii

LIST OF FIGURES
Figure

Page

1. The Biopsychosocial Model for the Study of Depression and
Gestational Diabetes
2. Enrollment Flow Diagram

9
71

xiii

ABSTRACT
Antenatal depression occurs in about 20% of all pregnancies and gestational
diabetes occurs in up to 14% of all pregnancies. Although there is sufficient information
on (1) depression during pregnancy and (2) depression and diabetes, there is little
information about depression and gestational diabetes. This comparative, longitudinal
research study was done to better understand the relationship between gestational
diabetes and depression. The study aims were the following: (1) to determine whether
women with gestational diabetes had more depression than women without gestational
diabetes, (2) to determine whether factors predictive of depression in pregnant women
with gestational diabetes were different from women without gestational diabetes, and (3)
to determine if minorities were more at risk for depression during pregnancy than
Caucasians. The sample included 135 pregnant women between 24 and 40 weeks’
gestation, of which 65 had gestational diabetes (GDM) and 70 had no gestational diabetes
(NGDM). Depression, anxiety, stress, and social support were measured using selfreport questionnaires completed during a prenatal care visit. Delivery outcomes were
collected from the electronic medical record. Using the CES-D, 28% of the entire sample
had depression and 32% of women with GDM had depression compared to 24% of
women with NGDM, although the difference was not statistically significant. However,
women with GDM were 2.7 times more likely to have depression (OR=2.72, 95% CI,
1.04, 7.13, p =.041).
xiv

Also, women with GDM were 3.07 times as likely to have a history depression
(OR=3.07, 95% CI, 1.01, 9.49, p = .05). Trait anxiety was found to be a significant
predictor of prenatal depression (p<.001). No significant difference was found between
race and depression. There were no clinically significant findings in delivery outcomes
between women with and without GDM or between women with and without depression.
This study may improve the prenatal care of women with depression and gestational
diabetes during pregnancy.

xv

CHAPTER ONE
PROBLEM STATEMENT
Depression affects approximately 121 million people and is the leading cause of
disability worldwide (World Health Organization, 2009). Depression is more common in
women than in men and is the leading cause of disease burden in developed and
developing countries for women between the ages of 15 and 44 (World Health
Organization, 2009). Since these are the childbearing years for women, the risk of
depression for women during pregnancy and the postpartum period increases.
Although many people believe that women are resistant to becoming depressed during
pregnancy, at least 20% of women are depressed during pregnancy (Bonari et al., 2004).
Some studies have reported depression rates as high as 45% during pregnancy (Lindgren,
2001; S. Orr, Blazer, & James, 2007; S. T. Orr, Blazer, & James, 2006). Depression
during pregnancy is often called antenatal depression or prenatal depression. An increase
in the percentage of antenatal depression has been reported in women with low social
support (C. Anderson, Roux, & Pruitt, 2002; Glazier, Elgar, Goel, & Holzapfel, 2004;
Records & Rice, 2007; Sleath et al., 2005; Westdahl et al., 2007), low socioeconomic
status (C. Anderson et al., 2002; T. Field et al., 2002; Glazier et al., 2004; Lindgren,
2001), lower education levels (Glazier et al., 2004; Lindgren, 2001; Marcus, Flynn,
Blow, & Barry, 2003; Rubertsson, Waldenstrom, Wickberg, Radestad, & Hildingsson,
1
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2005; Westdahl et al., 2007), and younger age (Glazier et al., 2004; Lindgren, 2001; S.
T. Orr et al., 2006; Rubertsson et al., 2005). During pregnancy, there is a heightened
inflammatory response and an increase in stress hormones, such as, cortisol (Dayan et al.,
2006). Interestingly, increased cortisol and inflammation markers are also found in
persons with depression (Black, 2006), suggesting a possible physiological mechanisms
for antenatal depression.
Depression is defined and diagnosed clinically according to the DSM-IV.

To

make this diagnosis, at least five of the following symptoms must be present during the
same two week period: (1) depressed mood most of the day, nearly every day; (2)
markedly diminished interest or pleasure in all or almost all activities; (3) significant
weight loss when not dieting or significant weight gain, or decrease or increase in
appetite nearly every day; (4) insomnia or hypersomnia; (5) psychomotor agitation or
retardation; (6) fatigue or loss of energy; (7) feelings of worthlessness or excessive or
inappropriate guilt; (8) diminished ability to think or concentrate, or indecisiveness; and
(9) recurrent thoughts of death, suicidal ideation without a specific plan, or suicide
attempt or a specific plan for committing suicide (American Psychiatric Association,
1994). Also, one of the two symptoms, (1) depressed mood or (2) loss of interest or
pleasure must be included in the five symptoms (American Psychiatric Association,
1994). The symptoms of depression are similar among pregnant and non-pregnant
women. However, pregnant women with depression are less likely to report intense
feelings of suicide and guilt, have less difficulty falling asleep, and are more likely to
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have slowed movement or speech (Manber, Blasey, & Allen, 2008). Although it is
necessary to use the DSM-IV criteria to make a diagnosis of depression, many research
studies use self-report measures to classify participants as depressed.
Postpartum Depression
Postpartum depression is common and occurs in 13% of postpartum women
(O'Hara & Swain, 1996). A meta-analysis of 141 articles on postpartum depression
indicated that low social support, low self-esteem, life stress, fatigue, and a history of
prenatal depression are risk factors for developing postpartum depression (C. T. Beck,
2008a). Another meta-analysis of 59 studies found similar risk factors, but had poor
marital relationship as an additional risk factor (O'Hara & Swain, 1996). Postpartum
depression was found to have a negative effect on mother-infant interactions during the
first year of life (C. T. Beck, 2008b). Also, postpartum depression has a negative effect
on cognitive and emotional development in children (C. T. Beck, 2008b). Postpartum
depression and prenatal depression occur at different points during the birth process and
although related, they are different concepts. Postpartum depression has been extensively
studied and thus, is not the focus of this study (C. T. Beck, 2008a).
Gestational Diabetes
Gestational diabetes is a significant problem in the United States, occurring in
about 7% of all pregnancies (American Diabetes Association, 2010b). However,
gestational diabetes has been found in up to 14% of all pregnancies (Jovanovic & Pettitt,
2001). Recently, it has been documented that there are more than 200,000 pregnancies
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which are complicated by gestational diabetes each year (American Diabetes Association,
2010b). Also, there was a 122% increase in the prevalence of gestational diabetes
between 1989 and 2004 (Getahun, Nath, Ananth, Chavez, & Smulian, 2008). Other
studies have shown an increase in gestational diabetes between 16% and 127% in
different races over the past 20 years (Ferrara, 2007). The increase in gestational diabetes
may be attributed to a modification in the diagnosis standards. These modifications
include an increase in the number of women screened for gestational diabetes and the
lowering of the plasma glucose threshold needed to make a diagnosis of gestational
diabetes (Ferrara, 2007). However, with such a large increase in the prevalence of
gestational diabetes, the increase in obesity has been suggested as a valid reason for the
increase in gestational diabetes (Ferrara, 2007).
Gestational diabetes is defined as glucose intolerance found for the first time
during pregnancy (Buchanan, Xiang, Kjos, & Watanabe, 2007). During pregnancy, the
maternal body goes through many changes. Increased maternal adiposity in early
pregnancy and increased insulin resistance in late pregnancy are physiological reasons
for a woman developing gestational diabetes (Barbour et al., 2007). In gestational
diabetes, the pancreatic β-cells are not able to increase insulin secretion to meet the
demands of the insulin resistant pregnant woman (Buchanan et al., 2007). Gestational
diabetes is diagnosed based on the result of an oral glucose tolerance test. Criteria to
interpret elevated results of the glucose tolerance test are used to diagnosis gestational
diabetes (O'Sullivan, 1980; O'Sullivan & Mahan, 1964).
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Parity, maternal obesity, advanced maternal age, and race are risk factors for
developing gestational diabetes (Casey, Lucas, McIntire, & Leveno, 1997; Ferrara, 2007;
Getahun et al., 2008). Women with gestational diabetes are more likely to deliver a baby
with macrosomia and have an increased risk of a shoulder dystocia during delivery
(Jovanovic & Pettitt, 2001). Also, stillbirth and infant hypoglycemia are increased in
women with gestational diabetes (Getahun et al., 2008).
Women with gestational diabetes were more likely to have a cesarean section
(46%) compared to women without gestational diabetes (32%) (Wier, Witt, Burgess, &
Elixhauser, 2010). Also, the hospital costs related to delivery of infants were 18% more
expensive (about $4,500) for women with gestational diabetes than for women without
gestational diabetes (Wier et al., 2010).
The increased state of insulin resistance in pregnancy that contributes to the
diagnosis of gestational diabetes may also predispose a woman to develop depression.
Lower insulin sensitivity was found in depressed patients, and insulin resistance
improved with depression treatment indicating that increased insulin resistance may be
connected to depression (Lustman, Penckofer, & Clouse, 2007; Okamura et al., 2000).
Hyperglycemia, a complication that occurs with gestational diabetes, has also been found
to be related to depression (Lustman, Anderson, Freedland, de Groot, & Carney, 2000).
Therefore, the combination of increased insulin resistance and hyperglycemia that occurs
with gestational diabetes may increase the chance of depression occurring in women with
gestational diabetes.
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The combined effects of gestational diabetes and depression in pregnant women
increases the chance of multiple complications in mothers and infants. Although there is
potential for increased risk, there has been limited research to study the relationship
between gestational diabetes and depression.
Purpose
The purpose of this study was to determine if women with gestational diabetes are
more likely to suffer from depression. Depression and gestational diabetes are common
occurrences during pregnancy; however, the relationship between the two has not been
extensively studied. Depression occurs in 25% of persons with type 1 and type 2 diabetes
(Lustman et al., 2000). Whether there is more depression in women with gestational
diabetes is unknown. If women with gestational diabetes have more depression, it would
seem that they would be at even greater risks for complications because of their comorbid depression. The factors that predict depression (anxiety, stress, age, income, and
marital status) in both women with and without gestational diabetes were also assessed to
determine if women with gestational diabetes have different predictive factors of
depression than women without gestational diabetes. Lastly, a potential difference in the
prevalence of depression between White and minority women was investigated.
Theoretical Framework
The biopsychosocial model developed by George Engel (1977) was used to guide
the study. This model includes the biological, psychological, and sociological effects
incorporated with disease. In the biopsychosocial model, the biological, psychological,
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and sociological components of a person are all equally important when treating an
illness (Engel, 1977). The biopsychosocial model is holistic in that it explains how a
person can be understood as a whole including the interaction between the components
(Molina, 1983).
The components of the biopsychosocial model are (1) the concept of
multicausality of illness, (2) illness as a dynamic process, (3) holistic understanding of
the human being, and (4) the concept of vulnerability of systems (Molina, 1983). The
concept of multicausality of illness is the idea that an illness is caused by the interaction
of several factors. For example, depression is caused by both biological factors
(neurotransmitters dysfunction) and psychological (learned helplessness or negative
thinking) (Molina, 1983). Illness is a dynamic process rather than a steady state and
changes constantly as biological, psychological, and sociocultural factors interact with
each other and the environment (Molina, 1983). Holistic understanding of the human
being is the belief that body and mind are not separate entities, and that there is complex
interaction between body and mind. These complex interactions need to be considered
when caring for the person as a whole (Molina, 1983). The human being is considered
an open system of complex relationships with the internal and external environment,
which defines the concept of vulnerability. The biological and psychosocial systems
interact with each other and can be affected by a change in the internal or external
environment (Molina, 1983).
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A benefit of the biopsychosocial model is that it allows the researcher or clinician
to consider the person as a whole including quality of life, social role performance, and
emotional status during evaluation of a patient (Fava & Sonino, 2008). The
biopsychosocial model has been used to study depression (Covinsky & Landefeld, 1996)
and diabetes (Peyrot, McMurry, & Kruger, 1999). The factors examined in this study
include psychological, sociological, and biological variables and will be thoroughly
described in Chapter 2. The psychological variables were as follows: depression, history
of depression, anxiety, stress and social support. The sociological variables were as
follows: socioeconomic status, race, ethnicity, and marital status. The biological factors
were as follows: body mass index (BMI), oral glucose tolerance test results, gravida and
parity, presence of delivery complications, type of delivery (vaginal or cesarean section),
gestational age at delivery, Apgar (Appearance, Pulse, Grimace, Activity, Respiration)
scores, and infant weight.
Figure 1 illustrates the biopsychosocial model used for this study.
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Sociological

Psychological
-Depression
-History of Depression
-Anxiety
-Stress
-Social Support

-SES
-Marital Status
-Race
-Ethnicity

Health

Biological
-BMI
-OGTT
-Delivery Type
-Gravida and Parity
-Delivery Complications
-Apgars
-Gestational age
-Birth Weight

Figure 1: The Biopsychosocial Model for the Study of Depression and Gestational
Diabetes

Specific Aims
The primary aims for this study were (1) to determine whether women with
gestational diabetes had more depression than women without gestational diabetes and
(2) to determine whether factors predictive of depression in pregnant women with
gestational diabetes were different from women without gestational diabetes.
Hispanic and African American women are at greater risk for developing
gestational diabetes than Caucasians. One study has found African Americans are more
likely to be depressed during pregnancy (S. T. Orr et al., 2006). However, other studies
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have not shown race to be a significant risk factor for depression during pregnancy
findings (Diego, Field, & Hernandez-Reif, 2005; Marcus et al., 2003; Sleath et al., 2005;
Westdahl et al., 2007). If women with gestational diabetes have more depression, race
may be a significant factor. Therefore, it is important to study these minority populations
in order to determine if a health disparity exists. Thus, an exploratory aim for this study
was to determine if minorities were at more at risk for depression than Caucasians.
In summary, depression and gestational diabetes are common during pregnancy.
There is a known link between type 1 and type 2 diabetes and depression. A possible
relationship between gestational diabetes and depression exists due to the increased
insulin resistance and occurrence of hyperglycemia. However, the relationship between
gestational diabetes and depression has not been extensively studied. The
biopscyhosocial model was the theoretical framework used to guide the study. The study
had three aims: (1) to determine whether women with gestational diabetes had more
depression than women without gestational diabetes, (2) to determine whether factors
predictive of depression in pregnant women with gestational diabetes were different from
women without gestational diabetes, and (3) to determine if minorities were at more at
risk for depression than Caucasians.

CHAPTER TWO
LITERATURE REVIEW
This chapter addresses the biopsychosocial variables that contribute to depression
and gestational diabetes. In order to gain an understanding of these variables, a literature
search was completed. Using CINAHL, Medline, and PsychInfo, articles studying
depression during pregnancy were examined. The time frame from 2002 onward was
selected as this was the time that most literature on depression during pregnancy was
published. The keywords used in the search were as follows: depression, pregnancy,
antepartum, and prenatal. A librarian was also consulted to aid in the search to insure
that the most relevant articles were found. Approximately 120 articles were found in the
search, about 45 articles were included in this literature review. Articles not included
were (1) not written in English, (2) editorials, or (3) focused on postpartum depression.
Most articles excluded were those that focused on postpartum depression which was not
the intent of this study. Eight literature review papers were found on the topic of
depression during pregnancy. The articles included in the review will be summarized and
organized according to risk factors for developing depression during pregnancy, factors
related to maternal health, and factors related to infant health. Evidence from the
literature suggests that depression is a common problem during pregnancy and has an
impact on the health of the mother and infant. It is important that this evidence be
known, so practice can change and the care given to pregnant women improved.
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Risk Factors
The literature review revealed four risk factors most often associated with
depression during pregnancy: (1) decreased social support, (2) low income or
socioeconomic status, (3) low education, and (4) younger age. Race as a risk factor was
found to be inconclusive and will be discussed as well.
The relationship of social support, emotional distress, and stress were examined in
a large cross-sectional, descriptive study (n=2052) (Glazier et al., 2004). Healthy
pregnant women between 15 and 18 weeks’ gestation were requested to complete the
following tools: Perceived Social Support, the Center for Epidemiologic Studies
Depression Scale (CES-D), and the State-Trait Anxiety Inventory (STAI). Results
showed that depression was inversely correlated with education (r=-.21, p<.01) and
income (r=-.24, p<.01), and similar relationships were found with anxiety. Low social
support was related to depression (r=-.32, p<.01) and anxiety (r=-.27, p<.01). Stress was
also significantly related to low social support and having more symptoms of anxiety and
depression. Limitations to this study were the lack of information regarding the racial
distribution of the sample and the cross-sectional design.
Social support and social conflict have been examined as predictors of prenatal
depression (Westdahl et al., 2007). One prospective, longitudinal study examined social
support and social conflict as it relates to depression in women during their second
trimester of pregnancy and followed them to one year postpartum. Social conflict and
social support were found to account for 34% of the variance for depression during
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pregnancy. Although education and relationship status with the infant’s father were the
only socio-demographic variables found to be significant, they accounted for only 5% of
the variance for depression. Women with less education, who were not in a relationship
with the father of the baby, were more likely to be depressed. Low social support and
high social conflict predicted depression and social conflict was more strongly related to
depression (r=.58, p<.01) than social support (r=-.45, p<.01). The finding that social
conflict was a greater predictor of depression suggests that social support may be an
important risk factor when studying depression. One strength of the study included a
diverse sample (80% African American and 13% Hispanic participants); however, its
generalizability to White participants was limited.
Depression and social support have been examined relative to ethnicity (Sleath et
al., 2005). In a study of 73 pregnant women (23 Hispanic, 25 Black, and 25 White)
between 12 and 32 weeks’ gestation, women with lower quality of social interactions as
measured by the Quality of Social Interactions Scale had significantly more depression
(Mean=11.64 ) than those who did not have low social interactions (Mean= 5.53,
p<.001). No significant difference in the incidence of depression (moderate or severe
depression measured by the Beck Depression Inventory-II (BDI-II)) among the ethnic
groups of African Americans (24%), Hispanics (13%), and Whites (20%) was found.
Limitations of the study included the small sample and the lack of an operational
definition of quality of social interactions which made the results difficult to interpret.
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Depression and support were also studied by Anderson, Roux, & Pruitt (2002).
In a sample of 31 women between 32 and 39 weeks’ gestation, 29% of the sample scored
higher than a 12 on the Edinburgh Postpartum Depression Scale (EPDS) which indicated
depression. Significant relationships between depression and marital dissatisfaction
(r=.378, p=.02), partner satisfaction (r=-.584, p=.001), partner support (r=-.578 p=.001),
partner closeness (r=-.663, p=.000) and partner love (r=-.506, p=.004) were found.
Researchers also found that women with lower education levels (Tau=-.290, p=.027) and
lower socioeconomic status (Tau=-.362, p=.019) were also found to have higher
depression scores. A limitation to this study was the small and predominately White
(84%) sample. Another potential limitation was the use of a tool developed by the
researchers to measure social support; although the Cronbach’s alpha of .85 indicated it
was a reliable measure.
Records & Rice (2007) conducted a study focusing on depression and social
support in 139 women during the third trimester of pregnancy. Thirty-eight percent of
the sample was found to have depressive symptoms (CES-D≥16). Intermittent negative
mood states, social support, marital satisfaction, and gravida accounted for 46% of the
variance in depression during the third trimester. In this model, social support accounted
for 6% of the variance of depression and brief, intermittent negative mood states
accounted for 24% of the variance. Although this study was unique in that it focused on
women in the third trimester, the Postpartum Depression Predictor Inventory-Revised
Scale (which includes 12 items to measure social support) was used to measure social
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support. In addition, the reliability of this tool was not reported, which is a limitation of
this study.
Depression in relation to life circumstances was studied in a large, cross-sectional
study of 1,321 women between 16 and 26 weeks’ gestation (Holzman et al., 2006). Life
circumstances were defined as life stressors relating to physical or sexual abuse,
economic problems, substance abuse in a loved one, and legal problems. For the
analysis, the participants were divided into three groups: teenagers, women older than 20
years and on Medicaid (disadvantaged), and women older than 20 years and not on
Medicaid (advantaged). Depression was found in 46% of the teens, 47% of the
disadvantaged group, and 23% of the advantaged group. Depression was higher in
women who had problems with abuse, economics, and illegal substance use in someone
close in the past six months for all three groups of women. Overall, disadvantaged
women and teens consistently had higher depression scores when compared to
advantaged women.
Another study was conducted in which the primary aim was to determine risk
factors associated with prenatal depression (Leigh & Milgrom, 2008). Depression,
anxiety, self-esteem, and social support were measured in a sample of 367 pregnant
women (between 26 and 36 weeks’ gestation). Depression was measured using the Beck
Depression Inventory (BDI) and anxiety was measured using the Beck Anxiety Inventory
(BAI). To measure social support, the Social Provisions Scale was used and the
Rosenberg Self-Esteem Scale was used to measure self-esteem. Using a cutoff score of

16

16.5 of the BDI to determine depression, 16.9% of the sample had prenatal depression.
Multiple regression analysis indicated that the significant predictors of prenatal
depression were as follows: low self-esteem (β= -.34, p<.001), antenatal anxiety (β= .32,
p<.001), social support (β= -.18, p<.001), income (β= -.05, p=.04), history of abuse (β=
.06, p=.03), major life events (β= .07, p=.01), and negative cognitive style (β= .11,
p<.001). The regression model explained 78% of the variance in prenatal depression.
Interestingly, age, education, and depression history were not found to be significant
predictors. However, these factors were reported to be significantly correlated with
antenatal depression (although the correlation coefficients and corresponding p values
were not provided). Limitations to this study include that only 1.6% (n=6) reported being
without a partner, all other participants were married or with a significant other. Also,
87.5% of the sample was from Australia (where the study was conducted) which
decreases generalizability of findings.
Social support, education, and income were found to be significant factors related
to perinatal depression (C. Anderson et al., 2002; Glazier et al., 2004; Marcus et al.,
2003; Records & Rice, 2007; Westdahl et al., 2007). However, race as a risk factor was
inconclusive. In a study with a sample of 3,472 women (73% White and 13.3% Black)
the CES-D was used to measure depression, but race was not related to depression
(Marcus et al., 2003). Only 20% of the sample was found to be depressed. The sample
was largely White which may have affected the findings regarding race. This study did
find that women with a history of depression were 4.9 times more likely to have antenatal
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depression (p<.05). Also, poorer health (β=.39, p<.001), greater alcohol use (β=.211,
p<.001), smoking (β=.13, p<001), lower education achievement (β=-.10, p=.04),
unemployment (β-.30, p=.01), and not being married (β=-.56, p<.001) were significant
predictors of depression during pregnancy. A limitation of this study was the crosssectional design, and the large variability of gestational age (3 to 41 weeks, Mean=25
weeks).
Another study of 112 minority women in the second trimester of pregnancy (54%
Hispanic, 46% Black) did not find a relationship between race and depression (T. Field et
al., 2002). However, differences were found in depression and socioeconomic status: the
women with higher socioeconomic status had lower levels of depression. Women in the
low socioeconomic status group had a mean CES-D score of 13.78 and women in the
higher socioeconomic status group had a mean score of 9.16 (p=.006). Because this study
only included minority women, a true comparison by race was not able to be examined.
Another study of minority women compared Latina women in the United States
(n=108) to Latina women in Mexico (n=117) and did not find significant racial
differences (Lara, Le, Letechipia, & Hochhausen, 2009). This study reported that 32.4%
of Latinas from the U.S with depression compared with 36.8% of Latinas from Mexico
using the cutoff score of 16 on the CES-D. Also, the mean CES-D score for U.S. Latinas
was 12.9 and it was 14.7 for Latinas in Mexico; however, these differences were not
statistically significant.
A similar study, which also used the CES-D, but had a sample size of 252
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women between 20 and 40 weeks’ gestation (77% White, 13% Black, 10% other) and
reported that minority women had higher depression scores than White women
(Lindgren, 2001). However, it was not reported if the differences in depression scores
between races were statistically significant. This study also found that younger women
(r=-.26, p<.05), less education (r=-.34, p<.05), and lower income (r=-.38, p<.05) were
related to depression. Perhaps the larger sample accounted for the ability to detect race as
a factor related to depression.
Orr, Blazer, and James (2006) reported differences between races and incidence
of depression in 1,163 pregnant women in their first or second trimester of pregnancy
(70% Black and 30% White). Although the age range of patients was not provided,
21.8% of the sample was younger than 20 and 78.2% was older than 20. The CES-D was
used to measure depression and 44% of the sample had depression based on a CES-D
score of greater than or equal to 16. The mean CES-D score for Black women was 17.37
and was 13.65 for White women—which was significantly different, indicating Blacks
were more depressed than Whites. Black women had a 50% greater prevalence rate of
depression even after adjustment for age, education, and marital status. However,
socioeconomic status, which has been associated with depression, was not controlled for
(T. Field et al., 2002; Marcus et al., 2003). Also, approximately 67% of the sample was
enrolled in Medicaid (of which 72% of were Black). Because Blacks were more likely to
be on Medicaid, the difference found in depression scores between races may be more
attributable to socioeconomic status instead of race.
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Social support was found to be related to depression in all of the articles
reviewed. All of the articles that had a cross-sectional design measured social support
and depression during the pregnancy, but the time was quite variable (between 3 to 41
weeks’ gestation). Only one study included pregnant women during the first trimester
and all other studies focused on the second and third trimesters of pregnancy. Regardless
of the time when depression and social support were measured, women with more social
support had less depression. Many of these studies also included measurements of age,
socioeconomic status and education. Overall, it was noted that pregnant women who
were younger had lower socioeconomic status, and those with less education were more
likely to be depressed. Although all studies agreed on the risk factors of age, low social
support, education, and socioeconomic status, race as a risk factor to depression was not
conclusive. Race as it relates to depression needs to be studied further while controlling
for the risk factors of age, low social support, education, and socioeconomic status in
order to determine if it is a risk factor to depression.
Maternal Health Factors
Overall Health
Pregnant women with depression are more likely to report having poor health.
Women with a poor health status may require more complex prenatal care or they may
elicit poor self-care behaviors which would suggest they are less likely to adhere to a
complex prenatal care plan. Women with a psychiatric diagnosis were reported to have
poor prenatal care (Kelly et al., 1999). Orr, Blazer, James, and Reiter (2007) studied
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depression and maternal health status during pregnancy in a cross-sectional study of
1,163 women in their second trimester (70% White, 30% Black). Forty-four percent of
the sample was found to have a score greater than 16 on the CES-D, indicating
depression. A total of 16.9% of the sample reported fair or poor health. It was found that
women with higher depression scores had twice the risk of poorer health (OR=1.74, CI=
1.27-2.39) even when age, marital status, smoking, education, type of insurance,
trimester, and race were accounted for. The large, diverse sample size was a strength of
the study. However, with a 68% of the sample on Medicaid, the results may not be
generalizable.
Marcus et al., (2003), also found a relationship between overall health status and
depression in a large, cross-sectional study (n=3742) of women between 3 to 41 weeks’
gestation. Approximately twenty percent of the sample was found to be depressed. As
discussed earlier in this paper, there was a significant relationship between depressive
symptoms and marital status, education level, employment status, history of depression,
self-rated overall health, smoking, and alcohol and substance abuse. A strength of this
study was the large sample size.
Anxiety
Many women with depression also report feelings of anxiety. This relationship
has also been reported in pregnancy (Breitkopf et al., 2006; Hart & McMahon, 2006).
Hart & McMahon (2006) analyzed relationships between depression, anxiety, and
psychological adjustment in 53 women between 20 and 38 weeks’ gestation using a
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cross-sectional design. Psychological adjustment was described as including two
concepts: maternal representation of herself as a mother and a positive relationship with
the fetus. Maternal representation of self was described as the mother being competent
and confident in mothering behaviors and her role as a mother (Hart & McMahon, 2006).
Relationship with the fetus was defined as the attachment developed between mother and
fetus. This attachment is represented by maternal behaviors such as healthy eating,
talking to the fetus, stroking the belly, abstaining from cigarettes and alcohol, buying
baby clothes and furniture, reading about child development, and attending antenatal
classes. Nine percent of the sample was found to score above 13 on the EPDS indicating
depression. Scores on the EPDS and the STAI were significantly correlated (r=.77 and
.63, respectively, for state and trait anxiety, p<.001). Relationship with the fetus and
maternal fetal attachment was measured using the Maternal Antenatal Attachment scale.
Mean STAI scores were significantly higher for women with low attachment scores
(p=.015 for state anxiety and p=.038 for trait anxiety). However, mean EPDS scores
were not significantly different between women with high and low attachment scores
(Mean EPDS 7.52 for women with low attachment scores and 5.57 for women with high
attachment scores, p=.078). Although depression was not found to be significantly
related to maternal-fetal attachment, there was a trend indicating exploration of this
relationship is needed. However, the significant relationship between anxiety and
depression suggests that it may be beneficial to measure anxiety when researching
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antenatal depression. Because this study was conducted in Australia, there may be
limitations in the generalizability of the findings to U.S. women.
Breikopf et al. (2006), examined the relationship between anxiety and depression
symptoms in a group of pregnant, postpartum, and non-pregnant women. The sample
consisted of 807 women (36% pregnant, 23% postpartum, and 41% non-pregnant). The
measurements were done between 24 and 36 weeks’ gestation for the pregnant women
and between 2 and 8 weeks postpartum for the postpartum group. Twenty-eight percent
of the sample was found to have depression symptoms. The Beck Depression Inventory
(BDI-II) was administrated (recommended cutoff score of 16 for use in pregnant
women), but the cutoff score was 14 because the sample included non-pregnant women
(Holcomb, Stone, Lustman, Gavard, & Mostello, 1996). Pregnant women had the highest
depression scores with a mean value on the BDI-II of 11.5. The mean values on the BDIII were 8.1 and 10.6 for postpartum and non-pregnant women, respectively. A significant
difference in mean scores was found between pregnant and postpartum women (p<.001),
but not between pregnant and non-pregnant women (p=.66). Depression scores were
found to increase as anxiety scores increased. Regression analysis suggested that anxiety
scores would increase by 5.81 points (p<.001) in women reporting mild depression
compared with women reporting minimal depression symptoms. Anxiety scores would
increase by 17.53 points (p<.001) for women reporting severe depression symptoms
compared with women reporting minimal depression symptoms. A history of depression
and anxiety, as well as current depressive symptoms, were found to be significant
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predictors of anxiety. The strengths of this study were the diverse (50% Hispanic, 25%
African American, 21% White, and 3% other) and large sample as well as use of a nonpregnant comparison group. A limitation of this study was the use of a lower cutoff
value to determine depression which may have increased the number of women classified
as depressed and potentially biased the results.
Obstetric Complications
Women with depression have been reported to have an increase in obstetric
complications. Larsson et al. (2004), reported that in a sample of 518 participants,
women who were depressed (17.4% of the sample) were more likely to be multiparous
and single. The multiparous women in the depressed group were more likely to have had
a previous pregnancy with complications when compared with the multiparous women
without depression. Complications of pregnancy (acute or elective cesarean sections,
instrument delivery, perineal tears, excessive bleeding, premature contractions, back pain,
or preeclampsia) were more often found in the depressed group. Depressed women were
also more likely to have premature contractions, back pain, and shorter gestational length
by one week. A limitation to this study was that only p values were reported in the
analysis section making it difficult to interpret the strength of the relationships found in
the study.
Another study, which also analyzed obstetric complications, used medical records
and a much larger sample of 32,156,438 deliveries between the years of 1998 and 2005
(Bansil et al., 2010). This study found that women with a depression diagnosis were 1.2
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to 2.8 more times likely to experience maternal and fetal complications including:
preterm labor, preeclampsia, diabetes, cesarean section, anemia, placental abnormalities,
urinary tract infections, infections during labor, fetal growth restriction, fetal
abnormalities, fetal distress, and fetal death. This study was a cross-sectional study and
so it is impossible to determine causality. Although the use of medical records allowed
for a very large sample size, the use of diagnosis codes to determine cases of depression
may have resulted in some cases of depression being missed. The researchers believed
that only the most severe cases of depression would be coded because it is the most
severe cases that would be likely to interfere with the routine care of a pregnant woman
(Bansil et al., 2010); therefore the less severe cases of depression may not have been
coded and included in the analysis.
Preeclampsia is a serious obstetric complication that usually occurs during the
third trimester of pregnancy where delivery of the infant is the only cure. A prospective
study of 623 Finnish women enrolled in the study between 8 and 17 weeks’ gestation
found that depression (OR 2.5, CI 1.2-5.3) and anxiety (OR 3.2, CI 1.4-7.1) in early
pregnancy increased the risk of preeclampsia (Kurki, Hilesmaa, Raitasalo, Mattila, &
Ylikorkala, 2000). This study also reported that 30% of the sample was found to be
depressed and that older age (greater than 30 years) was another risk factor (OR 3.4, CI
1.3-8.8) in developing preeclampsia. The BDI was modified for this study; no
information was provided on its reliability or validity. Another limitation was the use of
one item to measure anxiety.
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Recurrent spontaneous abortions are another obstetric complication that can be
challenging for health care providers to treat. Two studies reviewed this complication
and reported conflicting results (Bergant et al., 1997; Sugiura-Ogasawara et al., 2002).
Depression was found to be related to recurrent spontaneous abortions in a prospective
study of 61 women (Sugiura-Ogasawara et al., 2002). This study recruited women who
had a history of two recurrent spontaneous abortions and followed them longitudinally to
see if there were differences in women that had another abortion and women that were
able to conceive. The participants entered the study at an average of ten months after
their last miscarriage. Out of the 61 women included in the study, 45 became pregnant
again and ten of them had another subsequent spontaneous abortion. Using the Symptom
Checklist-90 to measure mental status, only the depression subscale was found to be a
significant predictor of the subsequent pregnancy outcome, where women with
depression were more likely to have a subsequent spontaneous abortion. However, no
specific statistics were reported, which is a limitation of this study. The study was done
in Japan with a small sample size which may decrease the generalizability of the findings.
Bergant et al. (1997), compared women with a history of two recurrent
spontaneous abortions (n=36) to women without a history of recurrent spontaneous
abortions (n=36). Women with recurrent spontaneous abortions all desired children and
entered the study at six to eight weeks after their last miscarriage. These women were
followed for two years. Those without a history of recurrent abortions were randomly
selected from a sample of women that attended a hospital for a preventive checkup.
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Their desire for children was unknown. There was no difference between groups in
depression scores on the BDI. The sample size may be the reason for the non-significant
findings. This study was done in Germany and may decrease the generalizability of the
findings to U.S. women.
Poor Prenatal Care
Women with a psychiatric diagnosis are more likely to have poor prenatal care.
Kelly et al. (1999), used five psychiatric disorders to study this relationship: (1)
substance-related disorder, (2) schizophrenic disorders, (3) mood disorders, (4) anxiety
disorders, and (5) other psychiatric disorders. Women were determined to have a
psychiatric diagnosis by International Classification of Diseases, 9th Revision (ICD-9)
codes documented in the California Health Information for Policy Project (CHIPP)
database. Poor prenatal care was defined as initiating prenatal care after the fourth month
of pregnancy and/or attending less than 50% of recommended visits. Women with a
psychiatric diagnosis were 2.3 times (CI 2.23-5.50, p<.001) more likely to delay initiation
of prenatal care and 2.18 times (CI 2.06-2.31, p<.001) more likely to receive inadequate
prenatal services after controlling for potential confounding demographic variables. Chi
square analysis indicated that women without private insurance, of single marital status,
of lower educational status, having one previous delivery, at a younger age, and of
Hispanic and Native American race were more likely to receive poor prenatal care.
Although this study suggests that Hispanics and Native Americans are more likely to
have a diagnosis of psychiatric disorder, it did not provide any specific information about
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the number of participants with depression compared to the other psychiatric diagnosis
which limits the interpretation of the findings.
In another study, poor prenatal care was not found to be significantly related to a
psychiatric disorder (H. G. Kim et al., 2006). Similar to the study discussed above, poor
prenatal care was defined as initiating prenatal care after the fourth month of pregnancy
and/or attending less than 50% of recommended visits. This Primary Care Evaluation of
Mental Health Disorder Patient Health Questionnaire was used to determine the
psychiatric diagnosis of 154 participants. Participants were given the questionnaire while
attending prenatal care visits; the mean gestational age when interviewed was 28 weeks.
After the women had delivered the infant, the medical chart was reviewed to determine
the number of prenatal care visits attended. A benefit of this study is that it indicated that
of the 29% of participants who had a psychiatric disorder, 26% had major or minor
depression. Inadequate prenatal care was significantly related to domestic abuse in the
past year, but not with current psychiatric disorder, alcohol abuse, age, primiparity,
marital status, government assistance, or unplanned pregnancy. Another difference with
this study was the use of a questionnaire instead of ICD-9 codes to determine a
psychiatric diagnosis. A limitation of this study is that all women were interviewed
during a prenatal care visit which may confound the results since these women were
already receiving prenatal care.
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Postpartum Depression
Postpartum depression is serious and may lead to postpartum psychosis, a serious
mental illness where suicide, infanticide, and homicide may result. Suicide is a risk of
untreated depression and 86% of maternal deaths were related to psychiatric illness where
68% of deaths were due to suicide (Oates, 2003). Women with prenatal depression are
more likely to suffer from postpartum depression. Heron et al. (2004), conducted a large
(n=8,323), prospective, longitudinal study. Women were assessed for depression using
the EPDS at 18 and 32 weeks’ gestation and 8 weeks and 8 months postpartum. Women
who had depression at 32 weeks’ gestation were found to be six times (OR=6.55, CI
4.68-9.17) more likely to have postpartum depression. Also, 43.7% of women with
postpartum depression reported elevated depression symptoms during pregnancy. The
strengths of this study were the large sample and the longitudinal design to examine the
relationship between prenatal and postpartum depression. This study was done in
England, which may decrease the generalizability of the findings because of socialized
medicine.
Another longitudinal study reported that 39% of women (n=2,674) who had
depression during pregnancy also had postpartum depression (Rubertsson et al., 2005).
Women were assessed for depression using the EPDS sometime during their prenatal care
(16 weeks’ gestation was the average gestational age) and then at two months
postpartum. A significant positive correlation (r=.52, p<.01) between antenatal
depression and postpartum depression was reported. Unemployment (RR 2.8, CI 2.6-
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5.8), younger age (RR 1.7, CI 1.2-2.5), single marital status (RR 3.9, CI 2.6-5.8), and less
education (RR 2.1, CI 1.3-3.3) were associated with antenatal depression. Although the
study had a large sample and used the EPDS to determine the relationship between
prenatal and postpartum depression, it was conducted in Sweden, which may decrease its
generalizability.
Infant Health Factors
Depression has been found to be related to many infant factors including: preterm
birth (A. Beck & Steer, 1996; Dayan et al., 2006; Steer, Scholl, Hediger, & Fischer,
1992), maternal-fetal attachment (Lindgren, 2001), negative infant reactivity (Davis et
al., 2007; Davis et al., 2004; Diego et al., 2005; Huot, Brennan, Stowe, Plotsky, &
Walker, 2004; Steer et al., 1992), fetal heart rate (Allister, Lester, Carr, & Liu, 2001),
infant colic (Sondergaard et al., 2003) and developmental delay (Deave, Heron, Evans, &
Emond, 2008). It is important for health care providers to be aware and understand the
impact of depression on the fetus and infant, and more importantly to recognize and treat
depression to prevent poor infant outcomes.
Preterm Birth
Dayan et al. (2006), examined the relationships between depression, anxiety, and
spontaneous preterm birth in a prospective cohort study (n=681). The EPDS was used to
assess for depression and the STAI to assess for anxiety between 20 and 28 weeks’
gestation. Preterm birth (defined as birth before 37 weeks’ gestation) was assessed using
medical records. Depression was found to be significantly related to preterm birth, where
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9.7% of women with high depression scores had a preterm delivery compared to 4.0% of
non-depressed women (p=.023). There was not a significant relationship found between
anxiety and preterm birth. This study took place in France, which may limit the
generalizability of the findings to U.S. women.
Steer et al. (1992), also found a relationship between preterm birth and
depression. This prospective study used the BDI to measure depression at 28 weeks’
gestation in 389 adults (greater than 18 years of age) and 323 teens. In this study, low
birth weight was defined as a baby weighing less than 2500 grams, small for gestational
age was defined as having a birth weight below the tenth percentile for that gestational
age, and preterm delivery was defined as delivering before the 37th week gestation. For
adult participants with a score higher than 16 on the BDI, indicating depression, there
was an increased risk for delivery of a low birth weight infant (OR 2.86, CI 2.73-2.99), a
small for gestational age infant (OR 2.32, CI 2.21-2.43), or delivering a preterm infant
(OR 2.53, CI 2.42-2.65). All odds risk ratios were adjusted for ethnicity, low prepregnancy body mass index, inadequate pregnancy weight gain, smoking, and history of
complications. The risk of a low birth weight infant rose approximately 5% to 7% for
each point the total score on the BDI increased (p <.05). This study did not find a
relationship between depression and low birth weight, preterm delivery, or small for
gestational age infants in the teen population, which may suggest that the BDI may not be
an appropriate tool for the teen population.
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Maternal-Fetal Attachment
Lindgren (2001) examined the relationship between depression, maternal-fetal
attachment, and health practices in 252 pregnant women between 20 and 40 weeks’
gestation, in which 44% had depression defined as scoring 16 or higher on the CES-D.
Women who had more children (r=.14, p<.05), were younger (r=-.26, p<.05), less
educated (r=-.34, p<.05), lower income (r=-.38, p<.05), single (.r=30, p<.05), and from
the inner city (r=.25, p<.05) had higher depression scores. After controlling for age,
income, and education there was a significant relationship between increased depression
and less maternal-fetal attachment (measured by the Maternal Fetal Attachment Scale).
However, depression explained only three percent of the variance in maternal-fetal
attachment.
Negative Infant Reactivity
Depression and anxiety during pregnancy have been found to have negative
effects on the infant (Davis et al., 2004). Maternal depression and anxiety were measured
in women at 32 weeks’ gestation and 8 weeks postpartum. Forty-two percent of the
sample was found to have scores greater than 16 on the CES-D indicating depression at
32 weeks’ gestation. Infant behavioral reactivity was assessed at four months of age
using the Harvard Infant Behavioral Reactivity Protocol. To measure infant behavioral
reactivity, various stimuli were used to elicit a response. The type of response such as
movement and crying are recorded as a negative response. The measures of anxiety and
depression were highly correlated (r =.74, p=.0001) at 32 weeks’ gestation. Prenatal
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anxiety accounted for 20% and prenatal depression accounted for 27% of the variance in
negative infant behavioral reactivity. Postnatal measurements of anxiety and depression
did not contribute significantly to infant behavioral reactivity. This finding suggests that
it is important to intervene during prenatal care to detect and treat depression symptoms,
in order to prevent negative infant reactivity.
Maternal depression during pregnancy has been found to impact infant
temperament at six months (Huot et al., 2004). This study included 123 mother-infant
pairs. Women were assessed for depression using the BDI sometime during pregnancy
and postpartum; however, exact times of measurement were not reported and this is a
limitation of the study. Women who were assessed during the first or second trimester
were combined into one group for analysis because there was a smaller number of
women during these times compared to women assessed in the third trimester. Higher
BDI scores during the first two trimesters of pregnancy (but not the third trimester) were
significantly related to negative infant affect (R2=0.11, p=.02). There was no significant
relationship found between postpartum scores on the BDI and negative infant affect. The
results indicate the importance of detecting and treating antenatal depression to improve
infant health outcomes.
The effects of depression during pregnancy and cortisol levels on infant
temperament were studied by Davis et al. (2007), in a longitudinal study of 247 motherinfant pairs. Maternal assessments of depression using the CES-D and anxiety using the
STAI were done between 18 and 20 weeks’ gestation, 24 and 26 weeks’ gestation, 30 and

33

32 weeks’ gestation, and 2 months postpartum. Depression scores on the CES-D and
cortisol levels were found to be higher during pregnancy compared to the postpartum
period. At 30 to 32 weeks’ gestation, higher cortisol levels were found to be significantly
related to negative infant reactivity (r=.20, p<.01). However, postpartum cortisol levels
were not found to be significantly related to negative infant reactivity. Prenatal anxiety
(r=.17, p<.01) and depression (r=.18, p<.01) were also found to be related to negative
infant reactivity. The effects of prenatal depression and cortisol levels on negative infant
reactivity remained significant after controlling for postpartum depression and anxiety.
These findings indicate that anxiety and depression during pregnancy have an impact on
infant behavior regardless of postpartum depression and anxiety; and again, this supports
the importance of diagnosing and treating prenatal depression and anxiety. This study
was unique because cortisol levels to determine a relationship between stress, depression,
and anxiety were measured, and few studies have included physiologic markers. Future
studies may want to include measures of stress hormones to confirm the findings of this
study.
Diego et al. (2005), also reported a relationship between infant behavior and
maternal depression. This prospective, longitudinal study of 80 women used the CES-D
to measure depression between 23 and 27 weeks’ gestation and then 2 weeks postpartum.
When infants of mothers with prenatal depression were compared to infants of mothers
without prenatal depression, women with prenatal depression had infants who spent more
time crying and fussing (14% compared to 3%, p<.05), exhibited more stress behaviors
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(9% compared to 5%, p<.05), and spent less time awake and alert (5% compared to 16%,
p<.05) than infants of women without prenatal depression. Also, women with both
prenatal and postpartum depression had infants with lower mean motor scores (3.45
compared to 4.59, p <.05) and mean orientation scores (3.36 compared to 4.99, p<.05) as
measured by Brazelton Neonatal Behavior Scale. Similar to the other studies on infant
behavior, this study reported findings that are consistent with the need to treat prenatal
depression to improve infant outcomes.
Fetal Heart Rate
Fetal heart rate is a measure of fetal well-being. Allister et al. (2001), reported a
relationship between fetal heart rate and prenatal depression in a cross-sectional study of
20 women (10 with depression, 10 without depression) between 32 and 36 weeks’
gestation. Depression was measured using the BDI and fetal heart rate was measured
using a fetal heart monitor. After a baseline fetal heart rate was obtained, a vibroacoustic
stimulus was given. Vibroacoustic stimulation applies an auditory stimulus to the
maternal abdomen to stimulate the fetus. Women with depression had higher baseline
fetal heart rates (Mean FHR 145 bpm compared to 136 bpm), had smaller heart rate
accelerations after the stimulus (Mean acceleration 6 bpm compared to 12.5 bpm), and
required a longer amount of time to return to baseline after the stimulus (6 min. compared
to 2.5 min.) than women without depression. For the depressed group, a smaller
acceleration suggested a slower response to the environment, and a longer time period to
return to baseline suggested an inability to adjust to the external stimuli (Allister et al.,

35

2001). The inability to adjust to external stimuli may be related to an immature
autonomic nervous system or an abnormality in the overall well-being of the fetus
(Allister et al., 2001). A weakness of this study is the small sample size and the use of a
cutoff score of ten on the BDI, which is lower than the recommended cutoff score of 16
for the pregnant population (Holcomb et al., 1996), which may have classified more of
the women as depressed.
Developmental Delay
Depression during pregnancy has been found to be related to child developmental
delay at 18 months of age (Deave et al., 2008). Women (n=14,062, 96% White) were
screened four times for depression (18 and 32 weeks’ gestation and 8 weeks and 8
months postpartum). Fourteen percent of women were found to be depressed at least
once during pregnancy (but not postpartum), 4.8% were depressed at least once during
postpartum (but not during pregnancy), and 1.4% were found to be depressed at least
once both during pregnancy and postpartum. Nine percent of children were reported to
be developmentally delayed. For women who had depression during both prenatal
measurements, their child was 1.24 times (CI 1.04-1.49) more likely to be delayed. Once
smoking, maternal age, and life events were adjusted for, the risk of delay for their child
increased to 1.34 times (CI 1.11-1.62). This relationship between depression and delay
remained significant after controlling for postpartum depression. A limitation of the
study was the small number of women reported to have depression during pregnancy and
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postpartum. A strength of the study was the large sample size; however, the sample was
predominately White, limiting the generalizability of the findings.
Sudden Infant Death Syndrome (SIDS)
SIDS is the most common cause of infant death in the first year of life (Howard,
Kirkwood, & Latinovic, 2007). A retrospective, case control study (n=831) was
conducted to determine if there was relationship between antenatal depression and SIDS
(Howard et al., 2007). Antenatal depression was defined as a diagnosis of depression by
an ICD-9 code during the year before birth. Women who had an infant death related to
SIDS (n=169) were compared to women without an infant death (n=662). There were
no differences in substance use or alcohol consumption between groups. However,
smoking was more common in the women with cases of SIDS. Also, depression during
the year before birth was found to be associated with SIDS (OR=4.93, 95% CI 1.1022.05). Postpartum depression was not associated with SIDS, indicating the importance
of diagnosis of depression during pregnancy. A limitation to this study was that women
in the depression group were determined to have depression at some point during the year
before birth but not necessarily during pregnancy. The racial distribution of the sample
was not reported and the study was done in England, which may also make
generalizability of the findings problematic.
Antenatal Depression Treatment
Only one research article was found studying a treatment program for depressed
women during pregnancy (Spinelli & Endicott, 2003). A review paper on treatments for
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depression during pregnancy cited the Spinelli & Endicott paper as the only intervention
study to meet the criteria to be included in the paper (Dennis, Ross, & Grigoriadis, 2007).
Spinelli & Endicott (2003) conducted a controlled clinical trial in a sample of 50 pregnant
women to compare a 16 week Interpersonal Therapy (IPT) treatment to a parenting
education control. Women began the IPT treatment or the parenting education class at
about 21 weeks’ gestation. Depression was measured by the Hamilton depression scale
(HDS), the BDI, the EPDS, and the Structured Clinical Interview for DSM-IV Axis I
Disorder. Mood improved in both groups; however, mood improved significantly more
in the IPT treatment group compared to the parenting education group on all
measurements of mood (HDS: p<.03, BDI: p<.02, EPDS: p=.005). This study was
unique in testing an intervention treatment for prenatal depression. A strength of the
study was that it included minority women with more than half having an annual income
of less than $25,000 a year. Another strength of the study was the use of a structured
interview for depression and the randomized study design.
Synthesis of the literature indicates there are multiple health risks to the mother
and infant when the mother has depression during pregnancy. Many of the longitudinal
studies found that depression during pregnancy, but not in the postpartum period, had a
significant impact on the health of the infant, indicating the importance of continued
research in the area of antenatal depression. Almost all of the studies used self-report
measures to determine depression, which is a limitation to this body of research. The
results of the studies using only self-report measures would be strengthened if there had
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been a diagnostic interview to validate the findings of the self-report questionnaires.
Many of the studies included women in the second or third trimester, so it may be
beneficial for future studies to include women in early pregnancy to determine when
depression is most prevalent and its impact on the health of the mother and infant.
Most studies used a sample of women that were already receiving prenatal care.
Because depressed women may be more likely to receive poor prenatal care and miss
prenatal care visits, many of the studies could be missing a large population of depressed
women. Also, many studies did not have diverse samples. Future studies should target
women who are at risk for receiving poor prenatal care and include racially diverse
samples.
Depression and Diabetes
There is a known link between diabetes and depression. Depression is more
commonly found in women with type 2 diabetes (28%) than in men with type 2 diabetes
(18%) (R. Anderson, Freeland, Clouse, & Lustman, 2001). Whether the neuroendocrine
changes in depression cause hyperglycemia or the effects of hyperglycemia cause
depression is yet to be determined. However, three meta-analyses have indicated that
depression may predispose the onset of type 2 diabetes (Lustman et al., 2000; Lustman et
al., 2007; Musselman, Betan, Larsen, & Phillips, 2003). It has been shown that
depression-induced changes in neurotransmitter functions may negatively affect glycemic
control by causing hyperglycemia (Von Kanel, Mills, Fainman, & Dimsdale, 2001).
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Also, depression has been found to be significantly related to hyperglycemia in both type
1 and type 2 diabetes (Lustman et al., 2000).
The effects of hyperglycemia have been known to cause depression because
insulin resistance has been related to depression. Insulin sensitivity was found to be
significantly lower in depressed patients when compared to non-depressed people and
insulin resistance improved with treatment of depression (Lustman et al., 2007). Also,
the pathophysiological relationship between insulin resistance and psychological stress
may be due to the exposure to the stress hormones, the catecholamines and
corticosteroids, the proinflammatory cytokines, and the free fatty acids acting in
combination to cause increased insulin resistance (Black, 2006).
Although the hyperglycemia and insulin resistance that occur during diabetes has
been related to depression, the relationship between gestational diabetes and depression
has not been extensively researched. Hyperglycemia is also a complication of gestational
diabetes and is related to increased stillbirths and increased infants born with macrosomia
(Dudley, 2007; Metzger et al., 2008). Whether hyperglycemia during pregnancy is
associated with increased incidence of depression is unknown and is an area for future
research.
Gestational Diabetes and Depression
Despite the association between depression and type 1 and 2 diabetes, there is
little known about gestational diabetes and depression. During the literature review, only
five studies were found that examined depression and gestational diabetes.
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A cross-sectional, descriptive study of 90 high risk pregnant women between 34
and 36 weeks’ gestation to determine if a high risk pregnancy was associated with
depression and maternal fetal attachment was conducted by Chazotte, Freda, Elovitz, &
Youchah (1995). The CES-D was used to compare the following groups: (1) women
with gestational diabetes (n=30), (2) women at risk for a preterm delivery (n=30), and (3)
women with an uncomplicated pregnancy (n=30). Fifty-seven percent of the gestational
diabetics, 70% of the women at risk for preterm delivery, and 33.3% of the
uncomplicated pregnant women were found to be depressed (≥ 16 on the CES-D).
Although the pregnant women with gestational diabetes had a greater incidence of
depression than women with an uncomplicated pregnancy, this difference was not
statistically significant. The researchers suggested that this lack of difference may have
been due to the small sample size, thus insufficient power necessary to find significant
differences between the groups. Most of the sample consisted of minority women (94%),
therefore, it is unknown if these findings would be generalizable to White women.
A similar study examined health-related quality of life and depressive symptoms
in pregnant women (n=90). Here a prospective, longitudinal study compared women
with hypertension (n=18), gestational diabetes (n=11), preterm birth (n=32), and healthy
pregnant women (n=29) (Mautner et al., 2009). The EPDS was used to measure
depression at three times throughout the perinatal period (24-37 weeks’ gestation, 2-5
days postpartum, and 3-4 months postpartum). No significant differences in depression
scores were found between women with gestational diabetes and women without
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gestational diabetes. However, the highest rates of depressive symptoms occurred during
late pregnancy (24-37 weeks’ gestation). In addition, women with preterm delivery
followed by women with hypertensive disorder reported the greatest number of
depressive symptoms. The only significant difference in depressive symptoms was found
between women with preterm delivery and women with healthy pregnancies. Limitations
to this study included the small sample of women with gestational diabetes who were
from one hospital located in Austria.
The diagnosis of gestational diabetes and its impact on emotional adjustment was
studied by Langer & Langer (1994). In this study, 206 women with gestational diabetes
and 95 non-diabetic pregnant women between 37 and 38 weeks were assessed for
depression using the Profile of Mood States-Bipolar (POMS-B). No differences in
depression scores were noted between gestational diabetics and non-diabetics. However,
the study reported that the mean score on the POMS-B was in the normal range for both
groups with the mean score of 45 for the women with gestational diabetes and 44 for the
women without diabetes on the elated-depressed subscale (Langer & Langer, 1994).
This study was unique because it classified the women with gestational diabetes by the
type of treatment (diet or insulin therapy) and by their level of glycemic control (good
control or poor control). In this study, good control was defined as a mean glucose <105
mg/dL and poor control was a mean glucose ≥ 105 mg/dL. Also, the target range was
defined as an overall mean blood glucose of 90-100 mg/dL, fasting blood glucose of 6090 mg/dL, and postprandial blood glucose less than 120 mg/dL. Participants were
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classified as having good control if their average blood glucose was less than 105 mg/dL
and women were said to have poor control if their average blood glucose was greater than
105 mg/dL. Intense treatment for gestational diabetes (insulin therapy and close
monitoring of blood glucose) was not related to increased depression symptoms.
However, women with good control of their diabetes were less distressed than women in
poor control. Twenty-one percent of the variance in the average mood disturbance score
was explained by the number of glucose readings in the normal range, number of glucose
readings above the target range, marital status, and maternal age. A limitation of this
study is that the number of women with depression was not reported, and there may have
not been a sufficient number of women with depression to find differences between
women with and without depression. Finally, the use of the POMS-B has not been
widely used in pregnancy and the reliability and validity of the tool was not reported for
this study.
Kim, Brawarsky, Jackson, Fuentes-Afflick, & Haas (2005) examined health status
in pregnant women with gestational diabetes (n=64), pregnancy induced hypertension
(PIH) (n=148), or uncomplicated pregnancy (n=1233). Although the focus of this cohort
study was not depression, it was assessed using the CES-D between 12 and 20 weeks’
gestation and between 8 and 12 weeks postpartum. Although women were measured
between 12 and 20 weeks’ gestation, they were asked to answer questions regarding the
month prior to conception. Therefore, perceived depression before pregnancy was
assessed rather than actual antenatal depression. Depression was present in 7.8% of
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women with gestational diabetes, 10.1% of women with PIH, and 11.6% of unaffected
women. Group differences were not significant for depression; however, researchers
reported that women with gestational diabetes had poorer self-rated health in the third
trimester (20%) compared to women without gestational diabetes (9.2%). The
researchers suggested the study may not have been powered sufficiently to detect
significant differences for depression. Differences in self-rated health during the third
trimester were reported but it is unclear how this was measured. A weakness of this
study is that women were asked to recall feelings of depression and health the month
prior to conception at 12 to 20 weeks’ gestation which may have measurement error due
to recall bias.
A recent study reported that women with diabetes during pregnancy were more
likely to have depression (Backes Kozhimannil, Pereira, & Harlow, 2009). A large
sample (n=11,024) using a retrospective cohort design used medical records from New
Jersey’s Medicaid administrative claims database and ICD-9 codes to determine women
with diabetes and depression. After controlling for age, race, and preterm birth, 15.2% of
women with diabetes during pregnancy had depression compared to 8.5% of women
without diabetes (OR 1.85, 95% CI 1.45-2.36). This study also reported that women with
diabetes but no depression during pregnancy were more likely to develop postpartum
depression (OR 1.69, CI 1.27-2.23). The strength of this study was the large sample size.
However, one weakness was that women with gestational diabetes, type 1 diabetes, and
type 2 diabetes were grouped together in the study.
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These five studies were the only studies found that examined depression and
gestational diabetes. Four studies did not show that pregnant women with gestational
diabetes are at greater risk for depression; however, all four of the studies had small
sample sizes and inadequate power (Chazotte, Freda, Elovitz, & Youchah, 1995; C. Kim,
Brawarsky, Jackson, Fuentes-Afflick, & Haas, 2005; Langer & Langer, 1994; Mautner et
al., 2009). One large study reported a difference in depression between women with
diabetes compared to women without diabetes. However, this large study studied women
with type 1, type 2, and gestational diabetes making it difficult to make conclusions
specifically about gestational diabetes. Therefore, a gap in the literature exists and the
need for a study with a large sample and adequate power to determine if women with
gestational diabetes are more at risk for depression is needed.
A relationship between depression and poor self-care in people with diabetes has
been established (Lin et al., 2006). Women who are depressed during pregnancy were
more likely to smoke, use alcohol, miss prenatal care visits, or delay initiation of prenatal
care (Kelly et al., 1999; Marcus et al., 2003). Pregnant women with depression and
gestational diabetes may find it difficult to perform all the self-care behaviors necessary
to effectively manage the diabetes. Future studies may want to include measurements of
self-care to determine if women with depression and gestational diabetes are more at risk
for complications.
The relationship between hyperglycemia, increased insulin resistance, and
depression has been documented in type 2 diabetes and suggests that depression may
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cause gestational diabetes. However, this has not been established through research in
the area of gestational diabetes. Future studies may find it beneficial to measure insulin
resistance, hyperglycemia, and depression in a prospective study beginning in the first
trimester of pregnancy before the diagnosis of gestational diabetes is made later in the
third trimester. This study would provide evidence as to whether depression is a risk
factor for developing gestational diabetes.
Electronic Medical Record
The electronic medical record (EMR) is defined as a digital collection of patient
data that is accessible to multiple authorized users and is exchanged and stored securely.
It includes retrospective, current, and prospective information and has the primary
purpose of providing efficient and high quality health care (Hayrinen, Saranto, &
Nykanen, 2008). Although the EMR is primarily used for clinical purposes, it may also
be used for research. When using the EMR for research, it is important to consider the
quality of the retrieved data information. Information quality includes the concepts of
completeness, accuracy, and reliability.
A review paper analyzed the information quality in 299 studies using the EMR as
a data source (Hayrinen et al., 2008). This paper reported that of the 299 studies
reviewed, 55 reported on the completeness of the data in the EMR. Completeness is a
measure of the amount of missing data. Many of the studies (n=31) found that
documentation by the health care provider was more complete and included more details
in the EMR than in another data source. Data accuracy is a measure of how accurate the
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data in the EMR is compared to another data source. A review of data accuracy was
included in 29 of the papers and it was found that data in the EMR was accurate.
Another study involving respiratory illness in an emergency department compared
electronic data to data retrieved from a paper chart and found the electronic data to be
accurate (Townes et al., 2004). When the electronic data was compared to a dictated
clinical note, it was found that 95% of the notes included a history of one respiratory
symptom or an objective sign of a respiratory tract infection on physical examination.
Reliability is a measure of how often the data shows the same results over
multiple measurements. Electronic medical records have been found to produce reliable
data (Hayrinen et al., 2008). Reliability and accuracy of EMR’s were analyzed in a study
on the amount of prescribed medication to the elderly for osteoarthritis in general
practitioners’ offices (Vandenberghe et al., 2005). In this study, the general practitioner
had the option of using a semi-automatic data extraction system from an EMR or data
collection with paper registration sheets. Semi-automatic data extraction was completed
by the EMR software developers creating a data extraction software program to extract
the necessary data for the study. Once the necessary data was extracted from the chart,
the general practitioner had the ability to review the data and modify data or add missing
data. This step allowed the general practitioner to improve the quality of the data. The
data collected from the charts included age, sex, diagnosis and location of osteoarthritis,
treatment type (medication, physiotherapy, diet, surgery, other, or none), and prescribed
medications for osteoarthritis (paracetamol, NSAID, or other painkillers). The analysis

47

included 222 general practitioners who collected data on 4,231 patients using paper
sheets and 146 general practitioners who collected data on 3,055 patients using EMR.
Although there were fewer practitioners using EMR, they were able to collect data on
more patients indicating the ease and timely manner in which data can be collected using
EMR. This study also found that the proportion of patients who were prescribed drugs to
treat osteoarthritis was almost twice as high for the general practitioners recording data
on paper sheets (64%) when compared to the general practitioners using EMRs (36%).
One possible explanation for this difference is that the general practitioners wrote the
prescriptions on paper and did not record them in the EMR. Another possibility is that
the prescriptions were recorded in a different place in the EMR and the semi-automatic
extraction was not able to capture the total number of patients on medications.
Missing data and problems with data entry are two weaknesses that may be found
when using EMR as a data source. Missing values can be found in any large database
(Cios & Moore, 2002). The missing value may be due to an oversight or intentionally
due to a technical, economic, or ethical reason (Cios & Moore, 2002). Missing values
may be substituted with the most likely value, with all possible values, or with a likely
range of possible values (Cios & Moore, 2002). A statistician who is familiar with large
data sets may be needed to assist in methods to replace missing data. Data entry
problems can also occur because many terms are used to describe the same conditions
(Cios & Moore, 2002). An example of this would be terms for high blood pressure
during pregnancy which include the following: hypertension, pregnancy induced
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hypertension, and preeclampsia. All three diagnoses include high blood pressure
occurring during pregnancy, so when studying the complication of high blood pressure
during pregnancy, it is important to search the EMR for all three terms. Similarly, when
health care providers document this problem in the chart, they may use one or all three of
these terms, also creating a challenge for accurate data extraction for research.
One of the strengths of using EMR as a data source is the ability to collect a large
amount of data on many people in a short time. For example, a large study using EMR as
a data source found that hypertension was under-diagnosed in the pediatric population
(Hansen, Gunn, & Kaelber, 2007). This study had a sample size of 14,187 patients and
data was collected for 53,911 patient visits over seven years. The author reported that the
study took about 100 hours of work time, and was completed without significant
resources as compared to a study of this magnitude that did not use EMR that would have
required many hours and cost hundreds of thousands of dollars. Another strength of
using the EMR as a data source is that preliminary data can be generated to provide
support for a possible intervention study.
Use of the electronic medical record systems has the ability to transform research
and may change the way research is conducted in the future. However, it will be
important to assess and understand the data quality issues (completeness, accuracy, and
reliability) that may occur or may be inherent with electronic documentation so that these
can be controlled in study design. Assurances of high quality data is essential for
research to be conducted using new and different methods of automated data captured at
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the point of care and aggregated across patient populations (Thiru, Hassey, & Sulllivan,
2003).

CHAPTER THREE
METHODOLOGY
This chapter addresses the study design, sampling criteria, recruitment strategies,
enrollment procedures, and data collection methods (including all measurements). As
stated previously, the purpose of the study was to determine if women with gestational
diabetes were more likely to suffer from depression. Although depression and gestational
diabetes are common occurrences during pregnancy, the relationship between the two has
not been extensively studied. The study aims were as follows: (1) to determine whether
women with gestational diabetes had more depression than women without gestational
diabetes, and (2) to determine whether factors predictive of depression in pregnant
women with gestational diabetes were different from women without gestational
diabetes. An exploratory aim to determine if minorities were more at risk for depression
during pregnancy than Caucasians was also examined.
Design
This study used a comparative, longitudinal design. It was comparative because
women with gestational diabetes were compared to women without gestational diabetes
(Nieswiadomy, 1998). It was longitudinal because data was collected in the antepartum
period from the mother and information regarding infant and maternal outcomes was
collected following delivery. The study explored whether having depression or
gestational diabetes impacts
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health outcomes in the mother and infant when compared to pregnant women who do not
have depression or gestational diabetes. The psychological factors (depression, history of
depression, anxiety, perceived stress, and social support), biological factors (body mass
index (BMI)), oral glucose tolerance test results, type of delivery, complications during
delivery, Apgar scores, gestational age at delivery, and infant birth weight), and
sociological factors (socioeconomic status, race, marital status, and medical history) were
studied.
Setting
The study was conducted primarily in outpatient clinics of a large, urban,
Midwestern medical center (99% women). Because data collection was slower than
anticipated, another outpatient clinic approximately five miles from the primary site was
also used (1% women). Data collection occurred over a period of one year (January 2010
to 2011). Both data collection sites serve the ethnically and economically diverse
population of the greater Chicago area.
Sample
The sample was a convenience sample of pregnant women who met selected
inclusion and exclusion criteria. The sample inclusion criteria were as follows: women
who received prenatal care at the research sites, between 24 and 40 weeks’ gestation,
spoke and read English, and older than 18 years. The exclusion criteria were as follows:
women under the age of 18 because expression of symptoms of depression varies with
developmental stage and some adolescents may have difficulty identifying and describing
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mood states (Bhatia & Bhatia, 2007). Also, women who did not read or speak English
were excluded because of insufficient funds to pay for translation. In order to classify
women as having gestational diabetes, the results of the three-hour oral glucose tolerance
test, an ICD-9 code of gestational diabetes, and/or a one-hour OGT greater than 200
mg/dL (see measurement section for how women with gestational diabetes was defined)
were used.
To determine the sample size needed for statistical significance, a power analysis
was conducted. Using the data from Chazotte et al. (1995), there was an incidence of
significant depressive symptoms (CES-D ≥ 16) in women with gestational diabetes of
57% and of 33% in women without gestational diabetes. Using G-Power, in order to
detect a difference between groups using these percentages with an alpha of 0.05, power
of .80, and one-sided tail distribution, 58 women per group are needed. Thus, 120
women were needed to determine whether women with gestational diabetes had more
depression than women without gestational diabetes. To determine whether
psychological (anxiety, stress), biological (gestational diabetes, age), and sociological
(social support, marital status, socioeconomic status) factors were predictive of
depression in pregnant women with and without gestational diabetes, a conservative rule
of 10 to 15 subjects per major variable, or a total of 80 to 120 subjects, was required.
Thus, a sample of 147 women was recruited in order to account for missing data.
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Recruitment of Study Participants
Participants were recruited from outpatient obstetrics offices. The investigator
approached pregnant women while they were attending a routine prenatal care visit.
After the nurse or technician had completed the patient vital signs and the patient was in
the exam room, the nurse or technician asked the patient for permission for the
investigator to come in and discuss the study. If the patient agreed, the investigator went
in the room to explain the study and determine if the patient was interested. If the patient
agreed to participate, the investigator explained the informed consent document and the
self-report questionnaires (Appendix A). The participant had the option of signing the
informed consent document and completing the self-report questionnaires while at the
visit or take them home and return them in a pre-paid envelope or at another scheduled
visit. The investigator also recruited gestational diabetics who had a scheduled visit with
the dietician.

The process was the same: the dietician would ask permission for the

investigator to talk about a study and if the patient agreed, the investigator would
approach the patient and explain the study, the informed consent document, and the selfreport questionnaires. All participants were made aware that by signing the consent they
were giving the investigator permission to access their electronic medical record. A flyer
(Appendix B) was also posted around the clinics and institution regarding participation;
however this method of recruitment did not lead to any participants.
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Collection of Data
Data was collected using self-report questionnaires and medical records.
EpicCare (Epic) is a common type of EMR and was used at the institution where most of
the data was collected. The use of Epic began in the ambulatory care setting in 2004 and
in the inpatient setting in 2007 and has been successfully used in documenting patient
information and providing quality care. At the other data collection site, information was
collected using paper medical records. These records were only from the outpatient
obstetric clinic; the inpatient hospital records were not accessed.
The self-report questionnaire included the following: the depression score
measured by the CESD and the EPDS, the anxiety score, the perceived stress scale, the
social support scale, and demographic and health information (including age, race,
marital status, socioeconomic status, depression history, other chronic conditions,
estimated date of delivery, list of current medications, gravida, and parity) (Table 1).
Data taken from the EMR included the following: weight, height, gravida, parity,
ethnicity, race, results of oral glucose tolerance test, gestational age at delivery, type of
delivery, complications during delivery, perineal tears, infant birth weight, and Apgar
scores (at one, five, and ten minutes) (Table 1).
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Table 1: Data Collection Methods
Variable

Data Collection Method

Depression (CESD and EPDS scores)
Anxiety (STAI score)
Stress (Perceived Stress Scale)
Social Support (MSPSS score)
Age
Race & Ethnicity
Marital Status

Self-report questionnaire

Socioeconomic Status
Depression History
Chronic Conditions
Current Medications
Estimated Date of Delivery
Gravida & Parity
Result of OGT test
Infant Birth Date
Infant weight
Infant Length
Apgar Scores
Gestational Age at Delivery
Type of Delivery
Delivery complications
EPDS Scores
Maternal Height
Maternal Weight
Perineal Tears & Episiotomy
Maternal Height & Maternal Weights
Infant Hypoglycemia

Electronic Medical Record
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Other variables extracted from the EMR for a possible secondary analysis
included the following: past medical history, current medical diagnoses, depression
scores measured by the EPDS (done at four time points: 28 weeks’ gestation, time of
delivery, two weeks postpartum, and six weeks postpartum), history of tobacco, alcohol
or illegal substance, type of anesthesia used during delivery, occurrence of induction,
plan to breastfeed, infant size (average for gestational age (AGA), small for gestational
age (SGA), or large for gestational age (LGA)), and infant blood glucose levels to
determine episodes of hypoglycemia.
The self-report questionnaire booklet (Appendix A) took participants about 15 to
30 minutes to complete. Upon successful completion, the participants were given a $10
gift card. Participants who took the self-report questionnaire booklets home were sent the
$10 gift card once the booklet was received in the mail. The phone number and address
of patients who took the questionnaire booklet home was obtained and the gift card was
mailed once the completed booklet was received. If patients had not returned the booklet
within a couple of weeks, the investigator called the patient to remind them to complete
and mail back the booklet.
After the patient had completed and returned the self-report questionnaire booklet,
data was collected from the EMR (electronic medical record) of both the mother and the
infant. Data extracted from the EMR of the mother included the following: weight,
height, gravida, parity, ethnicity, race, results of oral glucose tolerance test, gestational
age at delivery, type of delivery, complications during delivery, and perineal tears. The
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data to be extracted from the infant EMR included the following: infant birth weight and
Apgar scores (at one, five, and ten minutes). See Appendix C for variables collected
from the EMR.
Data collection from the EMR occurred in two stages. The first stage entailed the
investigator accessing the EMR to obtain the participant OGTT results, gravida, and
parity. The second phase was done using a template to extract variables from the EMR.
The template was created specifically for the study by an informatics specialist. This
template was created as a way to expedite data retrieval from the EMR. To create the
template, the investigator worked with the informatics specialist to determine what
variables should be extracted from the chart. The medical record numbers of the
participants were given to the informatics specialist. The informatics specialist then
entered the numbers into the template and the variables collected from the EMR were
automatically pulled and provided in a word document. The template for this research
study included the following maternal variables: maternal height and weight, past
medical history, gravida, parity, type of delivery, perineal tears, episiotomy, and
substance abuse. The template included the following infant variables: date of birth,
Apgar scores (at one, five, and ten minutes), birth weight, birth length, and any results for
a blood glucose level for the infant.
Only information which could be documented as a discrete variable in the EMR
was provided on the template. Therefore, to collect information which was only
contained in physician notes (such as complications during delivery), the investigator
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accessed the EMR of all participants. The information provided in the template was also
checked to ensure that accurate information was being recorded. This check was done by
reading four notes in the maternal EMR: the history and physical admission note when
the participant began prenatal care, the history and physical admission note when the
participant was admitted to the hospital for delivery, the delivery summary note, and the
discharge note. Also, two notes were read in the infant EMR: the admission note to the
nursery and the discharge summary note.
Measurements
The measurements were organized using the biopsychosocial model previously
discussed in Chapter 1 (see Table 2). See Appendix A for a copy of all the
measurement tools used.
The psychological factors assessed included depression, social support, anxiety
and stress. For depression, the CESD and EPDS instruments were used to measure
depression and were included in the self-report questionnaire booklet. The EPDS is a tenitem tool in which each item is scored on a four-point scale (0-3). The score from each
item is then summed to give a total score ranging from 0-30.
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Table 2: Variables and Measurements of Study
Variable

Measurement

Depression

EPDS score
CESD scores
History of Depression

Psychological Factors

Social support

MSPSS

Anxiety

STAI

Stress

PSS

Maternal Health

BMI

Factors

OGTT Results
Gravida and Parity
Current medications
Type of Delivery

Biological Factors

Delivery Complications
Infant Health

Apgar scores

Outcomes

Gestational age
Birth weight

Sociological Factors

Socioeconomic Status

Income

Demographic

Maternal Age
Race
Ethnicity
Marital Status
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Higher scores indicate more depressive symptoms in the individual. The
recommended cutoff score to indicate prenatal depression is 12/13 resulting in a
sensitivity of 64% and specificity of 95% (Murray & Cox, 1990). In the study, a cutoff
score of 12 was used to indicate depression. The EPDS was developed for use in the
postpartum population but has been validated for use during pregnancy (Murray & Cox,
1990). In addition, reliability has been established (Cox, Holden, & Sagovsky, 1987).
The EPDS for the current study had a Cronbach’s alpha of .91.
The CES-D was developed by Radloff (1977) and is a 20-item tool that has items
scored on a scale of 0 to 3 and then summed to give a total score ranging from 0 to 60. A
higher score indicates more depressive symptoms. A score equal to or greater than 16
indicates depression (Radloff, 1977). Similar to the EPDS, the CES-D asks the
individual to answer the items based on his or her feelings in the past week. The CES-D
has established reliability in pregnancy (Maloni, Seunghee, Anthony, & Musil, 2005). In
the current study the Cronbach’s alpha of the CES-D was found to be .90.
For anxiety, the Speilberger State Trait Anxiety Inventory (STAI) scale is a 40item tool which measures both a person’s current level of anxiety (state anxiety) and a
person’s general and long standing anxiety (trait anxiety). The measure of state anxiety
includes 20 items using a four point Likert scale (1=not at all to 4=very much so), with a
total score ranging from 20-80. Another four point Likert scale (1=not at all to 4=almost
always) is used to measure trait anxiety in 20 items, again with the total score ranging
from 20-80. Higher scores on the STAI indicate higher levels of anxiety. The STAI has
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been frequently used in pregnant populations (Allister et al., 2001; Bergant et al., 1997;
Breitkopf et al., 2006; Davis et al., 2004; Dayan et al., 2006; Glazier et al., 2004; Hart &
McMahon, 2006) with acceptable reliability for state and trait anxiety (Dayan et al.,
2006). In the current study, the Cronbach’s alpha for the state anxiety was .93 and .94 for
trait anxiety.
The Multidimensional Scale of Perceived Social Support (MSPSS), a 12-item
tool, was used to measure social support (Zimet, Dahlem, Zimet, & Farley, 1988). Each
item is scored on a 7-point Likert scale (1=very strongly disagree to 7=very strongly
agree). To compute a total social support scale, the mean of all items are used with
higher scores indicating more social support (with total scores ranging from 1-7). There
are three subscales to the tool including significant other support (item numbers 1, 2, 5,
10), family support (item numbers 3, 4, 8, 11), and friend support (item numbers 6, 7, 9,
12). The tool has established reliability and validity in the pregnant population (Zimet,
Powell, Farley, Werkman, & Berkoff, 1990). In the current study, the Cronbach’s alpha
was .94 for the total scale and for the subscales, .95 for significant other support, .90 for
family support, and .97 for friend support.
To measure stress, the Cohen’s Perceived Stress Scale (PSS) was used. This is a
commonly used 10-item tool to measure a person’s amount of stress. Each item is scored
on a 5 point Likert scale (0=never to 4=very often) and then scores are summed with
higher scores indicating higher levels of stress. This tool has established reliability
(Cohen & Williamson, 1988). In the current study, the Cronbach’s alpha was .92.
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For the history of depression and chronic conditions, the self-report questionnaire
asked women if they had a history of depression by the question: “Have you ever been
diagnosed with depression?” The women were also asked if they had a current diagnosis
of asthma, diabetes, hypertension, depression, bipolar disorder, or schizophrenia.
Women had the option to write in any other current diagnosis. Women who had a
positive history of depression were not excluded. Women with type 1 or type 2 diabetes
were excluded.
The biological factors assessed included maternal health and infant factors. For
the mother, body mass index (BMI), gravida and parity, oral glucose tolerance test
results, current medications, type of delivery, and complications of delivery were
assessed. For BMI, weight (lbs) and height (in) at the time of the prenatal care visit when
the patient filled out the self-report questionnaire was extracted from the EMR. To
calculate BMI, the formula 703 times the weight divided by the height squared was used.
Gravida was recorded as the number of times a woman has been pregnant. Parity
consisted of the results of those pregnancies and included full term deliveries, preterm
deliveries (infants born between 20 and 37 weeks’ gestation), abortions (including
spontaneous and miscarriages), and current living children. In the self-report
questionnaire, women were asked to report their gravida and parity. This information
was also extracted from the EMR.
Women were routinely screened for gestational diabetes with an oral glucose
tolerance test to diagnose gestational diabetes. Typically, to make a diagnosis of
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gestational diabetes two OGTT were done: a one-hour test and a three-hour test. For the
one-hour OGTT, women were given a 50-gram glucose drink to ingest and then a blood
glucose reading was obtained one hour later. The American Diabetes Association and the
American College of Obstetricians and Gynecologists accept either value (130 mg/dL or
140 mg/dL) as an abnormal value on the one-hour OGTT that indicates further testing for
gestational diabetes by a three-hour OGTT (Turok, Ratcliffe, & Baxley, 2003). The
three-hour OGTT involves the ingestion of a 100-gram glucose drink followed by
glucose testing at one, two, and three hours after the ingestion of the drink. The results of
the three-hour OGTT were used to determine a diagnosis of gestational diabetes based on
criteria for abnormal results for the three-hour OGTT. There are two sets of criteria that
can be used to make a diagnosis of gestational diabetes. The American Diabetes
Association suggests the following criteria with two of the following values being met or
exceeded: fasting 95 mg/dL; one hour 180 mg/dL; two hour 155 mg/dL; three hour 140
mg/dL (American Diabetes Association, 2003). However, in the current study, the
following criteria were used, any two of the four blood glucose values being met or
exceeded: fasting 90 mg/dL; one hour 165 mg/dL; two hour 145 mg/dL; three hour 125
mg/dL (O'Sullivan, 1980; O'Sullivan & Mahan, 1964).
For this study, if the one-hour test result was greater than 130 mg/dL , a threehour OGTT was typically done. The result of the one-hour OGTT was recorded in the
EMR for all patients who were screened for gestational diabetes. If the result of the onehour OGTT is greater than 130 mg/dL, the glucose results of the three-hour glucose test
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were also recorded in the EMR. Therefore, almost all women had glucose results of the
one-hour test documented in the EMR. If a woman did not have a result for a gestational
diabetes screen by a one-hour OGTT or a diagnosis of gestational diabetes, she was
excluded from the sample, because it was impossible to classify her as a gestational
diabetic or non-gestational diabetic. Women who had an abnormal one-hour OGTT had
results for the three-hour OGTT. The results of the three-hour OGTT were used to define
gestational diabetes in women for the present study.
Anyone who had a one-hour OGTT result greater than 200 mg/dL was diagnosed
with gestational diabetes without further testing. In this study, women with a one-hour
OGT result greater than 200 mg/dL, an ICD-9 code of gestational diabetes, a diagnosis of
gestational diabetes written by the health care provider in the EMR, and/or abnormal
results on the three-hour OGTT (as described above), were defined as having gestational
diabetes. The results of the glucose tests were extracted from the EMR.
For maternal outcomes following delivery, the type of delivery, complications
during pregnancy, and medications were assessed. Deliveries were documented in the
EMR using the following terms: Spontaneous Vaginal Delivery, Cesarean, Low-forceps
Delivery, Mid-forceps Delivery, Forceps Outlet, Vacuum, Breech Assisted, or Breech
Extraction. This information was extracted from the EMR. A history of cesarean section
was also extracted. For complications during delivery, the following were noted:
shoulder dystocia, presence of meconium, nuchal cord, postpartum hemorrhage,
chorioamnionitis, prolonged rupture of membranes, partial abruption, or maternal fever.
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Presence of perineal tears were documented according to the degree of the tear (1st, 2nd,
3rd, or 4th) and were extracted. Although the use of a vacuum may be recorded when the
type of delivery was recorded, the health care provider has the option of writing in the
use of a vacuum as a complication. If the health care provider chose to write in the use of
a vacuum, it was classified as a vacuum delivery.
For medication, participants were asked to list medications currently being taken
in the self-report questionnaire. The following medications were categorized for data
analysis purposes: insulin, oral diabetes medications, anti-depressants, and anti-anxiety
medications.
For the infant outcomes, the Apgar scores, gestational age at delivery, and weight
were used. Apgar scores were routinely measured at one, five, and ten minutes after birth
to reflect the health of the infant. Apgar scores can range from zero to ten: a score of
zero, one, or two are assigned to each of the five aspects of the score (Appearance, Pulse,
Grimace, Activity, Respiration) and then summed to provide a total score. Therefore,
three Apgar scores were extracted for the study (scores at one, five, and ten minutes).
Gestational age at delivery was extracted in “weeks” from the EMR. Finally, infant birth
weight was recorded in grams and was taken from the infant EMR.
The sociological factors that were assessed included socioeconomic status, race,
ethnicity, marital status, and planned pregnancy. For socioeconomic status, a question
regarding income was included on the demographic questionnaire administered in the
self-report questionnaire booklet. For race and ethnicity, participants were asked to
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report their race as: Alaska Native, Native American, Asian, Black, White, Native
Hawaiian or Other Pacific Islander, Preference not Indicated, or Other. Non-Hispanic or
Hispanic were the choices available for ethnicity in the self-report questionnaire. This
information was also extracted from the EMR. For marital status, a question regarding
marital status was included in the self-report questionnaire booklet. Participants had to
pick one of the following categories: married, divorced, separated, single and not living
with partner, and single and living with partner. For planned pregnancy, women were
asked in the self-report questionnaire booklet if the pregnancy was planned or unplanned.
Human Subjects Protection
The involvement of human subjects involved the completion of the self-report
questionnaires that were completed by the participant. Also, medical data (maternal and
infant) was collected from the EMR. Characteristics of the sample were women older
than 18 years of age who could read and speak English. Women younger than 18 years
of age were excluded from the sample due to the differences in depression symptom
expression for adolescents. It was necessary to study pregnant women, because it is not
possible to conduct a study on gestational diabetes without including pregnant women.
Sources of materials were the data collected from the self-report questionnaire
booklet and the data extracted from the EMR. These variables have been previously
delineated.
There were very few potential risks to this study. However, upon completion of
study tools, there was potential for participants to report feelings of anxiety and/or
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depressive symptoms during the antepartum visit. Since all prenatal patients are given
the EPDS screening during their regular prenatal care visit and there is a protocol for
treatment established at the institution where data collection occurred, patients were
encouraged to discuss their feelings with their health care provider. The consent stated
that if the patient expressed “the thought of harming myself has occurred to me” on the
EPDS, the health care provider was notified. Data was also collected from the EMR and
the informed consent stated that the medical record will be accessed and information
obtained.
To ensure adequate protection against risks to the participants, proper recruitment
techniques and informed consent documents were obtained. Participants were recruited
from the outpatient obstetrics clinic. Before recruitment began, permission for
recruitment at the clinic was provided by Dr. John Gianapoulos. Women attending the
outpatient obstetric clinic for routine prenatal care between 24 and 40 weeks pregnant
were approached for participation in the study by the investigator. Informed consent was
obtained by all participants (See Appendix D for a copy of the informed consent).
In order to protect participants against risks, participants were informed of the
possibility of experiencing depressive or anxious feelings while filling out the self-report
questionnaires in the informed consent document. If participants informed the
investigator of feelings of depression or anxiety, they were encouraged to share these
feelings with the health care provider they were seeing in the clinic. If participants
shared feelings of harming oneself on the EPDS questionnaire, this information was
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shared with the health care provider of the participant. Participants were informed of the
possibility of sharing this information with the health care provider in the informed
consent. Loyola University has an established protocol for patients who report feelings
of harming oneself on the EPDS. The protocol was followed by informing the health
care provider of the participant’s feelings.
Collected data was kept in a locked file cabinet. Only members of the research
team had access to this data. During data entry patient identifiers were not recorded,
assuring participant anonymity. Participants were informed that there were no identifiers
recorded in the informed consent. This research study involved pregnant women because
pregnancy is necessary to study gestational diabetes. However, because of the design of
this study and information collected, there was no increased risk to the mother, fetus, or
neonate.
At this point there are no known benefits to human subjects or others. However,
if women with gestational diabetes were found to be at increased risk for depression, the
care provided to them could be improved. Also, with significant results, future studies to
test an intervention that would improve depression symptoms in this population could be
conducted which would provide benefit.
Important knowledge may be gained at the completion of this study. If women
with gestational diabetes were found to be more at risk for depression, the care provided
to this population would be improved. Recognizing depression during pregnancy will
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help improve the outcome of maternal and infant health and could decrease the effects of
postpartum depression. These benefits outweigh the minimal risk of this study.
It was necessary to include women in the study; however, children were not
included. This study involved gestational diabetes and pregnancy, therefore only women
were included. Children and adolescents were not included because expression of
symptoms of depression varies with developmental stage and some adolescents may have
difficulty identifying and describing mood states (Bhatia & Bhatia, 2007). The sample
had a good representation of minority women: about 23% of the sample was African
American, 33% was Hispanic, and 11% of the sample was of another minority group.

CHAPTER FOUR
RESULTS
This chapter addresses the findings from the study. First, the description of the
sample and all study variables is provided. Second, the results of the study aims are
delineated. As previously stated, there were three aims to this study. The primary aim
was to determine if women with gestational diabetes mellitus (GDM) had more
depression than women without GDM. The secondary aim was to determine if the
factors predictive of depression in women with GDM were different than factors
predictive of depression in women without GDM. The exploratory aim was to determine
if minority women were more at risk for prenatal depression than White women.
Description of the Sample
One hundred and seventy two women were approached and asked to participate in
the study (See Figure 2 for enrollment diagram). Of these, 14 women refused and
therefore 158 women were enrolled in the study. Of the 158 women enrolled, 147
women completed the self-report questionnaires. Of those 147, eight had no results in the
chart of their oral glucose tolerance test or a diagnosis of GDM, three had type 2 diabetes,
and one had type 1 diabetes. The final sample included a convenience sample of 135
women (65 with gestational diabetes and 70 without gestational diabetes).
The majority of the sample was non-Hispanic (66.7%), married (65.2%), had an
unplanned pregnancy (52.6%), had no history of depression (84.4%), and had an average
70
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age of 29.7 years. The average gestational age at the time participants completed the
self-report questionnaire booklet was 31.3 weeks’ gestation. The race of the sample was
evenly distributed with 32.6% being White, 32.6% Hispanic, 23.0% Black, and 11.9%
other (Table 3). T-tests were done to determine if there were differences in age, and
gestational age at when participants filled out the questionnaire booklet. Women with
GDM were significantly older (p<.001). Chi-square tests were done to determine if there
were differences between groups in marital status, income, and history of depression.
Although women with GDM had higher incomes and more were married, these were not
significantly different than women without GDM according to the chi-square results.
Figure 2: Enrollment Flow Diagram
172 Approached

14 refused

158 Enrolled
9 never returned the
questionnaires
147 Participants

65
GDM

70
Non GDM

2 returned after the
end of study

3 Type 2
1 Type 1
8 missing
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However, women with GDM were more likely to have a history of depression (χ2=5.40,
p=.02). See Table 3 for differences in the demographic variable between gestational
diabetics and non-gestational diabetics. The 12 women who were not included in the
final sample because of missing results to an oral glucose tolerance test or a diagnosis of
type 1 or type 2 diabetes had demographics similar to the women included in the sample
(see Table 3). The ethnic and racial makeup of the sample is representative of the
population where the sample was collected.
Table 3: Description of Sample
Variable
Age* Mean (SD)
Range

Total Sample
GDM
N=135 (%)
N=65 (%)
29.7 (6.02)
32.12 (5.53)
18-47
18-47

Non-GDM
N=70 (%)
27.36 (5.55)
18-41

Gestational Age
Mean (SD)
Range

31.3 (3.90)
24.1-39.3

31.8 (3.77)
24.1-38.3

30.86 (4.00)
24.1-39.3

31.63
(4.08)
26.5-39.3

3.0 (2.0)
1-9

3.0 (2.0)
1-8

3.0 (2.0)
1-9

3.0 (2.0)
1-7

45(33.3%)
90 (66.7%)

25 (38.5%)
40 (61.5%)

20 (28.6%)
50 (71.4%)

4 (33.3%)
8 (66.7%)

44 (32.6%)
31 (23.0%)
44 (32.6%)
16 (11.9%)

20 (38.5%)
11 (16.9%)
25 (38.5%)
9 (13.8%)

24 (34.3%)
20 (28.6%)
19 (27.1%)
7 (10%)

1 (8.3%)
6 (50%)
4 (33.3%)
1 (8.3%)

88 (65.2%)
3 (2.2%)
2 (1.5%)
15 (11.1%)

48 (73.8%)
2 (3.1%)
1 (1.5%)
6 (9.2%)

40 (57.1%)
1 (1.4%)
1 (1.4%)
9 (12.9%)

5 (41.7%)
1 (8.3%)
N/A
4 (33.3%)

Gravida
Mean (SD)
Range
Ethnicity
Hispanic
Non-Hispanic
Race
White
Black
Hispanic
Other
Marital Status
Married
Divorced
Separated
Single, not living with
partner

Excluded
26.25
(7.65)
18-36
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Single, living with
26 (19.3%)
7 (10.8%)
19 (27.1%)
partner
Income
Less than $5,000
23 (17.0%)
9 (13.8%)
14 (20%)
$5,000-$9,999
4 (3.0%)
1 (1.5%)
3 (4.3%)
$10,000-$19,999
16 (11.9%)
8 (12.3%)
8 (11.4%)
$20,000-$29,999
23 (17.0%)
9 (13.8%)
14 (20.0%)
$30,000-$39,999
19 (14.1%)
9 (13.8%)
10 (14.3%)
$40,000-$49,999
10 (7.4%)
5 (7.7%)
5 (7.1%)
$50,000-$59,999
9 (6.7%)
5 (7.7%)
4 (5.7%)
$60,000-$69,999
9 (6.7%)
4 (6.2%)
5 (7.1%)
Over $70,000
15 (11.1%)
12 (18.5%)
3 (4.3%)
Planned Pregnancy
31 (44.3%)
32 (49.2%)
63 (46.7%)
Yes
39 (55.7%)
32 (49.2%)
71 (52.6%)
No
History of
Depression*
6 (8.6%)
15 (23.1%)
21 (15.6%)
Yes
64 (91.4%)
114 (84.4%) 50 (76.9%)
No
* Significant differences between GDM and non-GDM (p<.05)

2 (16.7%)

5 (41.7%)
N/A
2 (16.7%)
2 (16.7%)
N/A
N/A
1 (8.3%)
N/A
1 (8.3%)
1 (8.3%)
11 (91.7%)
1 (8.3%)
11 (91.7%)

Data Entry
All data from the self-report questionnaires and EMR was de-identified and
entered into a statistical software database (SPSS Windows Version 16.0, SPSS, Chicago,
IL). Data was then manually checked and corrected for any entry errors. Once the raw
data had been entered, only assigned ID numbers were used to analyze the data.
Missing Data
After data entry was complete, data was assessed for missing data. There was
very limited missing data in the self-report questionnaires (see Appendix E). This is
because all booklets were examined upon completion for missing data. If an item was
missing, the participant was asked if the item was accidently skipped or left blank on
purpose. If the participant desired to leave an item blank it was accepted. Missing data
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on the self-report questionnaires was replaced with the individual mean for that specific
instrument. There was limited missing data from self-report questionnaires that could not
be replaced with the individual mean (one marital status item, one pregnancy planned
item, and seven income items). Many participants when asked about income desired to
leave this blank or were unsure of the annual income because the spouse was the primary
wage earner.
There was also missing data from the EMR templates provided by the informatics
expert. When missing data was encountered on the template, the EMR was accessed and
examined to see if missing information could be found (Appendix E). This included
reading through the following physician notes: the admission history and physical note,
the delivery summary note, and the discharge summary note in the maternal EMR. Also,
the infant admission to the nursery and discharge summary notes were read. When
missing data was found, it was entered into the database. There were six participants that
did not deliver at the institution where data was collected and therefore all delivery data
is missing from these six people. See Appendix E for amount of missing data
encountered from the EMR. The variable with the most missing data was the Apgar
score at ten minutes. There were six participants with missing results for the one-hour
OGTT gestational diabetes screen; however, all six of these participants had a diagnosis
of gestational diabetes in their charts. The most common reason for the missing one-hour
OGTT results was because patients had transferred from other institutions and this data
was not available.
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Comparability of Data from Different Sources
Only information which could be documented as a discrete variable in a flow
sheet was provided on the template. Data such as the complications during delivery were
only written in physician notes. Therefore, physician notes were consulted to retrieve
information not provided on the template and to find missing data. Once the physician
notes were read, discrepancies were found between the information retrieved using the
EMR template and the physician notes in the EMR (Appendix F). The physician notes
from the maternal EMR that were reviewed included the following: the history and
physical note at the start of prenatal care, the history and physical note at the time of
admission to the hospital for delivery, the delivery summary note, and the discharge
summary note. Physician notes from the infant EMR that were reviewed included the
following: admission to the nursery and the discharge summary. Usually, the information
found in the physician note was entered into the database, because it was believed that the
physician note would be more accurate than flow sheet documentation.
Data Analyses of Key Study Variables
First, data was analyzed for normality and outliers. Normality was assessed by
examining histogram plots. The outcome variables found to be positively skewed were
the CES-D scores, the EPDS scores, the state anxiety scores, and the trait anxiety scores.
Social support was found to be negatively skewed. Lastly, perceived stress was found to
be normally distributed. Age and the gestational age when the self-report questionnaires
were completed were also found to be normally distributed. Although some variables
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were skewed, the scores represent scores expected for this sample and consistent with the
literature. After consultation with the statistician and given that the distribution of scores
was expected for this sample, transformation of scores was not done. Normality is not an
assumption for correlations and if dichotomous variables are used, normality is not a
necessary assumption.
The next step in data analysis was to analyze the descriptive statistics and
frequency distributions for all major outcome variables (gestational diabetes, depression,
anxiety, stress, and social support). A detailed analysis of each outcome variables is
provided next, starting with gestational diabetes.
Gestational Diabetes
For almost all participants (n=129), a one-hour OGTT test was done (as
mentioned previously, six women had these results missing but had a diagnosis of GDM).
These results are included in Table 4. If the OGTT at one hour was abnormal, patients
had further testing with a three-hour OGTT and these results are also presented in Table
4. The presence of gestational diabetes was determined based on the results of the threehour OGTT. In order to make a diagnosis of gestational diabetes, two of the following
four levels had to be abnormal: fasting>90 mg/dL, one hour >165 mg/dL, two hour >145
mg/dL, and three hour >125 mg/dL. The mean one-hour glucose for women with GDM
was 170.46 mg/dL (SD±33.34) and for women without GDM was 113.16 mg/dL
(SD±23.50), which were significantly different [t (127) = -11.40, p<.001].
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Table 4: Oral Glucose Tolerance Results*
Variable
Mean (SD)
Range
One-Hour OGTT (N=129)
139.36 (40.29)
65-300
3-Hour OGTT: fasting
88.36 (9.56)
68-113
(N=61)
3-Hour OGTT: 1
182.44 (28.70)
108-233
hour(N=61)
3-Hour OGTT: 2 hour
159.75 (33.70)
67-249
(N=61)
3-Hour OGTT: 3 hour
130.41 (30.72)
64-208
(N=61)
*n=61 because four women had OGTT results missing but had a diagnosis of GDM in
the chart
Depression
There were two self-report instruments used to assess depression (the CES-D and
the EPDS) and one question regarding history of depression. The CES-D is a 20-item
tool with four items (4, 8, 12, 16,) being reverse-coded before sum scores were
calculated. The EPDS is a 10-item tool with 7 items (3, 5, 6, 7, 8, 9, 10) being reversecoded before sum scores were calculated. The question “Do you have a history of
depression?” with response choices of “yes” or “no” was included in the self-report
questionnaire booklet.
For the CES-D the mean score for the entire sample was 12.73 (SD±9.8). The
women with GDM had a mean score of 12.97 (SD±10.66) and the women without GDM
had a mean score of 12.5 (SD±9.0) (Table 5). Using the recommended cutoff score of 16
or greater to suggest depression, 28% of the entire sample had depression, 32% of the
women with GDM had depression, and 24% of the women without GDM had depression.
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Table 5: Mean Depression Scores
Variable
CESD
EPDS

Entire Sample
Mean (SD)
12.73 (9.80)
6.26 (5.72)

GDM
Mean (SD)
12.97 (10.66)
6.45 (6.21)

Non-GDM
Mean (SD)
12.51 (9.00)
5.90 (5.25)

For the EPDS the mean score for the entire sample was 6.26 (SD±5.72). Women
with GDM had a mean score of 6.65 (SD±6.2) and women without GDM had a mean
score of 5.9 (SD±5.25) (Table 5). Using the recommended cutoff score of 12 or greater
to suggest depression, 16% of the entire sample had depression. Also, 20% of women
with GDM had depression, compared with 13% of women without GDM. Table 7
displays the individual item mean responses on the EPDS. For women without GDM, the
two items with the highest mean scores were numbers 4 and 6. For women with GDM,
the item with the highest mean score was number 4 followed by items 3 and 6 which both
had the same mean. Items 1 and 10 had the lowest mean scores for both women with and
without GDM.
Table 6 displays the mean item responses on the CES-D. For both women with
and without GDM, the two items with the highest mean were numbers 7 and 11 and the
items with the lowest means were numbers 15 and 19.
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Table 6: Item Means on the Center for Epidemiologic Studies Scale (CES-D)
Item
1. I was bothered by things that
usually don’t bother me
2. I did not feel like eating; my
appetite was poor
3. I felt that I could not shake off
the blues even with the help from
my family or friends
4. I felt I was just as good as other
people*
5. I had trouble keeping my mind
on what I was doing
6. I felt depressed
7. I felt that everything I did was
an effort
8. I felt hopeful about the future*
9. I thought my life had been a
failure
10. I felt fearful
11. My sleep was restless
12. I was happy*
13. I talked less than usual
14. I felt lonely
15. People were unfriendly
16. I enjoyed life*
17. I had crying spells
18. I felt sad
19. I felt that people dislike me
20. I could not get “going”
* Reverse-coded items

Sample
Mean (SD)

GDM
Mean (SD)

Non-GDM
Mean (SD)

.81(.88)

.71(.84)

.91(.91)

.47(.74)

.46(.81)

.49(.68)

.45(.83)

.46(.81)

.44(.85)

.87(1.13)

.97(1.17)

.79(1.09)

.76(.92)

.68(.87)

.84(.96)

.52(.85)

.55(.87)

.49(.85)

1.24(1.10)

1.20(1.13)

1.29(1.08)

.87(1.05)

.89(1.08)

.84(1.03)

.30(.66)

.31(.61)

.30(.71)

.48(.74)
1.31(.95)
.66(.79)
.59(.84)
.56(.85)
.29(.69)
.59(.84)
.59(.80)
.61(.79)
.18(.53)
.57(.74)

.55(.71)
1.29(1.00)
.74(.87)
.63(.88)
.65(.86)
.29(.74)
.66(.89)
.52(.75)
.60(.79)
.20(.56)
.60(.75)

.41(.77)
1.33(.91)
.59(.71)
.56(.81)
.49(.85)
.29(.64)
.51(.79)
.64(.83)
.61(.80)
.16(.50)
.54(.74)
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Table 7: Item Means on the Edinburgh Postpartum Depression Scale (EPDS)
Item
1. I have been able to laugh and see
the funny side of things
2. I have looked forward with
enjoyment to things
3. I have blamed myself
unnecessarily when things went
wrong*
4. I have been anxious or worried for
no good reason
5. I have felt scared or panicky for no
very good reason*
6. Things have been getting on top of
me*
7. I have been so unhappy that I have
had difficulty sleeping*
8. I have felt sad or miserable*
9. I have been so unhappy that I have
been crying*
10. The thought of harming myself
has occurred to me*
* Reverse-coded items

Sample
Mean (SD)
.30 (.59)

GDM
Mean (SD)
.32 (.56)

Non-GDM
Mean (SD)
.27 (.61)

.33 (.61)

.37 (.65)

.30 (.57)

.91 (.88)

.98 (.89)

.84 (.88)

.96 (.99)

1.05 (1.04)

.87 (.95)

.74 (.87)

.80 (.97)

.70 (.77)

.92 (.81)

.98 (.86)

.86 (.77)

.61 (.84)

.75 (.94)

.49 (.72)

.77 (.79)
.64 (.79)

.77 (.84)
.55 (.75)

.77 (.75)
.73 (.82)

.07 (.37)

.06 (.35)

.07 (.39)

Anxiety
The Spielberger State-Trait Anxiety Index (STAI) was used to measure state and
trait anxiety. It is a 40-item tool which measures both a person’s current level of anxiety
(state anxiety) and a person’s general and long standing anxiety (trait anxiety). There are
20 items (1-20) to measure state anxiety and 20 items (21-40) to measure trait anxiety.
Nineteen of the items were reverse-coded when computing the sum score for state and
trait anxiety. These items included numbers: 1, 2, 5, 8, 10, 11, 15, 16, 19, 20, 21, 23, 26,
27, 30, 33, 34, 36, and 39. Higher scores on the STAI indicate higher anxiety.
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On the STAI, the mean score for state anxiety of the entire sample was 35.67
(SD±11.62 and for trait anxiety the mean score was 36.25 (SD±11.57). For women with
GDM, the mean state anxiety score was 36.98 (SD±12.28) and for women without GDM
the mean state anxiety score was 34.44(SD±10.93). On trait anxiety, women with GDM
had a mean score of 38.22(SD±12.77) and women without GDM had a mean score of
34.43(SD±10.08) (Table 8). Table 9 and Table 10 display the means for individual items
for both state and trait anxiety. Due to copyright regulations, only the first five items are
written completely while the rest of the items are abbreviated to not violate the copyright
laws. For state anxiety, the items with the highest mean for the entire sample were
numbers 5 and 19. For women without GDM, items 5 and 15 had the highest means. For
women with GDM, items with the highest means were 5 and 16. Items 13 and 18 had the
lowest means for everyone (entire sample, women with GDM, and women without
GDM). Regarding trait anxiety, items 26 and 34 had the highest mean scores for the
entire sample and women with GDM. For women without GDM, items 26 and 27 had
the highest mean scores. For all groups (the entire sample, women with and without
GDM) the lowest mean scores were items 25 and 31.
Table 8: Mean Anxiety Scores
Variable
State Anxiety
Trait Anxiety

Entire Sample
Mean (SD)
35.67 (11.62)
36.25 (11.57)

GDM
Mean (SD)
36.98 (12.28)
38.22 (12.77)

Non-GDM
Mean (SD)
34.44 (10.93)
34.43 (10.08)
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Table 9: Item Means on the State Anxiety Scale
Item

Sample
GDM
Mean (SD)
Mean (SD)
1. I feel calm*
1.73 (.80)
1.82 (.75)
2. I feel secure*
1.61 (.78)
1.63 (.70)
3. I am tense
1.87 (.85)
1.94 (.85)
4. I feel strained
1.77 (.88)
1.80 (.91)
5. I feel at ease*
2.11 (.98)
2.18 (.95)
6. Upset
1.52 (.85)
1.51 (.83)
7. I am presently worrying
1.78 (.92)
1.92 (.91)
8. Satisfied*
1.97 (.95)
2.08 (.94)
9. Frightened
1.53 (.76)
1.51 (.71)
10. Comfortable*
1.98 (.97)
1.98 (1.00)
11. Self-confident*
1.87 (.90)
1.91 (.91)
12. Nervous
1.87 (.90)
1.92 (.94)
13. Jittery
1.33 (.67)
1.40 (.66)
14. Indecisive
1.52 (.82)
1.62 (.82)
15. Relaxed*
2.07 (.96)
2.11 (.94)
16. Content*
2.04 (.95)
2.20 (.97)
17. Worried
1.78 (.90)
1.88 (.91)
18. Confused
1.39 (.72)
1.45 (.77)
19. Steady*
2.09 (.92)
2.17 (.91)
20. Pleasant*
1.84 (.85)
1.97 (.88)
* Items that were reverse-coded when computing the sum score

Non-GDM
Mean (SD)
1.64 (.83)
1.59 (.86)
1.80 (.87)
1.74(.86)
2.06 (1.02)
1.53 (.86)
1.64 (.92)
1.87 (.95)
1.54 (.81)
1.97 (.95)
1.83 (.90)
1.83 (.87)
1.27 (.68)
1.43 (.81)
2.04 (.98)
1.89 (.91)
1.69 (.89)
1.34 (.68)
2.01 (.92)
1.72 (.81)
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Table 10: Item Means on the Trait Anxiety Scale
Item

Sample
Mean (SD)
1.84 (.87)
1.86 (.81)
1.83 (.91)
1.86 (.96)
1.36 (.65)
2.51 (.96)
2.10 (.92)

GDM
Mean (SD)
1.92 (.91)
2.02 (.78)
1.92 (.89)
2.03 (1.00)
1.40 (.68)
2.62 (.98)
2.18 (.92)

21. Pleasant*
22. Nervous, restless
23. Satisfied with self*
24. Happy as others
25. Like a failure
26. Rested*
27. “calm, cool, and
collected.”*
28. Difficulties are
1.62(.79)
1.71 (.82)
piling up
29. Worry too much
1.80 (.88)
1.88 (.93)
30. Happy*
1.74 (.86)
1.88 (.91)
31. Disturbing thoughts 1.41 (.74)
1.45 (.73)
32. Self-confidence
1.53 (.84)
1.65 (.86)
33. Secure*
1.81 (.89)
1.92 (.92)
34. Decisions easily*
2.13 (.88)
2.26 (.96)
35. Inadequate
1.45 (.68)
1.49 (.69)
36. Content*
2.00 (.95)
2.11 (.97)
37. Unimportant
1.81 (.87)
1.88 (.88)
thoughts
38. Disappointments
1.88 (.91)
1.97 (.95)
39. Steady person*
1.96 (.91)
2.06 (.98)
40. State of tension
1.76 (.84)
1.88 (.86)
* Items that were reverse-coded when computing the sum score

Non-GDM
Mean (SD)
1.77 (.82)
1.71 (.82)
1.74 (.93)
1.70 .(89)
1.31 (.63)
2.41 (.94)
2.03 (.93)
1.54 (.76)
1.73 (.83)
1.61(.80)
1.37 (.77)
1.41 (.81)
1.70 (.86)
2.00 (.80)
1.41 (.67)
1.90 (.93)
1.74 (.86)
1.80 (.86)
1.87 (.83)
1.64 (.82)

Stress
Stress was measured using the Cohen Perceived Stress Scale (PSS). It had a total
of ten items scored on a scale of 0-4. Four items were reverse-coded when computing the
sum score (items 4, 5, 7, 8). Higher scores on the instrument indicate higher levels of
stress. The mean score for the entire sample was 15.07 (SD±8.40). The women with
GDM had a mean score of 16.11 (SD±8.49) and women without GDM had a mean score
of 14.11 (SD±8.25) (Table 11).
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Table 11: Mean Perceived Stress Scores
Variable
Perceived Stress

Entire Sample
Mean (SD)
15.07 (8.40)

GDM
Mean (SD)
16.11 (8.49)

Non-GDM
Mean (SD)
14.11 (8.25)

Table 12 displays the means for individual items on the PSS. For the entire
sample and women with and without GDM, items 1 and 3 had the highest mean scores.
For the entire sample the items 4 and 5 had the lowest mean scores. For women without
GDM, items 4 and 10 had the lowest mean scores. For women with GDM, items 4 and 7
had the lowest mean score.
Table 12: Item Means on the Perceived Stress Scale
Item

Sample
Mean (SD)
1.81 (1.06)

GDM
Mean (SD)
1.94 (1.09)

1. Have you been upset because of
something that happened unexpectedly?
2. Have you felt that you were unable to 1.48 (1.21)
1.62 (1.21)
control the important things in your life?
3. Have you felt nervous or “stressed”? 2.04 (1.10)
2.20 (1.11)
4. Have you felt confident about your
1.19 (1.09)
1.17 (.96)
ability to handle your personal
problems?*
5. Have you felt that things were going
1.29 (1.02)
1.37 (.99)
your way?*
6. Have you found that you could not
1.51 (1.19)
1.62 (1.10)
cope with all things you had to do?
7. Have you been able to control
1.30 (1.02)
1.32 (.94)
irritations in your life?*
8. Have you felt that you were on top of 1.37 (1.02)
1.45 (1.12)
things?*
9. Have you been angered because of
1.73 (1.11)
1.86 (1.09)
things that were outside of your control?
10. Have you felt difficulties were
1.37 (1.24)
1.57 (1.25)
piling up so high that you could not
overcome them?
* Items that were reverse-coded when computing the sum score

Non-GDM
Mean (SD)
1.69 (1.03)
1.36 (1.20)
1.89 (1.07)
1.20 (1.21)

1.21 (1.05)
1.41 (1.21)
1.27 (1.02)
1.30 (.92)
1.60 (1.12)
1.19 (1.21)
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Social Support
Social support was measured by the Multidimensional Scale of Perceived Social
Support (MSPSS). The tool consisted of 12 items and contained three subscales. The
three subscales included the following: significant other support, family support, and
friend support. Items in the significant other subscale included numbers 1, 2, 5, and 10.
The family support subscale consisted of numbers 3, 4, 8, and 11. Lastly, the friend
support subscale included items, 6, 7, 9, and 12. Each item is scored on a seven point
Likert scale ranging from “very strongly disagree” (1) to “very strongly agree” (7).
There were no items that were reverse-coded for this tool. The items are averaged to
compute a sum score. Higher scores suggest higher levels of social support. The mean
score for overall social support in the entire sample was 6.00 (SD±1.10), the mean was
6.30(SD±1.18) for significant other support, 6.11(SD±1.16) for family support, and
5.59(SD±1.55) for friend support. For women with GDM the means for the total and
subscales were as follows: for overall social support 6.03(SD±1.03), for significant other
support 6.27(SD±1.10), for family support 6.06(SD±1.11), and for friend support
5.77(SD±1.38). For women without GDM the means were as follows: 5.97(SD±1.17) for
overall support, 6.27(SD±1.26) for significant other support, 6.15(SD±1.20) for family
support and 5.42(SD±1.69) for friend support (Table 13). Table 14 displays the item
means for the MSPSS. For the entire sample and the women without GDM, items 1 and
10 had the highest means, and items 6 and 7, the lowest means. For women with GDM,
items 3 and 10 had the highest means and items 7 and 8 had the lowest means.
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Table 13: Mean Overall Social Support and Subscale Scores
Variable
Overall Support
Significant Other
Support
Family Support
Friend Support

Entire Sample
Mean (SD)
6.00 (1.10)
6.30 (1.18)

GDM
Mean (SD)
6.03 (1.03)
6.27 (1.10)

Non-GDM
Mean (SD)
5.97 (1.17)
6.32 (1.26)

6.11 (1.16)
5.59 (1.55)

6.06 (1.11)
5.77 (1.38)

6.15 (1.20)
5.42 (1.69)

Table 14: Item Means on the Multidimensional Perceived Social Support Scale
Item
1. There is a special person who is
around when I am in need
2. There is a special person with whom I
can share my joys and sorrows
3. My family really tries to help me
4. I get the emotional help and support I
need from my family
5. I have a special person who is a real
source of comfort to me
6. My friends really try to help me
7. I can count on my friends when
things go wrong
8. I can talk about my problems with my
family
9. I have friends with whom I can share
my joys and sorrows
10. There is a special person in my life
who cares about my feelings
11. My family is willing to help me
make decisions
12. I can talk about my problems with
my friends.

Entire Sample
Mean (SD)
6.22 (1.39)

GDM
Mean (SD)
6.12 (1.41)

Non-GDM
Mean (SD)
6.31 (1.37)

6.27 (1.24)

6.25 (1.24)

6.30 (1.24)

6.26 (1.23)
6.17 (1.24)

6.29 (1.17)
6.14 (1.26)

6.23 (1.30)
6.20 (1.22)

6.25 (1.29)

6.26 (1.16)

6.24 (1.41)

5.61 (1.66)
5.45 (1.69)

5.86 (1.44)
5.60 (1.60)

5.39 (1.83)
5.31 (1.77)

5.90 (1.49)

5.74 (1.55)

6.04 (1.43)

5.67 (1.56)

5.85 (1.35)

5.50 (1.73)

6.44 (1.14)

6.45 (.97)

6.43 (1.29)

6.10 (1.31)

6.06 (1.16)

6.14 (1.45)

5.62 (1.63)

5.77 (1.46)

5.49 (1.77)
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Medication Use and Chronic Conditions
In the self questionnaire booklet, participants were asked to list any medications
they were taking. These medications were coded into the following groups: (1)
antidepressant, (2) anti-anxiety, (3) insulin, (4) oral diabetes medication, (5)
antidepressant and anti-anxiety, (6) oral diabetes medication and antidepressant, and (7)
oral diabetes medication and insulin. There were only 25 women taking medications
according to these categories (Table 15). Only five women were taking antidepressants
and 22 were taking medications to treat their GDM. As for chronic conditions,
participants were asked if they had been diagnosed with asthma, diabetes, hypertension,
bipolar disorder, or schizophrenia (Table 16). No women had bipolar disorder or
schizophrenia, only 10 (7.4%) had hypertension, and 14 (10.4%) had asthma.
Table 15: Medication Use
Medication Category
Antidepressant
Anti-anxiety
Insulin
Oral Diabetes Medication
Antidepressant and Anti-anxiety
Oral Diabetes Medication and Antidepressant
Oral Diabetes Medication and Insulin
Table 16: Chronic Conditions
Chronic Condition
Asthma
Diabetes
Hypertension
Bipolar Disorder
Schizophrenia

N (%)
14 (10.4%)
42 (31.1%)
10 (7.4%)
0 (0%)
0 (0%)

N (%)
2 (1.5%)
0 (0%)
2 (1.5%)
16 (11.9%)
1 (0.7%)
2 (1.5%)
2 (1.5%)
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Interestingly, out of the 65 women who had a diagnosis of gestational diabetes, only 42
marked down that they had diabetes. This may be due to the fact that the question asked
about “diabetes” and not “gestational diabetes”.
Correlations
The relationships between the variables (GDM, age, race, marital status, planned
pregnancy, income, gravida, BMI, depression, anxiety, stress, and social support) were
analyzed using Pearson correlations (r). Gestational diabetes was found to be
significantly related to age (r =.397, p<.001), marital status (r =-.217, p=.01), income (r
=.197, p=.03), gravida (r =.174, p=.04), and BMI (r =.265, p<.001). The relationship
between marital status and GDM was negative, meaning that more people with GDM
were married. Income and gravida were positively correlated with GDM, meaning that
women with GDM had higher incomes and more pregnancies. Depression was correlated
with marital status (r = .182, p = .04), if the pregnancy was planned (r = .227, p <.001),
and with income (r = -.177, p = .05).—indicating that women who were not married, had
an unplanned pregnancy, and had lower incomes had more depression. Regarding the
self-report instruments, the expected relationships were found with a positive correlation
between depression, anxiety, and stress. Also, a negative relationship was found between
social support, depression, anxiety and stress (Table 17). The strongest relationship was
found between state and trait anxiety (r =.871, p<.001), as expected. The weakest
relationship was found between gravida and GDM (r = .174, p<.04). The two depression
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measures (CES-D and EPDS) were also found to be strongly positively correlated
(r=.791, p<.001), as would be expected.

Table 17: Correlations between Key Variables
Age

Race

Marital
Status

Plan

Income

Gravida BMI

CESD

Social
State
Trait
Stress
Support Anxiety Anxiety

-.057
.030
.397** .109
-.217*
.197*
.174*
.266** .023
GDM
-.037
-.078
.023
-.429**
-.266** .610**
.343**
.178*
Age
-.129
-.007
-.029
.098
.095
.082
-.060
Race
-.047
-.135
-.101
-.490*
-.482**
.182*
Marital
Status
.127
.064
-.365**
.227**
-.188*
Plan
-.021
-.004
-.177*
.191*
Income
.331**
.103
-.245**
Gravida
-.038
.061
BMI
-.556**
CESD
Social
Support
State
Anxiety
Trait
Anxiety
Stress
**Significant correlations at the p<.001 level, *Significant correlations at the p<.05 level.

EPDS

.110
-.056
.166
.026

.164
.012
.140
.054

.119
.007
.122
.125

.065
-.026
.133
.092

.132
-.204*
.109
.031
.712**
-.520**

.176*
-.185*
.191*
.045
.805**
-.599**

.218*
-.130
.199*
.042
.757**
-.577**

.178*
-.206*
.134
.102
.791**
.587**

.871**

.769**

.805**

.855**

.861**
.844**
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Data Analysis for Study Aims
The primary aim of this study was to determine if women with GDM had more
depression than women without GDM. The secondary aim was to determine if the
factors predictive of depression in women with GDM were different than factors
predictive of depression in women without GDM. The third aim was to determine if
minority women were more at risk for prenatal depression than White women. In the
next section, the analysis for each aim will be described.
Data Analysis: Aim 1
The first aim of the study was to determine if women with GDM have more
depression than women without GDM. The analysis for this aim was done three ways:
one-tailed Fisher’s exact test, an independent t-test, and logistic regression. To present
the results of the data for the primary aim, the assumptions of each analysis will be
discussed followed by the results.
A Fisher’s exact test is done to test the relationship between two categorical
variables. The Fisher’s exact test is usually done when there are two variables and both
variables are dichotomous so a 2 x 2 table can be created (A. Field, 2009). There are two
assumptions associated with the Fisher’s exact test: (1) there must be independence of
data and (2) the expected frequency of each variable must be greater than five (A. Field,
2009). In this analysis, both of these assumptions were met. The variables of presence of
GDM and presence of depression were independent of each other and there were more
than five cases present in each category.
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The one-tailed Fisher’s exact test was done (since the hypothesis was directional)
to assess the difference in the proportion of depressed women (with and without GDM)
using the recommended cutoff score on the CES-D ≥ 16 and on the EPDS ≥ 12 to
indicate women who had depression. The results shown in Table 18 display that there
were no significant differences in the frequency of depression between women with and
without GDM when using the CES-D (p=.199). Similarly, there were no significant
differences in the frequency of depression found among women with and without GDM
when the EPDS was used (p=.187) (Table 19).
Table 18: Fisher’s Exact Test for Depression (CES-D)
CES-D<16 (Not Depressed)
N (%)
GDM
44 (67.7%)
No GDM
53 (75.7%)
p value for Fisher’s Exact test =.199

CES-D≥ 16 (Depressed)
N (%)
21 (32.3%)
17 (24.2%)

Table 19: Fisher’s Exact Test for Depression (EPDS)
EPDS<12 (Not Depressed)
N (%)
GDM
52 (80%)
No GDM
61 (87.1%)
p value for Fisher’s Exact test =.187

EPDS≥ 12 (Depressed)
N (%)
13 (20%)
9 (12.9%)

Independent t-tests compared mean depression scores between women with and
without GDM. There are four assumptions made when performing independent t-tests:
(1) the sampling distribution is normal, (2) data is measured at the interval level or
greater, (3) there is homogeneity of variance, and (4) scores are independent of each other
(scores come from separate people) (A. Field, 2009). Three of the four assumptions were
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met for this analysis (Appendix G). Data was collected at the interval level or greater,
depression scores between women with GDM and without GDM were independent of
each other, and there was homogeneity of variance among the two groups. The normal
distribution of the sample was the only assumption not met (Appendix F); however, the
scores generated were consistent with what has been published in the literature. Also,
both independent t-tests and regression analyses are relatively robust to moderate
deviations from the normal distribution; therefore, transformation of the data was not
done (Box & Watson, 1962).
Independent t-tests indicated that mean scores on the CES-D were slightly higher
for women with GDM (M=12.97, SE=1.32) when compared with women without GDM
(M=12.51, SE=1.08), but not statistically significant [t (133) = .269, p =.789 (Table 20)].
Similarly on the EPDS, women with GDM (M=6.65, SE=.77) had slightly more
depression than women without GDM (M=5.90, SE= .63), which was also not
statistically significant [t(133)= .755, p = .451 (Table 20)].
Table 20: Independent T-Tests for Depression Measures
Variable

Group

Mean

CES-D

GDM
NonGDM
GDM
NonGDM

12.97
12.51

Standard
Error
1.32
1.07

6.65
5.90

.771
.628

EPDS

Df

t statistic

p value

133

.269

.789

133

.755

.451

Although independent t-tests are robust, a Mann-Whitney analysis (nonparametric test of comparison of means) was done to determine if the non-normality of
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the data impacted the findings (A. Field, 2009). This test was also not significant for
both depression measures. Results for the CES-D (U=2212.00, p = .781) and for the
EPDS (U=2206.50, p = .762) indicated that the non-normality of the data did not affect
the ability to detect significant findings.
Logistic regression is done to predict which group a participant is likely to belong
to, based on known information (A. Field, 2009). In the logistic regression analysis, the
outcome variable must be dichotomous. In the current study, the outcome variable of
depression was dichotomized in two ways. The first was done using a score on the CESD≥ 16 to classify women as depressed and a score <16 to classify women as not
depressed. The second analysis was done using a score on the EPDS≥ 12 to classify
women as depressed and an EPDS score <12 to classify women as not depressed. In
logistic regression, covariates may be at the nominal to ratio level of measurement
(Munro, 2005). In the analysis age, income, and marital status were used as covariates
because these have been demonstrated in the literature to be related to depression. The
assumptions associated with logistic regression include the following: (1) linearity, (2)
independence of errors, and (3) multicollinearity. The assumption of linearity assumes
that there is a linear relationship between the continuous predictors and the logit of the
outcome variable. There was one covariate which was continuous in this analysis (age),
and to test this assumption, the logistic regression was run using the interaction between
the variable and the log of itself (A. Field, 2009). When the model was run this way the
interaction terms were not significant, therefore this assumption was met. The second
assumption of independence of errors is the same as the independence assumption
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discussed with the independent t-test. As mentioned previously, the assumption has been
met. The last assumption of multicollinearity indicates that predictor variables should not
be highly correlated (correlation coefficient>.8). To test this assumption, a linear
regression was done with the analysis of the collinearity diagnostics option (A. Field,
2009). These results indicate that relationships between age, income, marital status, and
GDM were not highly correlated and this assumption was met.
To continue the analysis between groups of women with and without GDM,
logistic regression analysis was done. According to the CES-D, there was not a
significant relationship between depression and GDM when controlling for age, income,
and marital status. Although women with GDM were more likely to have depression, it
was not statistically significant (OR=2.00, 95% CI, .84, 4.75, p=.115) (Table 21).
Table 21: Gestational Diabetes Predicting Depression (CES-D)*
95% CI for Odds Ratio
Lower
Odds Ratio

b (SE)
Constant
-2.16 (1.27)
GDM
.69 (.44)
.84
*Covariates were age, marital status, and income

2.00

Upper
4.75

Similar results were found for the second logistic regression using the EPDS.
When controlling for age, income, and marital status, women with GDM were more
likely to have depression but the findings were not statistically significant (OR=2.33,
95% CI, .80, 6.81, p=.12) (Table 22).
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Table 22: Gestational Diabetes Predicting Depression (EPDS)*
95% CI for Odds Ratio
Lower
Odds Ratio

b (SE)
Constant
-2.59 (1.51)
GDM
.85 (.55)
.80
*Covariates were age, marital status, and income

2.33

Upper
6.81

Depression has been found to be related to higher BMI in women (Keddie, 2011;
Zhao et al., 2009). Although no articles were found on BMI and prenatal depression,
BMI has been found to be related to postpartum depression (LaCoursiere, Baksh,
Bloebaum, & Varner, 2006; LaCoursiere, Barrett-Connor, O'Hara, Hutton, & Varner,
2010). Also, a relationship between gravida and depression has been documented
(Larsson, Sydsjo, & Josefsson, 2004; Lindgren, 2001; Records & Rice, 2007). The
logistic model was run to include these covariates. After controlling for age, income,
marital status, BMI, and gravida, women with GDM were 2.7 times more likely to have
depression (OR=2.72, 95% CI, 1.04, 7.13, p =.041) using the CES-D (Table 23). Using
the EPDS and controlling for age, income, marital status, BMI, and gravida, although
women with GDM were 2.36 times more likely to have depression (OR=2.36, 95% CI,
.79, 7.06, p = .126), it was not statistically significant (Table 24).
Table 23: Gestational Diabetes Predicting Depression (CES-D)*
95% CI for Odds Ratio
Lower
Odds Ratio

b (SE)
Constant
-1.09 (1.73)
GDM
1.00 (.49)
1.04
2.72
*Covariates were age, marital status, income, BMI, and gravida

Upper
7.13
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Table 24: Gestational Diabetes Predicting Depression (EPDS)*
95% CI for Odds Ratio
b (SE)
Lower
Odds Ratio
Constant
-2.59 (1.51)
GDM
.86 (.56)
.79
2.36
*Covariates were age, marital status, income, BMI, and gravida

Upper
7.06

When analyzing the descriptive statistics, more women with GDM were found to
have a history of depression than women without GDM (Table 4). To analyze these
differences further, a chi-square analysis and a logistic regression analysis were done.
Chi-square results indicated that women with a history of depression were significantly
more likely to have GDM (χ2=5.40 (1), p=.02). In the logistic regression analysis, when
controlling for age, marital status, and income, women with a history of depression were
also significantly more likely to have GDM (OR=2.95, 95% CI, .98, 8.82, p=.05) (Table
25). Results suggest that women with GDM are about three times as likely to have a
history of depression. Once the covariates of gravida and BMI were added, they were
3.07 times as likely to have a history of depression (OR=3.07, 95% CI, 1.01, 9.49, p =
.05) (Table 26).
Table 25: History of Depression Predicting Gestational Diabetes
95% CI for Odds Ratio
b (SE)
Lower
Odds Ratio
Constant
-2.49 (1.57)
GDM
1.08 (.56)
.98
2.95
*Covariates were age, marital status, income

Upper
8.82
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Table 26: History of Depression Predicting Gestational Diabetes
95% CI for Odds Ratio
b (SE)
Lower
Odds Ratio
Constant
-3.07 (2.09)
GDM
1.12 (.57)
1.01
3.07
*Covariates were age, marital status, income, BMI, and gravida

Upper
9.36

The results for the primary aim of this study indicate that women with GDM do
have higher depression scores as measured by both the CES-D and the EPDS; however,
the differences between groups were not statistically significant (using Fisher’s exact test
and the independent t-tests). However, logistic regression indicated that women with
GDM were two times more likely to have depression on both the CES-D and the EPDS
when controlling for age, marital status, and income. Gravida and BMI were found to be
related to depression in the literature, therefore, these variables were added into the
analysis. Once controlling for age, marital status, income, BMI, and gravida, women
with GDM were 2.7 times likely to have depression (when the CES-D was used) and this
was statistically significant. In addition, this is a clinically significant finding. Also, as
discussed in the descriptive statistics section, there was a significant difference between
women with and without GDM and a history of depression. Logistic regression also
indicated that women with a history of depression were 3.07 times more likely to have
GDM when controlling for age, marital status, income, gravida, and BMI.
Data Analysis: Aim 2
The second aim of this study was to determine the predictive factors of depression
and to determine if these factors differ between women with and without GDM. The
following variables: state anxiety scores, trait anxiety scores, age, marital status, and
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socioeconomic status which were based upon the literature were used as the predictors
for the multiple linear regression analyses.
Multiple regression is done to predict an outcome variable from several predictor
variables (A. Field, 2009). In the current study, depression is the outcome variable, while
anxiety, stress, gestational diabetes, age, marital status, and socioeconomic status were
predictor variables. There are nine assumptions associated with multiple regression.
These include the following: (1) variable types, (2) non-zero variance, (3)
multicollinearity, (4) predictors which are not correlated with external variables, (5)
homoscedasticity, (6) independent errors, (7) normally distributed errors, (8)
independence, and (9) linearity. These assumptions were met to allow for the testing to
be done (Appendix G).
First, the predictive factors (state anxiety, trait anxiety, GDM, age, marital status,
and socioeconomic status) were entered into the model using the forced entry method. In
the forced entry method, all predictors are entered into the model at the same time (A.
Field, 2009). Predictor variables are chosen based on theory and published research;
however, the order in which the predictor variables are entered into the model is not
determined. In the first analysis, the CES-D score was the outcome variable and in the
second analysis the EPDS score was the outcome variable. The analysis was also run
using social support as a predictor variable instead of marital status because the analysis
suggested that the effect of the marital status and social support were very similar. Only
the models using marital status are displayed because marital status had a greater effect
when analyzing the interaction effects between the variables. First, the regression
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analyses using the CES-D score as the outcome variable will be presented followed by
the regression analyses using the EPDS as the outcome variable.
The predictors (state anxiety, trait anxiety, GDM, age, marital status, and
socioeconomic status) explained 71% of the variance in depression as measured by the
CES-D [R2= .71, Adjusted R2=.69, F (7, 119) = 40.87, p < .001, Table 27]. Trait anxiety
was the only statistically significant predictor, b=.61 (SE=.11), t=4.73, p<.001. This
finding suggested that for every one unit increase in trait anxiety score there is a .61
increase in the depression score. Although this is a small increase, this finding was
statistically significant. Perceived stress and marital status were two other predictors
trending toward significance (Table 27).
Table 27: Multiple Regression with Depression (CES-D) as Outcome
Variable
State
Anxiety
Trait
Anxiety
Perceived
Stress
GDM
Age
Marital
Status
Income

B
.08

SE B
.09

β
.09

t
.86

p value
.394

.51

.11

.61

4.73

<.001

.20

.12

.17

1.72

.088

1.21
-.04
.64

1.06
.11
.35

.06
-.02
.10

1.14
-.36
1.83

.258
.723
.070

.21

.26

.06

.79

.429

To determine if women with GDM had different predictors of depression,
multiple regression analyses were done including the predictor variables (state anxiety,
trait anxiety, GDM, age, marital status, and socioeconomic status) and interaction effects.
An interaction occurs when the influence of one predictor variable depends on the level
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of another predictor variable. In the current study, the predictor variables of state
anxiety, trait anxiety, perceived stress, age, marital status, and income may have an
influence on the predictor variable of GDM. Therefore, regression analyses were run
with the predictor variables and the interaction effects of the predictor variables for both
depression measures (CES-D and EPDS).
Table 28: Multiple Regression with Interaction Terms for Depression (CES-D) as
Outcome
Variable
State
Anxiety
Trait
Anxiety
Perceived
Stress
GDM
Age
Marital
Status
Income
GDM X
State
Anxiety
GDM X
Trait
Anxiety
GDM X
Perceived
Stress
GDM X Age
GDM X
Marital
Status
GDM X
Income

B
.018

SE B
.12

β
.02

t
.15

p value
.883

.44

.15

.53

3.02

.003

.40

.14

.35

2.77

.077

-8.76
-.18
.08

6.84
.17
.42

-.45
-.11
.01

-1.28
-1.05
.20

.203
.294
..519

.28
.12

.43
.18

.07
.25

.65
.68

.249
.496

.20

.22

.44

.92

.362

-.53

.24

-.54

-2.21

.029

.21
-5.32

.23
2.26

.36
-.26

.95
-2.36

.346
.020

.20

.55

.07

.36

.718
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In the model with predictor variables and interaction effects, 73% of the variance
in depression measured by the CES-D was explained [R2= .73, Adjusted R2=.70, F (13,
113) = 23.41, p < .001]. In this model, there were two significant interaction terms: the
interaction between GDM and perceived stress [b= -.54 (SE=.24), t= -2.21, p=.029] and
the interaction between GDM and marital status [b= -.26 (SE=2.26), t= -2.33, p=.020]
(Table 28). A significant interaction term indicates that the influence of the predictor
variable on the outcome variable may depend on another predictor variable. According
to these findings, the interaction effects of perceived stress and GDM and of marital
status and GDM were significant, suggesting that perceived stress and marital status
depend on the GDM variable. This means that the relationship between perceived stress
and depression and the relationship between marital status and depression depend on
whether women have GDM or not. Therefore, the predictor variables of perceived stress
and marital status may differ for women with and without GDM. To further investigate
these differences, a third regression analysis was done. To determine where these
differences occurred, the file was split to compare women with and without GDM. In
this model, only the predictor factors (state anxiety, trait anxiety, GDM, age, marital
status, and socioeconomic status) were entered (no interaction effects were used). For
women with GDM, the factors explained 75% of the variance in depression measured by
the CES-D [R2= .75, Adjusted R2=.72, F (6, 54) = 27.18, p < .001] (Table 29). For
women with GDM, trait anxiety [b=.81 (SE=.18), t=3.79, p=.001] and marital status
[b=.29 (SE=.60), t=3.53, p=.001] were the significant predictors of depression. Also, for
women without GDM, the factors explained 73% of the variance in depression measured
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by the CES-D [R2= .73, Adjusted R2=.70, F (6, 59) = 26.21, p < .001] (Table 29).
However, for women without GDM, trait anxiety [b=.50 (SE=.13), t=3.35, p=.001] and
perceived stress [b=.40 (SE=.13), t=3.28, p=.002] were significant predictors of
depression (Table 29). Thus, trait anxiety was a significant predictor for women with and
without GDM. However, marital status was only a significant predictor for women with
GDM and perceived stress was only a significant predictor for women without GDM.
Table 29: Predictors of Depression (CES-D) for Women with and without Gestational
Diabetes
Group
GDM

No
GDM

Variable
State Anxiety
Trait Anxiety
Perceived
Stress
Age
Marital Status
Income
State Anxiety
Trait Anxiety
Perceived
Stress
Age
Marital Status
Income

B
.15
.67
-.17

SE B
.14
.18
.20

Β
.18
.81
-.13

t
1.09
3.79
-.82

p value
.282
<.001
.416

.08
2.10
.55
.01
.44
.42

.16
.60
.37
.11
.13
.13

.04
.29
.14
.01
.50
.40

.50
3.53
1.51
.06
3.35
3.28

.619
.001
.137
.955
.001
.002

-.19
-.25
.19

.15
.39
.38

-.12
-.05
.05

-1.28
-.65
.49

.206
.521
.629

When using the EPDS as the outcome variable, the predictive factors (state
anxiety, trait anxiety, GDM, age, marital status, and socioeconomic status) explained
81% of the variance [R2=.81, Adjusted R2=.80, F (7, 119) = 73.04, p < .001, Table 30].
In this model, trait anxiety [b=.42 (SE=.051), t=4.05, p<.001] and perceived stress [b=.40
(SE=.06), t=4.96, p<.001] were statistically significant predictors of depression. These
findings suggest that for every one unit increase in trait anxiety score, there is a .42
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increase in the depression score. Also, for every one unit increase in perceived stress,
there is a .40 increase in the depression score. Again, although small, these findings are
statistically significant.
Table 30: Multiple Regression for Depression (EPDS) as Outcome
Variable
State
Anxiety
Trait
Anxiety
Perceived
Stress
GDM
Age
Marital
Status
Income

B
.06

SE B
.04

β
.12

t
1.41

p value
.16

.21

.05

.42

4.05

<.001

.27

.06

.40

4.96

<.001

.69
.03
-.01

.50
.05
.17

.06
.03
-.01

1.37
.61
-.11

.17
.54
.91

-.14

.13

-.06

-1.14

.26

Once again the next regression analysis was done to determine if women with
GDM had different predictors of depression than women without GDM. This was done
by a regression analysis with the predictor variables (state anxiety, trait anxiety, GDM,
age, marital status, and socioeconomic status) and interaction effects. In this analysis,
the factors explained 82% of the variance in depression measured by the EPDS [R2=.82,
Adjusted R2=.80, F (13, 113) = 40.62, p < .001]. In this model, trait anxiety (b= .39
(SE=.07), t=2.74, p<.007] and perceived stress [b= .42 (SE=.07), t=4.20, p<.001] were
statistically significant predictor variables (Table 31). However, unlike in the CES-D
analysis there were no significant interaction effects. This suggests that there were no
differences in predictor variables between women with and without GDM. In order to
confirm this, a third regression analysis was done with a split file to compare women with
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and without GDM. This analysis also indicates that significant predictive factors were
the same for women with and without GDM. The significant predictor variables were
trait anxiety and perceived stress for both women with and without GDM (Table 32). For
women with GDM, the factors explained 89% of the variance in depression [R2=.89,
Adjusted R2=.87, F (6, 54) = 70.57, p < .001]. For women without GDM the factors
explained 74% of the variance in depression measured by the EPDS [R2 = .74, Adjusted
R2=.71, F (6, 59) = 27.28, p < .001].
Table 31: Multiple Regression with Interaction Terms and Depression (EPDS) as
Outcome
Variable
State Anxiety
Trait
Anxiety
Perceived
Stress
GDM
Age
Marital Status
Income
GDM X State
Anxiety
GDM X Trait
Anxiety
GDM X
Perceived
Stress
GDM X Age
GDM X
Marital
Status
GDM X
Income

B
.05
.19

SE B
.06
.07

Β
.09
.39

t
.80
2.74

p value
.43
.007

.29

.07

.42

4.20

<.001

-.82
.00
-.20
.02
.05

3.27
.08
.20
.20
.09

-.07
.00
-.06
.01
.16

-.25
.03
-1.00
.12
.55

.802
.979
.322
.908
.587

-.01

.11

-.03

-.08

.941

-.00

.11

-.01

-.03

.975

.04
-1.81

.11
1.08

.11
-.15

.36
-1.68

.720
.095

-.23

.26

-.13

-.88

.380

106

Table 32: Predictors of Depression (EPDS) for Women with and without Gestational
Diabetes
Group
GDM

No
GDM

Variable
State Anxiety
Trait Anxiety
Perceived
Stress
Age
Marital Status
Income
State Anxiety
Trait Anxiety
Perceived
Stress
Age
Marital Status
Income

B
.09
.19
.28

SE B
.06
.07
.08

Β
.18
.39
.39

t
1.69
2.70
3.51

p value
.097
.009
.001

.05
.35
-.22
.05
.19
.29

.06
.24
.15
.06
.08
.08

.05
.08
-.09
.10
.37
.46

.80
1.49
-1.51
.71
2.48
3.84

.425
.143
.136
.482
.016
<.001

.00
-.23
.02

.09
.23
.22

.00
-.08
.01

.01
-.99
.07

.992
.327
.944

There were a total of six multiple regression analyses done to determine the
predictor factors of depression in women with and without GDM. The first set of models
determined predictive factors of depression in general. These models determined that
when using the CES-D as the outcome variable, trait anxiety was the only significant
predictive factor. However, when using the EPDS, only trait anxiety and perceived stress
were significant predictors of depression.
The next set of analyses was done using interaction effects to determine if there
were differences in predictive factors of depression between women with and without
depression. In these models, it is the interaction effects that will determine what
differences exist between groups. When using the CES-D, there were two interaction
effects which were significant: the interaction effect between GDM and perceived stress
and between GDM and marital status. This indicates that there are differences in stress
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and marital status for women with and without GDM. To further investigate this, another
regression model was done splitting the file into groups (women with and without GDM)
to compare them. This regression analysis indicated that for women with GDM, trait
anxiety and marital status were significant predictors. However, for women without
GDM, trait anxiety and perceived stress were significant. Therefore, trait anxiety is a
significant predictor regardless of whether a woman has GDM or not. Marital status is
only a significant predictor if a woman has GDM. Women with GDM had significantly
higher depression scores if they were not married. However, perceived stress was only a
significant predictor for women without GDM where higher stress was related to higher
depression scores.
The same analysis was done using the EPDS as the outcome variable. Similar to
the CES-D model, there were two main effects which were significant; the trait anxiety
and perceived stress. However, in this analysis there were no interaction effects which
were statistically significant. Therefore according to the EPDS, there are no differences
in predictors of depression regardless if a woman has GDM or not. The regression
analysis that was done with the file split between women with and without GDM to
compare the two groups confirms that the regression analysis done with the interaction
terms. Therefore, both trait anxiety and perceived stress were significant predictors of
depression for women with and without GDM.
Data Analysis: Exploratory Aim
The exploratory aim of this study was to determine if minority women were more
at risk for depression than White women. To determine this, a chi-square analysis was
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done. Women were classified into four groups: White, Black, Hispanic, and Other
(included American Indian, Asian, and women who did not state a specific race). Two
chi-square analyses were done: one using the recommended cutoff score on the CES-D ≥
16 to categorize women as depressed and the second one using the EPDS ≥ 12 to indicate
women who had depression. To further explore the impact of race on depression, two
independent t-tests were done. In the t-test analyses the sample was grouped into White
or non-White. In one analysis, the continuous CES-D score was used as the outcome
variable and in the second analysis, the continuous EPDS score was used. The
assumptions of the Pearson’s chi-square test and the independent t-tests have been
discussed previously.
According to the results with the CES-D, there was no significant relationship
between race and depression (χ2 (3) =2.231, p=.526). Also, no significant relationship
was found when using the EPDS (χ2 (3) =4.515, p=.211).
The independent t-tests also indicated no significant difference between race and
depression. According to mean scores on the CES-D, White women (M=10.95, SE=1.38)
had slightly less depression than non-White women (M=13.59, SE=1.05). However, this
difference was not statistically significant [t (133) = -1.47, p =.143]. Similarly on the
EPDS, White women (M=5.30, SE=.75) had slightly less depression than non-White
women (M=6.73, SE= .63). Again, this difference was not statistically significant [t
(133)= -1.36, p = .175] (Table 33).
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Table 33: Independent T-Tests for Race (CES-D and EPDS)
Variable

Group

Mean

CES-D

White
NonWhite
White
NonWhite

10.95
13.59

Standard
Error
1.38
1.05

5.30
6.73

.75
.63

EPDS

Df

t statistic

p value

133

-1.47

.143

133

-1.36

.175

To determine if there were differences in depression between race, both Pearson’s
chi-square and independent t-tests were done. Although the results indicated that White
women had less depression, the differences between the groups were not statistically
significant.
Data Analysis of Maternal and Infant Health Outcomes
Although not a specific aim of this study, the reviewed literature indicated that
women with depression and gestational diabetes are more at risk for complications during
delivery. Therefore, some delivery information was analyzed to determine if women
with gestational diabetes were more at risk for complications and if women with
depression were more at risk for complications. The variables analyzed were as follows:
gestational age at delivery, type of delivery (vaginal, c-section, or instrument delivery),
presence of lacerations during vaginal delivery, delivery complications (shoulder
dystocia, presence of meconium, nuchal cord, maternal fever, postpartum hemorrhage,
chorioamnionitis, prolonged rupture of membrane, and partial abruption), Apgar scores at
one, five, and ten minutes, and infant birth weight. In order to analyze this, descriptive
statistics and frequency tables were done for women with and without GDM (Table 34).
The descriptive statistics and frequency tables were also completed for women with and
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without depression according to the CES-D score (≥ 16 being categorized as depressed)
and the EPDS score (≥ 12 being categorized as depressed) (Table 35). As mentioned in
the Missing Data section, there are six women for whom delivery data is missing. These
women delivered at an outside hospital where delivery information was unavailable.
Unfortunately, most of the women with the missing data were in the GDM group, which
may be a limitation in examining this data. Also, women with a twin pregnancy were
excluded from this analysis because of their increased risk of a cesarean section,
complications, and the inability to include more than one infant in the categories of birth
weight and Apgar scores.
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Table 34: Delivery Outcomes for Women with and without Gestational Diabetes
Variable

GDM
No GDM
N (%)
N (%)
Type of Delivery
N=56
N=65
Vaginal
27 (48%)
49 (72%)
C-section
26 (46%)
13 (20%)
Instrument
1 (2%)
4 (6%%)
VBAC
2 (4%)
1 (2%)
Lacerations
N=56
N=65
None
40 (71%)
23 (35%)
1st degree
6 (11%)
15 (23%)
2nd degree
8 (14%)
24 (37%)
3rd degree
N/A
1 (2%)
4th degree
1 (2%)
N/A
Sulcus Tear
1 (2%)
2 (3%)
Complications*
N=56
N=65
None
38 (68%)
48 (74%)
Shoulder dystocia
1 (2%)
2 (3.1%)
Meconium present
7 (13%)
11 (16.9%)
Nuchal cord
9 (16%)
6 (9.2%)
Maternal fever
2 (4%)
2 (3.1%)
Postpartum hemorrhage
2 (4%)
1 (1.5%)
Chorioamnionitis
3 (5%)
3 (4.6%)
Prolonged ROM
3 (5%)
5 (7.7%)
Partial abruption
N/A
1 (1.5%)
GDM
No GDM
Mean (SD)
Mean (SD)
Gestational Age at Delivery
38.2 (1.67)
39.0 (1.25)
Apgar: 1 min
8.07 (1.32)
8.09 (1.58)
Apgar: 5 min
8.75 (.58)
8.83 (.45)
Apgar: 10 min
8.87 (.45)
8.93 (.31)
Birth Weight (grams)
3.42 (.62)
3.32 (.48)
*Complication category will not total 100% because some women experience more than
one complication.
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Table 35: Delivery Outcomes for Women with and without Depression
Variable

Type of Delivery
Vaginal
C-section
Instrument
VBAC
Lacerations
None
1st degree
2nd degree
3rd degree
4th degree
Sulcus Tear
Complications*
None
Shoulder dystocia
Meconium present
Nuchal cord
Maternal fever
Postpartum
hemorrhage
Chorioamnionitis
Prolonged ROM
Partial abruption

Depressed
CES-D ≥ 16
N (%)
N=36
19 (52%)
15 (42%)
1 (3%)
1 (3%)

Not Depressed
CES-D < 16
N (%)
N=85
55 (65%)
24 (28%)
4 (5%)
2 (2%)

Depressed
EPDS ≥ 12
N (%)
N=21
8 (38%)
12 (57%)
1 (5%)
N/A

Non-Depressed
EPDS <12
N (%)
N=100
66 (66%)
27 (27%)
4 (4%)
3 (3%)

24 (67%)
7 (19%)
4 (11%)
N/A
1 (3%)
N/A

39 (46%)
14 (16%)
28 (33%)
1 (1%)
N/A
3 (4%)

15 (72%)
3 (14%)
3 (14%)
N/A
N/A
N/A

48 (48%)
18 (18%)
29 (29%)
1 (1%)
1 (1%)
3 (3%)

26 (72%)
3 (8%)
5 (14%)
4 (11%)
N/A
1 (3%)
N/A
2 (6%)
N/A

60 (71%)
N/A
13 (15%)
11 (13%)
4 (5%)
2 (2%)
6 (7%)
6 (7%)
1 (1%)

17 (81%)
N/A
2 (10%)
2 (10%)
N/A
1 (5%)
N/A
N/A
1 (5%)

65 (65%)
3 (3%)
16 (16%)
13 (13%)
4 (4%)
2 (2%)
6 (6%)
8 (8%)
N/A

Depressed
CES-D ≥ 16
Mean (SD)
38.2 (1.98)

Not Depressed
CES-D < 16
Mean (SD)
38.8 (1.21)

Depressed
EPDS ≥ 12
Mean (SD)
38.5 (1.18)

Non-Depressed
EPDS <12
Mean (SD)
38.6 (1.56)

Gestational Age at
Delivery
Apgar: 1 min
8.39 (.87)
7.95 (1.63)
8.10 (1.33) 8.08 (1.49)
Apgar: 5 min
8.86 (.35)
8.76 (.57)
8.90 (.30)
8.77 (.55)
Apgar: 10 min
9.00 (.27)
8.87 (.40)
9.00 (.00)
8.89 (.40)
Birth Weight
3.38 (.58)
3.36 (.53)
3.48 (.45)
3.34 (.56)
(grams)
*Complication category will not total 100% because some women experience more than one
complication.
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To determine if there were any significant differences between groups (women
with and without GDM and women with and without depression), independent t-tests
were done for the continuous variables of the following: gestational age at delivery,
Apgar at 1, 5, and 10 minutes, and birth weight. In order to do chi-square analyses, type
of delivery was made a dichotomous variable where only vaginal delivery and cesarean
section delivery were analyzed. The lacerations variable was also made dichotomous
where no tears was considered a group and the presence of a tear (first degree, second
degree, third degree, fourth degree, and sulcus tear) was considered a group.
According to the chi-square results, there was a significant difference in the type
of delivery between women with and without GDM [χ2 (1) =11.63, p=.001]. Women
with GDM had significantly more cesarean sections than women without GDM. There
was also a significant difference between groups in the presence of tears [χ2 (1) =15.66,
p<.001]. Women with GDM had significantly fewer tears than women without GDM.
However, given that the women with GDM had more cesarean sections (and you can
only have a vaginal tear if you deliver vaginally), it is not surprising that women with
GDM had fewer vaginal tears.
Assumptions for the independent t-test analysis have also been discussed
previously. The results of the independent t-tests indicate there are no differences in
Apgar scores or birth weight between women with and without GDM (Table 36).
However, there was a significant difference in gestational age at delivery: women with
GDM delivered earlier. According to the mean gestational age at delivery, women with
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GDM (M=38.23, SE=.22) delivered slightly earlier than women without GDM
(M=38.97, SE=.16). This difference was significant [t (119) = 2.81, p =.006, Table 36].
Table 36: Independent T-Tests for Infant Outcomes in Women with and without
Gestational Diabetes
Variable

Group

Mean

Gestational GDM
Age
NonGDM
1 min
GDM
Apgar
NonGDM
5 min
GDM
Apgar
NonGDM
10 min
GDM
Apgar
NonGDM
Birth
GDM
Weight
NonGDM

38.23
38.97

Standard
Error
.22
.16

Df

t statistic

p value

119

2.81

.006

8.07
8.09

.18
.20

119

.08

.938

8.75
8.83

.08
.06

103

.84

.401

8.87
8.93

.07
.04

105

.88

.381

3.42
3.32

.09
.06

115

-1.04

.302

The same chi-square analyses were done for women with and without depression.
Women were classified as depressed based on their CES-D score (≥16 as depressed) and
their EPDS score (≥12 as depressed). Type of delivery and presence of lacerations were
also dichotomized as in the previous analysis. According to the CES-D there was no
difference in the type of delivery between women with and without depression [χ2 (1)
=2.31, p=.129]. However, there was a significant difference in the presence of vaginal
tears [χ2 (1) =4.38, p=.036], where women without depression had more vaginal tears.
When using the EPDS, there was a significant difference in the type of delivery between
women with and without depression [χ2 (1) =4.01, p=.045], where women with
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depression had more cesarean sections. There were also significantly more vaginal tears
in women without depression [χ2 (1) =3.82, p=.051]. Again, because more women
without depression had vaginal deliveries, they are more likely to have vaginal tears.
Independent t-tests were also done to analyze differences in gestational age at
delivery Apgar scores (1, 5, and 10 minutes), and birth weight between women who were
and were not depressed. Two separate independent t-test analyses were done: one with
women who had a score ≥16 on the CES-D categorized as depressed and a second with
women who had a score ≥12 on the EPDS categorized as depressed. According to the
CES-D, there were no differences in gestational age at delivery, Apgar scores, or birth
weight between women with and without depression (Table 37). Gestational age at
delivery was trending towards significance where women with depression delivered
slightly earlier than women without depression. There was also a trend toward
significance with depressed women having an infant with a slightly higher ten minute
Apgar score than women without depression.
When the EPDS was used to classify women as depressed or not depressed,
similar results were found. In this analysis, the equality of variances was not met for
Apgar scores at five and ten minutes. However, there were significant differences in the
ten minute Apgar score between babies born to women who were and were not
depressed. Babies born to women with depression (M=9.00, SE=.00) had higher Apgar
scores at ten minutes than babies born to women without depression (M=8.89, SE=.04).
This difference was significant [t (92) = -2.58, p =.012]. The adjusted degrees of
freedom, t statistic, and p value have been reported in Table 38.
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Table 37: Independent T-Tests for Infant Outcomes in Women with and without
Depression (CES-D)
Variable

Group

Gestational Depressed
Age
NonDepressed
1 min
Depressed
Apgar
NonDepressed
5 min
Depressed
Apgar
NonDepressed
10 min
Depressed
Apgar
NonDepressed
Birth
Depressed
Weight
NonDepressed

Mean

Df

t statistic

p value

38.21
38.81

Standard
Error
.33
.13

46.50

1.69

.097

8.39
7.95

.15
.18

119

-1.51

.133

8.86
8.76

.06
.06

103

-1.13

.26

9.00
8.87

.05
.05

70.72

-1.84

.069

3.38
3.36

.10
.06

115

-.21

.837

Table 38: Independent T-Tests results for Infant Outcomes for Women with and without
Depression (EPDS)
Variable

Group

Gestational Depressed
Age
NonDepressed
1 min
Depressed
Apgar
NonDepressed
5 min
Depressed
Apgar
NonDepressed
10 min
Depressed
Apgar
NonDepressed
Birth
Depressed
Weight
NonDepressed

Mean
38.53
38.65

Standard
Error
.26
.16

Df

t statistic

p value

119

.32

.752

8.10
8.08

.29
.15

119

-.04

.965

8.90
8.77

.07
.06

52

-1.58

.12

9.00
8.89

.00
.04

92

-2.58

.012

3.48
3.33

.10
.06

115

-1.12

.266
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The results of the independent t-tests indicate that there are few very differences
in maternal and infant health outcomes between women with and without GDM. In fact,
only gestational age at delivery was significantly different with women with GDM
delivering earlier than women without GDM. When comparing women with and without
depression according to the CES-D there were no differences in delivery outcomes.
However, when comparing women with and without depression on the EPDS, women
with depression had more cesarean sections and babies born to women with depression
had higher Apgar scores at ten minutes. These differences were significant, but it is
important to note that there was very little difference between the means. In fact, the
small difference does not suggest a clinical significance between ten minute Apgar
scores. A larger sample size may produce different findings regarding differences
between women with and without GDM and women with and without depression.

CHAPTER FIVE
DISCUSSION
This chapter discusses the study findings, implications for nursing, and
recommendations for future research. Prenatal depression and gestational diabetes are
common complications during pregnancy. Although evidence suggested that a potential
relationship between prenatal depression and gestational diabetes exists, further research
was needed. This study found that women with GDM had higher rates of depression as
well as higher mean depression scores, but the results were not statistically significant.
However, it was determined that women with GDM were 2.7 times more likely to suffer
from depression than women without GDM when controlling for age, marital status,
income, BMI, and gravida. This finding was both statistically significant and clinically
significant. Also, women with a history of depression were 3.07 times more likely to
have GDM (when controlling for age, marital status, income, BMI, and gravida). Trait
anxiety was found to be a predictive factor of depression for both women with and
without GDM. There were no differences in depression between races, suggesting that
pregnant minority women were not at greater risk for depression. It was also determined
that gestational diabetes had little impact on delivery outcomes although women with
GDM delivered slightly earlier than women without GDM. There were very few
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differences in delivery outcomes between women who did and did not have depression.
When using the EPDS, women with depression had more cesarean sections and the ten
minute Apgar score was found to be slightly higher. Also, for both measures (CES-D and
the EPDS); women without depression were more likely to have vaginal tears.
The biopsychosocial model guided this study. This is a holistic model, in which
the biological, psychological, and sociological components of a person are all equally
important when treating an illness (Engel, 1977). The biopsychosocial model allows the
researcher or clinician to consider many factors such as quality of life, social role
performance, and emotional status during evaluation of a patient (Fava & Sonino, 2008).
There is a known relationship between depression and type 2 diabetes.
Depression is more commonly found in women with type 2 diabetes (28%) than in men
with type 2 diabetes (18%) (R. Anderson et al., 2001). Both hyperglycemia and insulin
resistance which occur in type 2 diabetes have been related to depression.
Hyperglycemia and insulin resistance are also present during gestational diabetes.
However, the relationship between gestational diabetes and depression has not been
extensively studied. This study was conducted to further investigate the possible
relationship between gestational diabetes and depression.
Description of the Sample
This convenience sample had a mean age of 29.7 years and was ethnically diverse
(33% White, 23% Black, 33% Hispanic, and 11% Other), which was representative of the
population where the data was collected. The average age of a woman giving birth for
the first time was 25 years in 2006 (Martin et al., 2009). The mean age in this sample
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may be older due to the inclusion of multiparous women and the trend in the United
States of older women having children (Martin et al., 2009). For the current study,
participants were enrolled during routine prenatal care visits and the average gestational
age at which participants filled out the self-report questionnaires was 31.1 weeks.
Women with GDM were found to be significantly older (Mean= 32.12 years) compared
with women without GDM (Mean=27.36 years). Advanced maternal age is a known risk
factor for developing GDM, therefore these findings were not surprising (Casey et al.,
1997; Jovanovic & Pettitt, 2001). In the current study, more women with GDM were
married and had higher incomes than women without GDM; however, these differences
were not statistically significant. Other studies have also not found significant
differences in marital status and income between women with and without GDM (Casey
et al., 1997; Jovanovic & Pettitt, 2001). The current study did not find differences in the
prevalence of GDM between races. This is contradictory to other studies which have
reported that GDM is more common in Black and Hispanic women (Getahun et al., 2008;
Lawrence, Contreras, Chen, & Sacks, 2008). Both of these studies had very large sample
sizes (over 100,000). The small sample size of the current study may be the reason that
GDM was not more common in minority women.
Discussion of the Variables
Depression
In the current study, two tools were used to measure depression (the CES-D and
the EPDS). To this researcher’s knowledge, this is the first study to use both tools and to
explore the relationship between the two commonly used prenatal depression measures.
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Results varied depending upon which tool was used. Using the CES-D, 28% of women
had depression when the recommended cutoff score of 16 was used. Thirty two percent
of women with GDM were found to have depression compared with 24% of women
without GDM. The items with the highest means on the CES-D for women with and
without GDM were question 7 (“I felt that everything I did was an effort”) and question
11 (“My sleep was restless”). This indicates that regardless of GDM, women during
pregnancy felt that they had to use a lot of effort in their everyday lives and that they had
problems with sleep. Other studies have reported that sleep deprivation and sleep
disturbances are common for women during pregnancy (Da Costa et al., 2010; Facco,
Kramer, Ho, Zee, & Grobman, 2010; Hall et al., 2009).
Rates of depression in this sample were compared with rates in studies examining
prenatal depression (Chazotte et al., 1995; Davis et al., 2007; Davis et al., 2004; Diego et
al., 2005; T. Field et al., 2002; Glazier et al., 2004; Holzman et al., 2006; C. Kim et al.,
2005; Lindgren, 2001; Marcus et al., 2003; S. Orr et al., 2007; S. T. Orr et al., 2006;
Records & Rice, 2007; Westdahl et al., 2007). In studies that used the CES-D in
pregnant populations, rates of depression ranged from 7.8% to 70% (Table 39).
Consistent with previous research, the women in this study (with and without GDM)
were found to have rates of depression within this range. When comparing the mean
scores on the CES-D from this study (12.73 for the entire sample, 12.97 for women with
GDM, and 12.51 for women without GDM), they were within the range cited in previous
work (6.5 to 21.9) (Table 39).
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Table 39: Prenatal Depression Research (CES-D)
Sample
Size
90 (30
GDM, 30
healthy,
30
preterm)

Sample
Characteristics
Average age
25.1 years
44% Black,
50% Hispanic,
6% White.

Percentage
Depressed
56.7% GDM,
70% at risk for
preterm labor,
33.3% healthy

Davis et al.
(2007)

247

12.7%-17.8%
(measured 3
times during
pregnancy)

Davis et al.
(2004)

22

Diego, Field,
&
HernandezReif, 2005

80

Field et al.
(2002)

112

Glazier et al.
(2004)

2,052

Holzman et
al. (2006)

1,321

Age unknown
49% White,
20% Hispanic,
11% African
American,
9% Asian.
Average age
28.0 years
68% White,
27% Hispanic,
5% Other.
Average age
27 years
46% Hispanic,
27% Black,
16% White,
11% Asian.
Average age
30.7 years
54% Hispanic,
46% African
American.
Average age
30.7 years
Racial Distr.
unknown.
Average age
unknown
69% White,
25% African
American,
6% Other.

Author
Chazotte,
Freda,
Elovitz, &
Youchah
(1995)

Mean (SD)

Range

GDM-17.0
(9.1)
PTL-20.9
(9.4)
Healthy13.7 (7.5)
6.5 (4.8)-7.3
(5.5)

Unknown

42%

14.9 (10.2)

2-34

Unknown

21.9 (6.34)

Unknown

Unknown

11.5 (8.39)

Unknown

Unknown

Unknown

Unknown

46% of teens
47%
disadvantaged
23%
advantaged

Teens-17.0
(10.3)
Disad-17.3
(11.0)
Advan-10.7
(8.7)

Unknown

0-27
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Kim, C, et
al. (2005)

1,445 (64
GDM,
148 PIH,
1,233
healthy)

Lindgren,
2001

252

Marcus, et
al. (2003)

3,742

Orr et al.
(2006)

1163

Orr et al.
(2007)

1163

Records &
Rice, 2007
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Westdahl et
al. (2007)

1,047

Average age
unknown
In women
with GDM
50% Hispanic,
25% White,
17% Black,
8%
Asian/Other.
Average age
29.5 years
77% White,
13% Black,
10% Other.
Average age
28.6 years
73% White,
13% Black.
Average age
24.1
70% Black,
30% White.
Average age
24.7
70% Black,
30% White.
Average age
27 years
89% White,
1% African
American,
4% Hispanic.
Average age
20.4 years
80% Black,
13% Hispanic,
7% White.

7.8% of GDM
10.1%
Pregnancy
Induced HTN
11.6% healthy

Unknown

Unknown

44.4%

14.37 (9.62)

0-48

20.4%

Unknown

Unknown

Unknown

16.2

0-55

44%

16.2

0-55

38%

Unknown

Unknown

33%

12.74 (8.45)

1-43
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According to the EPDS, 16% of this sample had depression using the
recommended cutoff score of 12. For women with GDM, 20% were found to have
depression compared with 13% of women without GDM. On the EPDS, items 4 and 6
had the highest mean scores for both women with and without GDM. Item 4 is “I have
been anxious or worried for no good reason.” Therefore, both women with and without
GDM were feeling worried and anxious during their pregnancy. Item 6 is “things have
been getting on top of me,” suggesting that women with and without GDM are feeling
like things are building up and may suggest feelings of stress during pregnancy. Other
studies have reported that pregnant women have high amounts of daily stressors and
feelings of anxiety (Hall et al., 2009; Reid, Power, & Cheshire, 2009).
In previous research, rates of depression ranged from 9% to 39% using the EPDS
in pregnant women (C. Anderson et al., 2002; Dayan et al., 2006; Deave et al., 2008; Hart
& McMahon, 2006; Heron et al., 2004; Larsson et al., 2004; Mautner et al., 2009;
Rubertsson et al., 2005) (Table 40). In the current study, women with and without GDM
had rates of depression within this range. In addition, the mean EPDS scores for this
sample was 6.26 for the entire sample, 6.45 for women with GDM, and 5.9 for women
without GDM, consistent with other studies which have reported scores ranging from 6.0
to 10.4 (C. Anderson et al., 2002; Dayan et al., 2006; Deave et al., 2008; Hart &
McMahon, 2006; Heron et al., 2004; Larsson et al., 2004; Mautner et al., 2009;
Rubertsson et al., 2005) (Table 40).
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Table 40: Prenatal Depression Research (EPDS)
Author
Anderson,
Roux, &
Pruitt, 2002

Sample
Size
31

Dayan et al.
(2006)

681

Deave et al.
(2008)

11,098

Hart &
McMahon,
(2006)

53

Heron et al.
8,323
(2004)
Larsson et al. 518
(2004)
Mautner et al. 90
(2009)

Sample
Characteristics
Average age
31.7 years
84% White,
10% Black,
3% Hispanic,
3% Other.
Average age
28.5 years
Racial
distribution
unknown.
Average age
28 years
96% White.
Average age
31.24 years
Racial
distribution
unknown.
*

Percentage
Depressed
29%

Mean (SD)

Range

8.71
(Unknown)

1-25

14.5% (>14)

7.2 (5.6)

0-28

14.1% (>12)

Unknown

Unknown

9% (>13)

6 (3.93)

0-16

11% (>13)

Unknown

Unknown

*

17.4%

Unknown

Unknown

Average age
31.2 years
Racial
distribution
unknown.

39% (>10)

GDM-7.55
(5.48)
HTN-9.06
(5.33)
Preterm
Labor10.41(4.79)
Healthy6.41(4.37)
Unknown

Unknown

Rubertsson et 2,674
*
14.9%
al. (2005)
* Average age and racial distribution unknown.

Unknown

126

In the general population, 10% of women have depression (Center for Disease
Control and Prevention, 2010). Therefore, pregnant women in this sample had higher
rates of depression than the general population, but did have rates consistent with
previous studies using the CESD and EPDS to measure depression in pregnant women.
The results of the current study were also consistent with another study which reported
that pregnant women had significantly higher depression scores when compared to nonpregnant women (Breitkopf et al., 2006).
When comparing the CES-D and the EPDS, the rates of depression and mean
scores were higher when using the CES-D in both the current study and in previous
research. Since the CES-D includes items that measure somatic symptoms of pregnancy
such as restless sleep and appetite, this may be the reason for the increased rate of
depression (Blaney et al., 2004; Holzman et al., 2006; S. T. Orr et al., 2006; Westdahl et
al., 2007). Because one of the items with the highest mean score was “restless sleep”,
this most likely contributed to the higher depression scores on the CES-D for the current
study.
At the site for data collection, women are informed that depression screening is
part of prenatal care and that the EPDS is used around 28 weeks’ gestation to screen for
prenatal depression. When women were enrolled into this study, they were informed that
the study was investigating moods during pregnancy. Thus, women may have recognized
the EPDS as a depression screen when filling it out for the current study. It is possible
that their familiarity with the tool may have impacted how they responded. It should be
noted that for all women, the CES-D was administered first, with the EPDS administered
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as one of the last questionnaires. Thus the ordering of the questionnaires may have
contributed to the difference in the rates of depression and the mean depression scores.
History of depression was assessed in the self-report questionnaires with “Have
you ever been diagnosed with depression?” A significant difference was found in that
women with a history of depression were more likely to have GDM . This is a clinically
significant finding because women with a history of depression may need to be screened
earlier and monitored more closely for GDM. Depression as a risk factor for type 2
diabetes has been proposed in three meta-analyses (Lustman et al., 2000; Lustman et al.,
2007; Musselman et al., 2003). It has been suggested that depression-induced changes in
neurotransmitter functions may negatively affect glycemic control by causing
hyperglycemia. This may be the physiological reason for depression predisposing a
person to diabetes (Von Kanel et al., 2001). Also, depression has been found to be
significantly related to hyperglycemia in both type 1 and type 2 diabetes (Lustman et al.,
2000). The current study supports the importance and clinical significance of a history of
depression being a risk factor for developing GDM.
Anxiety
In working women between the ages of 19 and 39, normal state anxiety scores
have been reported with a mean of 36.17 (SD±10.96) and trait anxiety scores with a mean
of 36.15 (SD±9.53) (Spielberger, Gorsuch, Jacobs, Lushene, & Vagg, 1983). For the
current study, the state anxiety scores (M=35.67) and trait anxiety scores (M=36.25) were
within 0.5 points of the normative scores. Women with GDM had about the same state
anxiety scores (M=36.98); however, they had higher trait anxiety scores (M=38.22).
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Lastly, women without GDM were found to have slightly lower state anxiety (M=34.44)
and trait anxiety (M=34.43) scores when compared to the documented norm. Two
studies using the STAI to measure anxiety reported that state and trait levels were about
equal (Allister et al., 2001; Bergant et al., 1997). However, two other studies examining
depression and anxiety using the STAI have found trait anxiety to be higher than state
anxiety as was noted in the present study (Dayan et al., 2006; Hart & McMahon, 2006).
The findings of the current study are consistent with previous research which found that
women with GDM had higher state and trait anxiety scores shortly after diagnosis of
GDM compared to women without GDM (Daniells et al., 2003).
Anxiety has been associated with prenatal depression (Allister et al., 2001;
Breitkopf et al., 2006; Glazier et al., 2004; Hart & McMahon, 2006). The current study
also found a relationship between depression and anxiety. State anxiety was correlated
with both CES-D scores (r=.712, p<.001) and EPDS scores (r=.805, p<.001). Trait
anxiety was also correlated with both CES-D scores (r=.805, p<.001) and EPDS scores
(r=.861, p<.001). Therefore, the current study was consistent with previous research.
Stress
The perceived stress scale had a reported mean score of 16.14 (SD±7.73) in a
large sample of women aged 40 and older (n=1032) (Cohen & Janicki-Deverts, in
press). It was also reported that women had higher levels of stress than men and that
stress was higher in younger people as well as individuals with lower income (Cohen &
Janicki-Deverts, in press). In the current study, women with GDM (M= 16.11) reported
similar stress levels. However, the sample as a whole (M=15.07) and women without
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GDM (M=14.11) had slightly lower levels of stress than the documented norms.
Although the current study noted that women with GDM were older, they had higher
stress which was most likely due to the diagnosis of gestational diabetes. Another study
found that women with GDM were found to have higher stress shortly after the diagnosis
of GDM when compared to women without GDM (Daniells et al., 2003). Also, one
study which used the PSS in a sample of pregnant women (n=247) reported much higher
means on the scale (M= 26.7). However, that study used a different version of the scale
(12 items) (Davis et al., 2007), making comparisons to the current study difficult.
The highest mean scores on the stress scale were the same for women with and
without GDM. Item 1 (“Have you been upset because of something that happened
unexpectedly?”) and item 3 (“Have you felt nervous or “stressed”?”) had the highest
mean scores. Literature has reported that it is common for women to experience stress
during pregnancy (Reid et al., 2009; Zust, Natwick, & Oldani, 2010).
Social Support
The mean overall social support in the current study was 6.0, which suggests that
the women had high levels of social support. Similar findings have been documented in
pregnant women (n=265) where the mean score on this tool was 6.01 (SD±.90) (Zimet et
al., 1990). This tool included three subscales: significant other support, family support,
and friend support. The mean scores in the current study for the three subscales were 6.3
for significant other support, 6.11 for family support, and 5.59 for friend support;
findings consistent with the research by Zimet et al. (1990) (significant other support
=6.39, family support=6.02, and friend support=5.64).
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For women with GDM, item 3 (“My family really tries to help me.”) and item 10
(“There is a special person in my life who cares about my feelings.”) had the highest
mean scores. Women without GDM also had item 10 as one of the highest mean item
scores and item 1 (“There is a special person who is around when I am in need”).
Because women with GDM had item 3 regarding help from family as a high item mean it
appears that they get more assistance from their family than women without GDM.
However, women without GDM had two items regarding their significant other which
indicates most of the support for women without GDM comes from the significant other.
The diagnosis of gestational diabetes may mean women require more support and
therefore these women look to family in addition to their significant other to support them
during their pregnancy. Other research has shown that women with gestational diabetes
have greater compliance with their management of diabetes if they have more social
support and fewer stressors (Ruggiero, Spirito, Bond, Coustan, & McGarvey, 1990).
Medications
Nineteen percent of women in the study were taking antidepressants, anti-anxiety,
insulin, and oral diabetes medication. Four percent of women were taking an antidepressant medication which is consistent with a large study (n=6,582) reporting that
4.5% of women used antidepressants during three months prior to pregnancy or until
delivery (Alwan, Reefhuis, Rasmussen, Friedman, & National Birth Defects Prevention
Study, 2011). For the current study, 66% of women were not taking medications for their
diabetes. However, of those taking medication (35%), only two (1%) were taking insulin
while the others were taking oral medication (glyburide). For the current study, the use
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of medications for glycemic control was consistent with a previous study where 63% of
women with gestational diabetes were diet controlled and 37% were treated with either
oral medications or insulin (Kremer & Duff, 2004).
Discussion of Study Aims
Aim 1: Difference in Depression between Women with and without GDM
The primary aim of this study was to determine if women with GDM had more
depression than women without GDM. Findings indicated that there were no statistically
significant differences between women with GDM and without GDM in terms of the
frequency of depression as well as the mean depression scores (both the CES-D and the
EPDS). Although more women with GDM reported depression (32.3%) compared to
women without GDM (24.2%), it was not statistically significant. Chazotte et al. (1995),
also reported no differences in depression between healthy women without GDM (37%)
and with GDM (57%) using the CESD-D). Although their study had higher rates of
depression, the sample was much smaller (n=30 per group), and the participants were
younger (M=26.6 years) and limited to women of 34 to 36 weeks’ gestation. Both
younger age (Glazier et al., 2004; Lindgren, 2001; S. T. Orr et al., 2006; Rubertsson et
al., 2005) and the third trimester (Records & Rice, 2007) have been associated with
higher levels of depression.
Although the current study reported that women with GDM had higher mean
depression scores than women without GDM on the CES-D (12.97 vs. 12.51) and the
EPDS (6.65 vs. 5.90), these findings were not statistically significant. Mautner et al.
(2009), also reported that women with GDM had higher mean EPDS scores (M= 7.55)
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when compared to women without GDM (M=6.41), but these differences were not
statistically significant. Limitations of this study were the small number of gestational
diabetics (n=11) and that the data was collected in Germany where generalizability to the
current study may be difficult. Chazotte et al. (1995), also reported that women with
GDM had a higher depression scores (mean CES-D=17) compared to women without
GDM (mean CES-D=13.7) which was also not statistically significant. The possible
reasons for the higher mean differences between the current study and Chazotte et al.
(1995), have been previously addressed. The lack of statistically significant findings in
all three studies may be attributed to the small sample sizes and inadequate power to
detect statistically significant findings.
For the current study, logistic regression did reveal that after controlling for age,
marital status, income, BMI, and gravida, women with GDM were 2.7 times more likely
to have depression than women without GDM when using the CES-D. A similar
analysis with the EPDS indicated that women with GDM were 2.3 times more likely to
have depression when controlling for age, marital status, income, BMI, and gravida, but
these findings were not statistically significant. The non-significant results with the
EPDS may be attributed to the difference in the measurement tools. As discussed
previously, the CES-D includes items which are somatic symptoms of pregnancy which
may increase the depression scores on the CES-D and the percentage of depressed
women in the sample, therefore impacting the logistic regression results.
The results of the current study are consistent with a research study with a sample
of over 11,000 which reported that women with diabetes during pregnancy were 1.85
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times more likely to have depression than women without diabetes (Backes Kozhimannil
et al., 2009). The findings of the current study are clinically significant. Since women
with GDM were at least two times more likely to be depressed than women without
GDM, health care providers may want to screen women with GDM more frequently for
depression during prenatal care visits.
Aim 2: Difference in Predictive Factors of Depression between
Women with and without GDM
The second aim of this study was to determine predictive factors of depression
and to examine whether women with GDM had different predictive factors of depression
than women without GDM. The first regression analysis was done to determine which
factors (state anxiety, trait anxiety, stress, GDM, age, marital status, and income) were
predictive of depression in the entire sample. When using the CES-D, it was found that
the model explained 71% of the variance in the depression scores and that trait anxiety
was the only significant predictor of depression. Perceived stress and marital status were
trending toward significance and also contributed to the amount of variance explained by
the model. Anxiety (Leigh & Milgrom, 2008) and marital status (Marcus et al., 2003)
have been found to be predictive of prenatal depression in previous research. Also,
anxiety (C. T. Beck, 2001; Heron et al., 2004), stress (C. T. Beck, 2001), and marital
relationships have been reported as significant predictors of postpartum depression (C. T.
Beck, 2001).
It was also interesting that the other factors entered into the model (state anxiety,
GDM, age, and income) were not significant predictors of depression. Some of the
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reviewed literature has reported that age (Glazier et al., 2004; Holzman et al., 2006;
Lindgren, 2001; S. T. Orr et al., 2006; Rubertsson et al., 2005; Steer et al., 1992;
Westdahl et al., 2007), marital status (H. G. Kim et al., 2006; Lindgren, 2001; Marcus et
al., 2003; S. T. Orr et al., 2006; Rubertsson et al., 2005; Westdahl et al., 2007), and
income (Glazier et al., 2004; Holzman et al., 2006; Lindgren, 2001) impact depression.
Studies had sample sizes ranging from 154 to 3,472 (Appendix H). Age, income levels,
and marital status were varied in these studies. Other research has not found significant
relationships between depression and age (Dayan et al., 2006; Diego et al., 2005; Hart &
McMahon, 2006; Marcus et al., 2003) and marital status (Dayan et al., 2006; Diego et al.,
2005). The sample sizes (53 to 3,472), ages, and marital status were also varied in these
studies. However, two of these studies had smaller samples (<100) (Diego et al., 2005;
Hart & McMahon, 2006). Although age, income, and marital status were associated with
depression in most studies, there were some studies that indicated these factors were not
related to depression, but these studies tended to have smaller samples. Therefore, the
sample size may dictate whether a significant relationship between age, marital status,
and income is found.
Regression was used to determine if predictive factors of depression were
different in women with GDM when compared to women without GDM. Trait anxiety
was a significant predictor for both groups. Trait anxiety is relatively stable and
reflective of long-term anxiety levels. People with high trait anxiety have been reported
to perceive stressful events as more unsafe (Spielberger et al., 1983). Previous research
has reported a positive correlation between depression and anxiety when using the STAI
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(Allister et al., 2001; Bergant et al., 1997; Davis et al., 2007; Davis et al., 2004; Dayan et
al., 2006; Glazier et al., 2004; Hart & McMahon, 2006). One study examined the
relationship between depression and anxiety, but only the state anxiety portion of the
STAI was used (Breitkopf et al., 2006). Findings indicated that depression scores
(measured by the Beck Depression Inventory) were predictive of state anxiety scores.
However, the current study found that trait anxiety was predictive of depression which is
consistent with longstanding anxiety as compared with state anxiety which is more
temporary. A high state anxiety score would indicate that a person is anxious at the time,
whereas a high trait anxiety score indicates that a person is more anxious over the long
term. Because the depression measures asked how women felt in the past week (and not
at the present time), it would be expected that the trait anxiety score would be the one that
is predictive of depression compared to the state anxiety score. In addition, clinical
practice has indicated that both anxiety and depression occur more often together rather
than in isolation (Ballenger, 1999).
When using the CES-D differences in predictive factors of depression were found.
Marital status was a significant predictor of depression for women with GDM and
perceived stress was significant for women without GDM. Married women with GDM
had lower depression scores than single women with GDM.

The finding that married

women had lower depression scores is consistent with previous research (Kelly et al.,
1999; H. G. Kim et al., 2006; Lindgren, 2001; Marcus et al., 2003; S. T. Orr et al., 2006;
Rubertsson et al., 2005; Westdahl et al., 2007). Still, being married did not have an
impact of depression scores for women without GDM. This finding was consistent with

136

the research which did not show a relationship between marital status and depression
(Dayan et al., 2006; Diego et al., 2005). Also, women without GDM had higher
depression scores if they had higher stress scores. Two previous studies reported a
positive relationship between prenatal depression and stress (Davis et al., 2007; Glazier et
al., 2004). As discussed previously, marital status (Marcus et al., 2003), stress (C. T.
Beck, 2001), and anxiety (C. T. Beck, 2001; Heron et al., 2004; Leigh & Milgrom, 2008)
are known predictors of depression.
Regression was also used to determine predictive factors of depression using the
EPDS. The first model showed that the factors explained 81% of the variance in
depression. In this model, trait anxiety and perceived stress were the significant
predictors of depression. As discussed previously, state anxiety, GDM, age, marital
status, and income were not significant predictors of the model. Unlike the CES-D which
found that marital status was predictive of depression for women with GDM and stress
was predictive in women without GDM, the EPDS found that trait anxiety and perceived
stress were significant predictors of depression for women with and without GDM.
Trait anxiety is a constant and significant predictor of depression when using the
CES-D and the EPDS. If the patient has a diagnosis of an anxiety disorder or a history of
an anxiety disorder, clinicians may want to screen for prenatal depression frequently
during prenatal care.
There were differences in predictor variables based on which outcome variable
(the CES-D or the EPDS) was used. This may be due to the fact that more women had
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higher scores on the CES-D than on the EPDS. As discussed earlier, this may be related
to the somatic symptoms of pregnancy items included on the CES-D.
Aim 3: Race and Depression
The third aim of this study was to determine if minority women were more at risk
for depression than White women. Although this study had a good representation of
minority women (32.6% White, 32.6% Hispanic, 23% Black, 11.9% Other), results
indicated that race was not associated with depression. Other studies have reported
similar findings (Diego et al., 2005; Marcus et al., 2003; Sleath et al., 2005; Westdahl et
al., 2007) (Appendix H). Two studies, however, have reported that race is related to
depression (Lindgren, 2001; S. T. Orr et al., 2006). Lindgren (2001) reported that nonWhite women had higher depression scores, but did not indicate if these differences were
statistically significant. Orr et al. (2006), did indicate that Black women had significantly
higher depression scores than White women. However, Blacks were more likely to be on
Medicaid so the difference found in depression scores between races may be more
attributable to socioeconomic factors than race. Other studies did not report the racial
distribution of the sample or did not indicate if race was related to depression scores,
making it difficult to compare the current study results to these studies (Glazier et al.,
2004; Hart & McMahon, 2006; Rubertsson et al., 2005; Steer et al., 1992). The current
study has results consistent with most research on prenatal depression and race which
suggests that minority women do not appear to be at increased risk for depression (Diego
et al., 2005; Marcus et al., 2003; Sleath et al., 2005; Westdahl et al., 2007).
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Other Findings: Maternal and Infant Health Outcomes
Delivery and infant health information were extracted from the EMR to determine
the impact of GDM on delivery complications and infant health. This was also analyzed
in terms of depression status. The outcomes analyzed were as follows: gestational age at
delivery, type of delivery, presence of lacerations, delivery complications (shoulder
dystocia, presence of meconium, nuchal cord, maternal fever, postpartum hemorrhage,
chorioamnionitis, prolonged rupture of membrane, and partial abruption), Apgar scores at
one, five, and ten minutes, and infant birth weight.
When comparing women with and without GDM in terms of gestational age at
delivery, it was found in that women with GDM delivered earlier (38.1 weeks) compared
to women without GDM (38.8 weeks). Although this was statistically significant, it was
not clinically significant. Women with GDM may have delivered slightly earlier because
they are at greater risk for macrosomia, and induction at 38 weeks may reduce the rate of
macrosomia (Nicholson et al., 2008). It should be noted that women with GDM had
significantly more cesarean sections than women without GDM, which is consistent with
previous research (Casey et al., 1997). Women without GDM were more likely to have
vaginal tears; which would make sense, since they were more likely to deliver vaginally.
Women were also compared according to whether they had depression or not.
This was done using the recommended cut scores for both tools (CESD-D and EPDS).
A significant difference was found using the EPDS where infants born to depressed
women had higher Apgar scores at 10 minutes (9.0) compared to non-depressed women
(8.91). However, this was not a clinically significant finding. Also, when using the
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EPDS, women with depression were significantly more likely to have cesarean sections
than women without depression. This finding is consistent with previous research
(Larsson et al., 2004). The last significant difference was found when using both the
CES-D and the EPDS: women without depression were more likely to have vaginal tears;
which would make sense, since they were more likely to deliver vaginally.
Data Quality of the Electronic Medical Record
There is an immense amount of information in the EMR that can be extracted and
used for research purposes. However, when using the EMR for research purposes there
are some aspects that are important to keep in mind. Hayrinen, Saranto, & Nykanen
(2008) have reported that information found in the EMR should be complete, accurate,
and reliable when compared to a paper medical chart. The current study did not compare
information from the EMR to a paper chart, so it is impossible to determine if the EMR
was more or less accurate, complete, and reliable than a paper chart. However, there
were some variables extracted from the EMR which had missing data (Appendix E),
suggesting that data from the EMR is not always complete. In the current study, it was
often found that the data missing on the provided template was located in the physician
notes. Information was not always consistent throughout the chart, which raises concerns
of accuracy. There were differences found between information provided in the template
and in the physician notes (Appendix F). For example, the gestational age at delivery
was documented differently between the template and the physician notes and this made
it difficult to determine which information was accurate and reliable. In the current
study, when contradictory information was found between the template and physician
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note, the information written in the note was used in the analysis, since the investigator
believed this information would be more accurate and reliable than information
documented in a flow sheet.
The current study also identified instances when data would have been missed or
mis-classified based on the information provided in the template. For example, there
were six participants for whom a diagnosis of GDM was written in a note in the chart but
was not listed in the active problem list. The active problem list was provided on the
template and was the list of active diagnoses the patient had at the time of delivery and a
way to identify women with GDM. Had the lab results and notes not been accessed, the
six women without GDM on the active problem list would never have been identified as
GDM or they would have been classified as non-GDM, resulting in an error in analysis.
Missing information on the template was also identified as a problem in a study which
compared the amount of prescribed medication to the elderly between two data sources
(Vandenberghe et al., 2005). This study compared a semi-automatic data extraction
system from the EMR (similar to the template in the current study) to the amount of
prescribed medication on the EMR to a paper chart (Vandenberghe et al., 2005). This
study found that the proportion of patients who were prescribed drugs to treat
osteoarthritis was almost twice as high for the general practitioners recording data on
paper sheets (64%) when compared with the general practitioners using EMR (36%).
Researchers in that study had two possible explanations for the difference in findings: (1)
the general practitioners wrote the prescriptions on paper and did not record them in the
EMR or (2) the prescriptions were recorded in a different place in the EMR and the semi-
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automatic extraction was not able to capture the total number of patients on medications
(Vandenberghe et al., 2005). The current study also found that information could be
missing on the template, but was often recorded in a place in the chart which the template
used for data retrieval was not able to capture. Although most data could be found when
accessing the notes, checking all the information in the template against the notes in the
chart was time-intensive and future studies may find it beneficial to develop a systematic
approach to extract data from the EMR in order to decrease the amount of time it takes
for data extraction. In the current study, a system was developed by the investigator.
First, lab results were extracted to determine which women had a diagnosis of GDM and
to ensure accurate classification of women with GDM. Next the information provided by
the informatics specialist on the template was compared to the information written in the
chart. To do the comparison, five notes in the chart were read. Three notes were read in
the maternal EMR: the admission note at the start of prenatal care, the admission note at
the time of delivery, and the discharge note. Two notes were read in the infant chart: the
admission to the nursery note and the discharge summary note. The investigator found
that by reading these five notes, most missing data could be retrieved and any inaccurate
data on the template could be captured in one of these physician notes. The utilization of
this systematic approach allowed for the information extracted from the EMR to be
complete, accurate and reliable.
Summary of Major Findings
When analyzing the scores on the self-report questionnaires, the mean scores on
the scales were similar to the normative scores. However, the standard deviations were
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large and may be a reason that statistically significant differences were not found.
Although women with GDM were found to have higher depression scores on both the
CES-D and the EPDS and the rates of depression were higher among these women, it was
not statistically significant. However, after controlling for age, marital status, income,
BMI, and gravida, women with GDM were 2.7 times more likely to have depression
(when measured by the CES-D), which was statistically and clinically significant. When
using the EPDS, women with GDM were 2.4 times more likely to have depression (when
controlling for age, marital status, income, BMI, and gravida), but the findings were not
statistically significant. Another important finding was that women with a history of
depression were more likely to have GDM. This finding suggests that a history of
depression is a risk factor in development of GDM.
When determining predictive factors of depression, trait anxiety was the one
factor that was significant in every analysis. Other significant predictive factors in some
of the models were stress and marital status. No significance difference was found
between race and depression in the current sample of women. When delivery outcomes
were compared between women with and without GDM, women with GDM had more
cesarean sections and were found to deliver earlier than women without GDM (but this
was not clinically significant). When comparing delivery outcomes in women with and
without depression, women with depression (on the EPDS) had more cesarean sections.
Women with depression (as measured by the EPDS) had infants with slightly higher tenminute Apgar scores, but again this was not clinically significant. Women without
depression had more vaginal tears (when measured by both the CES-D and the EPDS).
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The interpretation of these delivery outcomes must also be interpreted with caution
because a Bonferroni correction was not utilized.
Study Limitations
There were limitations in this study based on threats to internal and external
validity. The first threat to internal validity was selection bias. A convenient, nonrandom sample was used. Because of the sampling techniques, a significant difference in
age was noted in that women with GDM were older. This difference in groups was
accounted for in the analyses to address this impact of this limitation. The next threat to
internal validity was the use of self- report questionnaires as the measure for depression.
Depression self- report questionnaires do not always generate the same results as a
clinical diagnosis of depression (Murray & Cox, 1990). Therefore, some women may
have been classified as depressed based on the recommended cutoff score for the CES-D
and the EPDS, but they may not have been clinically depressed based on the diagnostic
criteria. The last threat to internal validity was the missing data. There was a limited
amount of missing data from the self-report questionnaires. In order to reduce missing
data, questionnaires were reviewed after they were completed by participants to reduce
this error. In cases where data was missing, a conservative method was used for
replacement where the individual’s mean score was used.
There were also two external validity threats which pose limitations to the study.
The first is that the study excluded non-English-speaking women and pregnant women
less than 18 years of age. Results and conclusions may not be generalizable to teenagers
and non-English-speaking women. Also, the sample size was small and was obtained
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from the greater Chicagoland area. The results are not generalizable beyond the
institution where data was collected. In addition, because women were recruited for the
study at prenatal care visits, all study participants were receiving prenatal care at some
point during their pregnancy. Therefore, women who did not receive prenatal care and
who may be at more risk for depression and delivery complications were not represented
in the study.
Nursing Implications
Nurses have a great deal of contact with patients during their prenatal care visits.
It is important for nurses to know and understand the prevalence and symptoms of
antenatal depression. Nurses need to be sensitive to women with prenatal depression and
provide care to treat them appropriately. Often nurses provide education to the women
diagnosed with gestational diabetes. It is imperative that nurses are aware that women
with GDM are more likely to have a history of depression and are at least two times more
likely to have antenatal depression. It may be desirable to include a depression screen in
the diabetic teaching session. A psychosocial screen (such as a depression screen), is
recommended for people with diabetes (American Diabetes Association, 2010a).
However, a depression screen is not included in the recommended guidelines for
treatment of gestational diabetes (American Diabetes Association, 2010b). Gestational
diabetes education could include the symptoms of depression which may develop during
pregnancy and the postpartum period. Also, involved family members or supportive
people in the pregnant woman’s life should be educated on the risk of depression and
symptoms of depression. Women with prenatal depression may need some help in
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identifying their depression and encouragement to seek help. If the family and support
system of the woman are educated on depression, they may be more likely to help and
encourage the woman to seek depression help and treatment. An Illinois Public Health
Act (Public Act 095-0469), indicates that depression education should provided to all
women receiving prenatal care. The act also encourages the inclusion of families in the
education. The act does not mandate a prenatal depression screen, but does recommend
that all women receiving prenatal care be given the option to complete a depression
screen. At the data collection site, the recommendations of this act were followed and
women were routinely screened for depression during prenatal care using the EPDS. The
number of women with prenatal depression found in the current study supports the
recommendations provided in the public act. Health care providers who are not currently
screening for depression during routine prenatal care visits, should implement a
depression screen in order detect and address depressive symptoms in pregnant women.
Women need to be reassured by nurses that depression is common and there is
treatment in order to help them deal with the symptoms. Nurses should strive to provide
understanding and sympathetic care while instilling hope that the depression symptoms
will improve. Antidepressant medication is a possible treatment option for women with
antenatal depression. Although there is research to suggest that antidepressants may be
associated with an increased risk of fetal anomalies, there is also research to indicate that
there is no association (Wisner et al., 2009). One study of pregnant women (n=238)
between 20 and 36 weeks’ gestation reported that although antidepressant use and
untreated depression were not related to an increased risk of physical anomalies in the
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infants, they were related to premature births (Wisner et al., 2009). Therefore, depression
should be assessed and evaluated for treatment in the antenatal period because of the
impact on the mother as well as on the unborn baby.
Another major finding of this study is that women with a history of depression
were three times more likely to develop GDM. Therefore, a history of depression was
found to be a risk factor in development of GDM. All health care providers should be
aware of the relationship between the history of depression and GDM. Health care
providers may want to consider earlier screening for GDM in women with a history of
depression.
Future Research
Because many of the findings in the current study were trending toward
significance, a larger study may be needed to determine if there are additional statistically
significant differences in depression between women with and without GDM. This study
indicated that 28% of women had depression according to the CES-D and 16% had
depression using the EPDS. Because the CES-D includes items which are somatic
symptoms of pregnancy, future research may want to use the EPDS or another
measurement which does not include somatic symptoms of pregnancy.
Future intervention studies should be done to decrease the amount of depression
and the depressive symptoms which occur during pregnancy. A meta-analysis paper
reviewed 11 studies which included the treatment of prenatal and postpartum depression
(Bledsoe & Grote, 2006). Of the 11 studies, only four were done during the prenatal
period. Three of these four studies used interpersonal therapy (IPT) and one study used
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an education intervention. Interpersonal therapy treats depression by addressing
interpersonal problems related to the current depressive symptoms (Bledsoe & Grote,
2006). The meta-analysis paper did not indicate if the depression treatments during
pregnancy were done on an individual basis or in groups (Bledsoe & Grote, 2006).
Cognitive behavioral therapy (CBT) was used to treat postpartum depression in three of
the studies and focuses on improving cognitive skills and changing negative thoughts
(Bledsoe & Grote, 2006). The current study found that stress and anxiety were common
symptoms which occurred with depression. Future intervention studies may want to use
IPT or CBT to treat depression, stress, and anxiety at the same time. The successful
treatment of prenatal depression, stress, and anxiety may improve the quality of life and
health outcomes of the mother and baby.
Group CBT has been used to successfully treat depression and anxiety in women
with type 2 diabetes (Penckofer et al., 2010). However, the use of group CBT has not
been done during pregnancy. Group therapy may provide an economical approach to
antenatal depression treatment. Also, pregnant women may like the aspect of a group
treatment during pregnancy because they could provide support for each other during all
the changes which occur in pregnancy.
Because women with GDM were more likely to have a history of depression and
twice as likely to have antenatal depression, future studies may want to test an
intervention that includes depression treatment incorporated into the gestational diabetic
teaching. Similar to the CBT treatments described above, these could be specific to
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women with GDM and could include treatment of depression and educational
information on how to manage gestational diabetes.

APPENDIX A
SELF-REPORT QUESTIONNAIRES
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Center for Epidemiologic Studies Depression Scale (CES-D)
Below is a list of ways you might have felt or behaved. Please tell me how often you
have felt this way during the past week.
Rarely or
none of the
time
(less than 1
day)

Some or
a little of
the time
(1-2
days)

1. I was bothered by things
that usually don’t bother me

1

2. I did not feel like eating;
my appetite was poor

2

Occasionally
or a
moderate
amount of
time
(3-4 days)
3

4

1

2

3

4

3. I felt that I could not shake
off the blues even with help
from my family or friends
4. I felt I was just as good as
other people

1

2

3

4

1

2

3

4

5. I had trouble keeping my
mind on what I was doing

1

2

3

4

6. I felt depressed

1

2

3

4

7. I felt that everything I did
was an effort

1

2

3

4

8. I felt hopeful about the
future

1

2

3

4

9. I thought my life had been
a failure

1

2

3

4

10. I felt fearful

1

2

3

4

Most or
all of the
time
(5-7 days)
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11. My sleep was restless

1

2

3

4

12. I was happy

1

2

3

4

13. I talked less than usual

1

2

3

4

14. I felt lonely

1

2

3

4

15. People were unfriendly

1

2

3

4

16. I enjoyed life

1

2

3

4

17. I had crying spells

1

2

3

4

18. I felt sad

1

2

3

4

19. I felt that people dislike
me

1

2

3

4

20. I could not get “going”

1

2

3

4
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Multidimensional Scale of Perceived Social Support
Instructions: We are interested in how you feel about the following statements. Read
each statement carefully. Indicate how you feel about each statement.

1. There is a special
person who is
around when I
am in need
2. There is a special
person with whom
I can share my
joys and sorrows
3. My family really
tries to help me
4. I get the emotional
help and support I
need from my
family
5. I have a special
person who is a
real source of
comfort to me
6. My friends really
try to help me
7. I can count on
my friends when
things go wrong
8. I can talk about
my problems with
my family
9. I have friends with
whom I can share
my joys and
sorrows
10. There is a special
person in my life
who cares about
my feelings
11. My family is
willing to help
me make
decisions
12. I can talk about
my problems with
my friends

Very
Strongly
Disagree

Strongly
Disagree

Mildly
Disagree

Neutral

1

2

3

4

1

2

3

1

2

1

Mildly
Agree

Strongly
Agree

Very
Strongly
Agree

5

6

7

4

5

6

7

3

4

5

6

7

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7
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Spielberger State-Trait Anxiety Scale (Only the first five items are printed so as not to
violate copy right laws).
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Perceived Stress Scale
The questions in this scale ask you about your feelings and thoughts during the
last month. In each case, you will be asked to indicate by circling how often you
felt or thought a certain way.

155

Edinburgh Postnatal Depression Scale (EPDS)
Are you pregnant or have recently had a baby? We would like to know how you are
feeling. Please check the answer that comes closest to how you have felt in the past 7
days, not just how you feel today.
In the past 7 days:
1. I have been able to laugh and see the
funny side of things
__As much as I always could
__Not quite so much now
__Definitely not so much now
__Not at all
2. I have looked forward with
enjoyment to things
__As much as I ever did
__Rather less than I used to
__Definitely less than I used to
__Hardly at all

6. Things have been getting on top of
me.
__Yes, most of the time I haven’t been
able to cope at all
__Yes, sometimes I haven’t been coping
as well as usual
__No, most of the time I have coped
quite well
__No, I have been coping as well as ever
7. I have been so unhappy that I have
had difficulty sleeping
__Yes, most of the time
__Yes, sometimes
__Not very often
__No, not at all

3. I have blamed myself unnecessarily
with things went wrong
__Yes, most of the time
__Yes, some of the time
__Not very often
__No, never

8. I have felt sad or miserable
__Yes, most of the time
__Yes, quite often
__Not very often
__No, not at all

4. I have been anxious or worried for no
good reason
__No, not at all
__Hardly ever
__Yes, sometimes
__Yes, very often

9. I have been so unhappy that I have
been crying
__Yes, most of the time
__Yes, quite often
__Only occasionally
__No, never

5. I have felt scared or panicky for no
very good reason
__Yes, quite a lot
__Yes, sometimes
__No, not much
__No, not at all

10. The thought of harming myself has
occurred to me
__Yes, quite often
__Sometimes
__Hardly ever
__Never
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Demographic and Health History Information

ID #____________

MRN#__________________ Date_________________

Please fill out the information below.
1.

Age: _______________

2.

Ethnicity: (please circle one)
1. Hispanic
2. Non-Hispanic

3.

Race: (please circle one)
1. Alaska Native
2. American Indian
3. Asian
4. Black
5. White
6. Native Hawaiian or Other Pacific Islander
7. Preference not indicated
8. Other

4.

Marital Status: (please circle one)
1. Married
2. Divorced
3. Separated
4. Single, and not living with partner
5. Single, and living with partner

5.

Estimated Due Date: __________________

6.

Was your current pregnancy planned?

YES

NO
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7.

Please list any medications you are currently taking:

______________________

____________________

______________________

____________________

______________________

____________________

______________________

____________________

8.

Have you ever been diagnosed with depression?

YES

9.

Please circle any of the following conditions you have been diagnosed with:
1.
2.
3.
4.
5.
6.
7.

NO

Asthma
Diabetes
High Blood Pressure
Depression
Bipolar Disorder
Schizophrenia
Other: _____________________________________

10.

How many times have you been pregnant? _______________

11.

How many of those pregnancies did you deliver a full term (after 37 weeks)

baby?

12.

___________

How many of those pregnancies did you deliver a preterm (between 20 and 37

weeks) baby?

13.

____________

How many miscarriages have you had? ___________________
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14.

How many abortions have you had? _______________

15.

How many living children do you have? ____________________

16.

Have you ever had a cesarean section?

17.

What is your annual income?
1.
2.
3.
4.
5.
6.
7.
8.
9.

Less than $5,000 _____
$5,000 to $9,999 ______
$10,000 to $19,999 ______
$20,000 to $29,999 ______
$30,000 to $39,999_______
$40,000 to $49,999_______
$50,000 to $59,999______
$60,000 to $69,999______
Over $70,000____

YES

NO

APPENDIX B
PREGNANCY AND MOOD STUDY FLYER
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APPENDIX C
ELECTRONIC MEDICAL RECORD DATA COLLECTION FORM
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Variables to be Collected From the EMR
ID # _____________

Date ___________

PREGNANCY DATA:
Maternal Date of Birth ______________________
Result of One Hour Glucose Tolerance Test _____________ Date of test ____________
Result of 3-hour Glucose Tolerance Test (only if 1 hour is greater than 130 mg/dl)
Fasting ______1___________ 2___________ 3__________ Date of test _________
Gestational Diabetes

YES

Pre-pregnancy Weight ____________lbs.

NO
Date of weight ___________

Weight at appointment when questionnaire completed: _____________lbs.
Height ____________in
BP at appointment when questionnaire completed: _________

Gravida __________
Parity __________

EPDS SCORE @ 28 weeks gestation ___________________

DATA TAKEN FROM CHART AT TIME OF DELIVERY:
Weight at Delivery admission ___________lbs.
History of abuse: YES
NO
If yes: what (physical, emotional, sexual) and when __________________________
History of tobacco use: YES

NO
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If yes: how much (packs per day) ___________________________
History of alcohol use: YES
NO
If yes: how much ______________________________________
History of illicit drug use: YES
NO
If yes: what drug and how much________________________________________
Active Patient Problem List ___________________________________
Past medical History (including history of depression) _________________________
Current
medications_____________________________________________________________
DELIVERY DATA:
Gestational age at delivery ________________weeks
Sex of infant: Male

Female

Infant weight ____________________ounces
Infant length____________________inches
SGA

AGA

Induction of Labor:

YES

LGA
NO

Type of Delivery:
Spontaneous Vaginal Delivery
Mid Forceps Delivery
Breech Assisted

Forceps Outlet

Vacuum

YES

YES

NO
NO

UNKNOWN

Delivery complications _______________________
Episiotomy:

Low Forceps Delivery

Breech Extraction

History of Previous C-section:
Shoulder Dystocia:

Cesarean

YES

NO
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Perineal Tear:

YES

NO

If yes, degree of laceration: 1

2

APGARS: 1 min _______________

3

4

5 min_____________ 10 min_______________

Infant Blood Glucose (from heel stick):
#1_________________

#2___________________

#3__________________

EPDS Score at Delivery _______________
Breastfeeding:

YES

NO

POSTPARTUM DATA:
EPDS Score at 2 weeks postpartum ______________________
EPDS Score at 6 weeks postpartum ___________________
Maternal weight at 6 weeks postpartum ________________kg
Fasting Blood Glucose at 6 weeks postpartum ________________mg/dL
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IRB NUMBER: 202019121609

LOYOLA UNIVERSITY HEALTH SYSTEM
MAYWOOD, ILLINOIS
NIEHOFF SCHOOL OF NURSING
STRITCH SCHOOL OF MEDICINE

INFORMED CONSENT
(a copy of consent must be inserted in participant's file)

Participant's Name:_________________________________

Project Title: “Pregnancy and Mood Study”

The project will undergo re-review on or before 6/16/2011.

Patient Information
PRINCPLES CONCERNING RESEARCH: You are being asked to take part in a
research project. It is important that you read and understand the principles that apply to
all individuals who agree to participate in the research project described below:

1. Taking part in the research is entirely voluntary.
2. You may not benefit from taking part in the research but the knowledge obtained
may help health professionals understand the experiences of women with
diabetes.
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3. You may withdraw from the study at any time without anyone objecting and
without penalty or loss of any benefits to which you are otherwise entitled.
The purpose of the research, how it is to be done, and your part in the research is
described below. Also described are the risks, inconveniences, discomforts and other
important information which you need to make a decision about whether or not you wish
to participate. You are urged to discuss any questions you have about this research with
the staff members.
PURPOSE OF RESEARCH: You are being asked to participate in this research
because you are having a baby. There is evidence to indicate that pregnant women may
experience hormonal fluctuations and have mood alterations during pregnancy. There is
also evidence to indicate that fluctuations in blood sugar are associated with mood
alterations. We are interested in studying whether the alterations in mood during
pregnancy are greater in women who have gestational diabetes. Gestational diabetes is
when a woman has high blood sugars that start or are first diagnosed during pregnancy.
Thus, we will be comparing the health and well-being of women who have gestational
diabetes with those who do not have gestational diabetes. The purpose of this study is to
find out if women with gestational diabetes experience more mood alterations than
women who do not have gestational diabetes.
Approximately 120 pregnant women will participate in this study. The information
obtained from this study will be used to develop future research projects on pregnant
women.
DESCRIPTION AND EXPLANATION OF PROCEDURES: If you agree to
participate in this research you will be asked to complete a questionnaire booklet that will
take about 20 to 30 minutes. The questionnaire booklet will ask you about your moods
(depression, anxiety, and stress), your support systems, and your demographic and health
history. We will also be obtaining information from your medical record that is part of
your routine care during your pregnancy and delivery. In addition, we will be obtaining
information from the medical record of your baby once it is delivered. .
POTENTIAL RISKS AND DISCOMFORTS: Because you will be filling out
questionnaires related to your moods, you may experience feelings of sadness or anxiety.
If you experience these feelings you should talk with the healthcare provider you are
seeing at your appointment.
It is important that you understand that if you need assistance with the management of
your emotions such as medication or counseling, you should talk to your health care
provider about this. If you report feelings of harming yourself on the questionnaire, this
information will be shared with your healthcare provider at the clinic.
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All information taken from your medical record will be kept confidential. There will be
no identifying information (name, birth date, or social security number).
POTENTIAL BENEFITS: We do not know if you will benefit from participating in
this study. The information learned in this study may help others in the future.
ALTERNATIVES: You do not have to participate in this project if you do not want to.
Your decision about participation will not affect your care in any way. If you are an
employee of Loyola University, your decision about participation will not affect your
evaluations or career or career opportunities in any way.
FINANCIAL INFORMATION: There are not costs associated with your participation
in this research. You will be responsible for all costs associated with your care and
treatment at Loyola.
You will be given a $10 gift card for participating in the study.
INFORMATION COLLECTED AND WHAT WILL HAPPEN TO IT: In order to
meet the goals of the research study (see Purpose of Research section of this consent), we
will collect information on you. The information will be collected by Mary Byrn, RN.
All data will be stored in a locked file cabinet in the researcher’s office. Only the
research team will have access to those files.
The results of this research study may be published in a journal for the purpose of
advancing medical knowledge. You will not be identified by name or by any other
identifying information in any publication or report about this research.
The information we will collect includes:
X_DEMOGRAPHIC INFORMATION (E.G., NAME, ADDRESS, PHONE
NUMBER)
X_QUESTIONNAIRES ABOUT YOUR MENTAL HEALTH INCLUDING MOOD
AND FEELINGS
X_INFORMATION TAKEN FROM YOUR MEDICAL RECORD (E.G., HEIGHT,
WEIGHT, ORAL GLUCOSE TOLERANCE TEST RESULTS, DEPRESSION
SCREENING SCORES, DELIVERY INFORMATION, SUBSTANCE ABUSE
HISTORY, PLANS TO BREASTFEED)
This authorization expires when the sponsor has collected all of the data and the analysis
is complete.
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Consent for Loyola University Health System (LUHS) to use and disclose your
information is required in order for you to participate in the study.
Withdrawal of Consent: Your consent to use and disclose your information for the
purpose of this research study is completely voluntary. You can withdraw your consent for
LUHS to use and disclose your information and your consent to participate in this study at
any time without affecting your ability to receive care and treatment at LUHS unrelated to
the research study. Withdrawal means that all study procedures and follow-up will stop
and we will not send any more information about you. However, information already used
and disclosed to the researcher prior to the time of your withdrawal from this study may
continue to be used and disclosed by LUHS.
If you withdraw from the study we will ask that you sign the form attached to this consent
and send it to Mary Byrn, RN. Your withdrawal from the study will not have any affect on
any actions by LUHS taken before the attached form is received by LUHS.
Your study doctor, the Institutional Review Board/Independent Ethics Committee, the
regulatory authorities, or Loyola University Chicago may terminate the study at any time
with or without your consent.
CONSENT
I have fully explained to ____________________________ the nature and purpose of the
above described procedure and the risks that are involved in its performance. I have
answered and will answer all questions to the best of my ability. I may be reached at 708216-9304, Mary Byrn, RN.
________________________________
(Signature)

_________________
Date

Mary Byrn, RN, principal investigator for this study, will be available to answer any
questions you may have. Sue Penckofer, PhD, RN can be reached at: 708-216-9303.
If you ever feel that you have been injured by participating in this study or if you have any
questions concerning your rights as a research participant, you may contact Dr. Kenneth
Micetich, Chairman, Institutional Review Board for the Protection of Human SubjectsMedical Center (708-216-4608).
You will receive a signed copy of this informed consent document.
You have been fully informed of the above-described research program with its possible
benefits and risks. Your signature below indicates that you are willing to participate in this
research study and agree to the use and disclosure of information about you as described
above.
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You do not give up any of your legal rights by signing this consent document.
_________________________________________________Date:_____________
(Signature: Patient)
_________________________________________________Date:_____________
(Signature: Witness)
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REVOCATION OF AUTHORIZATION TO RELEASE
PROTECTED HEALTH INFORMATION (PHI)

I, _____________________________________, hereby revoke my consent to
participate
in the “Pregnancy and Mood Study” at Loyola University Health System. I also revoke
my consent to release information I provided to LUHS or allowed LUHS to use and
disclose my information to Loyola University Chicago as outlined in the consent form,
which I signed on _______________. I understand that this revocation does not apply to
any action LUHS has taken in reliance on the consent I signed earlier.

___________________________________

______________________

Patient Name or Personal Representative

Date

Please return this form to:

Mary Byrn, RN
Professor, School of Nursing
Building 105, Room 2840
Loyola University Health System
2160 South First Avenue
Maywood, Illinois 60153
mbyrn@luc.edu
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Self-Report Questionnaire Missing Data
ID#
142
68
56
68
125
73
56
54
102
135
87
91

Tool and Item
CESD #4
CESD #10
MDPSS #5
STAI #16
STAI #16
STAI #35
STAI #36
PSS #1
PSS #2
PSS #4
PSS #7
PSS #10

Individual Mean
2.5
1.5
5.09
2.33
2.56
2.38
2.1
1.56
2.44
3
2
2.33

Group Mean
3.11
1.45
6.25
2.97
2.97
1.44
3.01
1.81
1.5
2.78
2.64
1.36

EMR Missing Data
Variable
Height
One hour OGTT
Status of ruptured membranes
Apgar score at 1 min
Apgar score at 5 min
Apgar at 10 min
Infant birth weight
Infant birth length

Number of Missing Items
1
6
18
6
6
20
10
18

Replaced
3
2
5
2
3
2
2
2
2
3
2
2
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ID
2
3
11
16
36

39
56
58
64
70
72
74

76
78
82
90
91
93
95
99

101
105
106
107
110

Notes
Induction of Labor (IOL) said no on template and yes in note, entered yes.
Operative note says 1st degree perineal tear, template says 2nd degree, entered 1st
degree.
LMP: 5/2/10 on template and 7/8/09 in note. Used the one in note. Delivery on
template said vaginal, note said vacuum. Entered vacuum.
IOL said no on template and yes in note, entered yes.
Template says cesarean section delivery and clear membranes and note says vacuum
and meconium membranes. Vacuum and meconium entered. Laceration says none
on template and 2nd degree in note. Entered 2nd degree.
Templates says no to induction, note says yes. Entered yes for induction.
No diagnosis of GDM in list, but diagnosis in note. Entered GDM has a diagnosis.
No diagnosis of GDM in list, but diagnosis in note. Entered GDM has a diagnosis.
Template has induction as yes, but note says no. Entered no (patient was only 34
weeks).
Template has no for induction, but note says yes. Entered yes. Template has
epidural, note has combined spinal/epidural. Entered combined spinal/epidural.
Note has preeclampsia, but not in diagnosis list. Entered it has a diagnosis.
Note has combined spinal/epidural, but template has epidural. Entered combined
spinal/epidural. Note has no LMP and has pregnancy due to IVF. IVF entered in
diagnosis list.
Oligohydramnios entered in note but not in template, put it in the diagnosis list.
Template has vaginal delivery, but note has Vaginal Birth after Cesarean (VBAC).
VBAC entered.
Template has no tears, note has bilateral labial tears. Labial tears entered.
Template has G:2, note has G5. Entered G5 because on self-report patient wrote G5.
Template has G:3, note has G2. Entered G3 because on self-report patient wrote G3.
Anesthesia on template had spinal/epidural, note had epidural. Entered epidural.
Anesthesia on template had epidural, note had spinal/epidural. Entered
spinal/epidural
Template says NSVD, note says vacuum. Entered vacuum.
Diagnosis of GDM in chart, but not on active problem list. Entered GDM has a
diagnosis. Also, epidural in template but spinal/epidural in note. Entered
spinal/epidural.
Diagnosis of GDM in chart, but not on active problem list. Entered GDM has a
diagnosis.
Diagnosis of GDM in chart, but not on active problem list. Entered GDM has a
diagnosis.
Diagnosis of pre-eclampsia in note but not in active problem list. Entered it into
active problem list.
Induction says no on template, yes in note. Entered yes.
Template has epidural and note has combined spinal/epidural. Combined
spinal/epidural entered.
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111
114
124

126
135

139
141
145
146
149
150

151

152

Diagnosis of GDM in chart, but not on active problem list. Entered GDM has a
diagnosis.
Diagnosis of pre-eclampsia in chart but in active problem list. Entered preeclampsia
as diagnosis.
Note has c-section with vacuum assist and template only has c-section. C-section
with vacuum entered. Also, template has epidural and note has combined
spinal/epidural. Entered combined spinal/epidural.
Template has yes for induction, note does not have induction. Entered no for
induction.
Delivery weight missing. Looked in anesthesia note at time of delivery. Note says
patient current weight is 262, however last weight on flow sheet was 164. Entered
164 as weight at delivery. Diagnosis of depression in note but not in diagnosis list,
entered depression in diagnosis list.
Template has no for induction, note says yes. Entered yes.
Template has LMP as 4/10/11, this date is incorrect since we have not had this date
yet. LMP in the note says uncertain, possibly 4/7/10 and therefore it was left blank.
Template has spinal and note has spinal/epidural. Entered spinal/epidural.
Template has NSVD, note has VBAC. VBAC entered.
Depression and oligohydramnios in note not in diagnosis list, entered them into
active problem list.
Template has spinal, note has spinal/epidural for anesthesia type. Entered
spinal/epidural. Note has G4, P2002. Note has G3. G3 entered because that makes
sense with P2002.
No diagnosis of GDM in active problem list, but diagnosis in note. Entered GDM as
diagnosis in APL. Epidural in template, combined spinal/epidural in note. Entered
spinal/epidural.
Template has 1st degree tear, note says no tears. No tears entered.
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Assumptions for Independent t-tests
Assumption
Normal distribution
Interval data
Homogeneity of
variance
Independence

Description
The sampling distribution is normal.
Data should be measured at the interval level, at least.
The outcome variable (depression) should be the same for each
group (GDM vs no GDM).
Data from groups (GDM vs no GDM) are independent of each
other.

Normal Distribution Tests
Test

Description

Skewness

Measure of symmetry. In a normal sample this score
is zero.
Degree to which scores group together at either end.
In a normal sample this score is zero
To determine if the distribution deviates from a
similar normal distribution. These tests compare the
scores to a sample with normally distributed scores
(with the same mean and standard deviation). If the
test is significant (p < .05) the distribution is different
from a normal distribution and the assumption of
normality is not met.

Kurtosis
KolmogorovSimirnov
Shapiro-Wilk

CES-D EPDS
Result Result
1.32
1.11
1.67

.80

p<
.001
p<
.001

p<
.001
p<
.001
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Multiple Regression Assumptions
Assumption
Variable types

Non-zero variance

Multicollinearity

Predictors
uncorrelated with
external variables

Homoscedasticity

Independent errors

Normally distributed
errors
Independence

Description
Quantitative means the variables
should be measured at the interval
level, at least. Unbounded is
defined as the variability having
no constraints (the range of scores
spans the entire scale for that
measure).
Predictor variables should have
variation (do not have a variance
of zero).
Predictor variables should not be
highly correlated.

External variables are variables
that have not been included in the
analysis but are related to the
outcome variable. Therefore
external variables should not be
correlated with predictor
variables.
Residuals of each predictor
variable should have the same
variance.
Residuals between two
participants should be
uncorrelated

Assumption Met
Met based on the description.

Met after review of
descriptive statistics.
Met after review of
correlation matrix, there
were no variables highly
correlated (r>.90) and all
variance inflation factors less
than ten.
Met after review of the
literature and correlation
results did not suggest other
variables to be correlated to
depression.

Met after review of Levene’s
test.
Met based on the Durbin
Watson statistic. Durbin
Watson value was 1.94 and a
value less than one or greater
than three indicates this
assumption has not been met.
Met; the means of the
residuals equals zero.

Residuals are random, normally
distributed, and have a mean of
zero.
All values of the outcome variable Met based on data collected
come from separate participants,
from separate participants at
and therefore are independent of
one time point
each other.
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Met based on definition of
Linearity The relationship in the model is
linear.
assumption.
Note: Assumptions and descriptions are from Field, 2009.
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Author
Dayan et al.
(2006)
Diego, Field,
&
HernandezReif (2005)
Glazier et
al., (2004)
Hart &
McMahon,
(2006)
Holzman et
al. (2006)

Sample
Size
681

Mean Age

Ethnicity/ Race

Income

Marital Status

Findings

28.5

Unknown

Unknown

89% married

80

27

Unknown

64% married

2,052

30.7

46% Hispanic
27% Black
16% White
11% Asian
Unknown

Age and marital status not related to
depression.
Age, marital status, and race not
related to depression.

89.7% married

53

31.24

Unknown

35.6%
>$70,000
Unknown

1,321

15% <20
69% White
56% 20-29 25% African
29% >30
American
6% Other
25
32% African
American
31% Hispanic
15% White
10% African
7% Native
American
29.5
77% White
13% Black
10% Other

Kim et al.
(2006)

154

Lindgren,
(2001)

252

94% married

Age and income related to
depression.
Age not related to depression.

54%
Medicaid

52% married

Teens and disadvantaged more likely
to be depressed.

Unknown

62% married

Marital status related to depression.

44% <
$30,000
56%
>$30,001

72% married

Age, marital status, and income
related to depression. Minority
women had higher depression scores
(not indicated if significant).
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Marcus et al.
(2003)

3,742

28.6

Orr et al.
(2006)

1163

20% <20
years

73% White
13% African
American
6% Asian
American
2% Hispanic
3% Other
70% Black
30% White

Rubertsson
et al. (2005)
Steer et al.
(1992)

2,674

Unknown

Unknown

712

Sleath et al.
(2005)

73

323 teens
(mean age
15.0)
389 adults
(mean age
21.59)
23.6

Westdahl et
al. (2007)

1,047

20.42

Unknown

74% married

Marital status related to depression,
age and race not related to
depression.

68%
Medicaid
6%
Uninsured
Unknown

44% married

Age, race, and marital status related
to depression.

Unknown

62.2% Black
28.6% Hispanic
18.5% White

Unknown

11% married

Age and marital status related to
depression.
Age related to depression.

25% White
25% African
American
23% Hispanic
80% African
American
13% Hispanic
7% White

Unknown

Unknown

Race not related to depression.

Unknown

70% in
relationship

Age and marital status related to
depression.
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